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Part One 
 
 
 
 
SYNTHESIS AND ANTIOXIDANT PROPERTIES OF 
VITAMIN B6 DERIVATIVES 
 
 
 
 
 
 
 
 
 
CHAPTER I 
 
 
INTRODUCTION 
 
 
Lipid Peroxidation 
 It is common knowledge that vegetable oils and animal fats turn rancid 
upon prolonged storage. This phenomenon, which we now associate with lipid 
peroxidation processes, could not have been explained until the first half of the 
20th century, when pioneering  studies on isolation of fatty acid components from 
oils and fats were conducted.1, 2 About 70 years ago, it was established that 
addition of molecular oxygen to polyunsaturated fatty acids (PUFAs) yields 
conjugated hydroperoxides as the primary oxidation products.3, 4 More and more 
detailed studies on mechanisms ruling PUFA autoxidation were conducted since 
the 1960’s, when new analytical instrumentation techniques, such as GC-MS and 
LC-MS, became available. In the early 1980’s, the formation of complex 
hydroperoxide products from PUFAs was explained on the basis of 
thermodynamic equilibration of participating radical species.5-7 
Due to the progress in medical and biochemical sciences over last few 
decades, the importance of lipid peroxidation in human health has also been 
revealed. The process has been associated with a number of diseases, among 
which the most extensively studied were: atherosclerosis, diabetes, cancer and 
neurodegenerative disorders, such as Alzheimer’s and Parkinson’s disease.8-12  
As a consequence of the discovery of the bio-relevance of lipid oxidation,         
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the field became interdisciplinary and our knowledge of the topic has quickly 
expanded since.  Figure 1.1 shows the increase in research attention to lipid 
peroxidation over last 5 decades, based on the number of relevant references 
input into a scientific database (SciFinder).13 Recently, a tremendous amount of 
publications have been focused on oxidation of PUFAs and their derivatives in 
various in vivo settings.14-16 The establishment of mechanistic foundations on   
the formation of biologically active lipid derived oxidation products is a desirable 
goal in current area of lipidomics. Another important part of research is directed 
towards development of an effective method for inhibition of lipid peroxidation     
in vivo (vide infra). 
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Figure 1.1. Increase in research attention on lipid peroxidation over the last 50                
years.13  
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Atherosclerosis, defined as progressive narrowing and hardening of 
arteries leading to increase risk of heart attack and stroke, is the single most 
important cause of death in the United States.17 The condition has been 
correlated with abnormal transport of cholesterol in the body. Cholesterol,         
an important cell membrane component and precursor of many hormones, is 
transported from the liver to cells at various locations with a help of lipoprotein 
particles, serving as carriers for this water insoluble molecule.18  Human blood 
plasma lipoproteins are classified with respect to their increasing density: 
chylomicrons (CM), very-low density lipoproteins (VLDL), low density lipoproteins 
(LDL), intermediate density lipoproteins (IDL), and high density lipoproteins 
(HDL). All of these different lipoprotein classes play various roles in cholesterol 
transport and metabolism. However two of them, commonly referred to as good 
(HDL) and bad (LDL) cholesterol, have attracted most of the attention of human 
health specialists, due to their involvement in development of cardiovascular 
diseases.19 HDL is responsible for cleaning up arteries from cholesterol 
molecules that have been released from decomposed cells and membranes.  
LDL, on the other hand, is a major cholesterol transporter, which under some 
conditions was found to fail serving its function.  Elevated plasma level of LDL 
(>1.3 g/L) and decreased concentration of HDL (<0.35 g/L) indicate increased 
tendency for development   of atherosclerosis and other cardiovascular diseases 
by an individual.20 
An average LDL particle, as shown in Figure 1.2, has molecular weight of 
2500 kDa, a diameter of 22 nm, and a volume of 4x10-21 L.21, 22 The neutral core 
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of this dynamic micellar system consists of triacylglicerols and cholesteryl esters 
(ca. 900), whereas the polar coat layer is built out of phospholipids and 
unesterified cholesterol molecules (ca. 600). Sample structures of the fatty ester 
constituents of LDL are presented in Figure 1.3. The cholesteryl esters found in 
LDL predominantly contain PUFA residues (arachidonate or linoleate) in their 
structures, whereas outer coat phospholipids may additionally include more 
saturated fatty acid residues.23 The exact composition of LDL is dependent on 
the fatty acid composition of the diet.24 The most common fatty acid precursors of 
the ester components found in LDL are presented in Figure 1.4. 
 
 
 
Figure 1.2. Schematic representation of an LDL particle.22 
 5
Inside the core as well as in the outer layer of the LDL, there are also 
antioxidant molecules present that help to spare LDL from oxidative 
modifications.21 This issue is however addressed separately in the next section of 
this chapter. 
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Figure 1.3. Classes of esterified fatty acids found within an LDL particle. 
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An important ingredient of the LDL structure is the Apo B-100 protein. This 
biopolymer containing 4536 amino acid residue is anchored to the outer layer of 
the particle and serves as a recognition site for LDL receptor proteins located on 
various target cells. Upon recognition, a fusion of the LDL and the target cell is 
observed, followed by a degradation of the protein and release of cholesterol into 
the cell.23 
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Figure 1.4. Structures of fatty acid residues found in an LDL.  
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It has been found that upon modifications to Apo B-100 (either due to       
a free radical attack or as a result of adduction to lipid peroxidation derived 
electrophiles), the oxidized lipoprotein is no longer recognized by its typical 
acceptors, but instead it is recognized by scavenger receptors on arterial 
macrophages (Figure 1.5).25 Initially serving a protective role by taking up 
oxidized LDL, macrophages become foam cells upon accumulation of large 
quantities of modified LDL.26 These foam cells are responsible for formation of 
fatty streaks on the internal walls of arteries. This process is recognized as       
an early hallmark of atherosclerosis.  
 
 
 
Figure 1.5. Schematic representation of the fate of oxidized LDL in artery.25 
 
Under free radical attack, the main LDL associated targets for oxidative 
damage are the unsaturated fatty acid hydrocarbon chains, such as those 
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presented in Figure 1.4.  Mechanistically, oxidation of these fatty acids is a free 
radical chain process consisting of initiation, propagation and termination steps 
(Scheme 1.1).27 
 
Termination
Propagation
Initiation
In + RH InH + R
R + O2 ROO
ROO + RH R + ROOH
2ROO non-radical products
(1)
(2)
(3)
(4)  
 
Scheme 1.1. Free radical chain in the autoxidation of lipids. 
 
In vivo, the radical chains are initiated by reactive radical species that 
either escape from their normal sites of operation or are produced as a result of 
some pathogenic mechanisms.28 In the laboratory set up, however, thermally 
activated azo-initiators are used as they provide a constant flux of radicals. 
Readily available radical initiators, commonly employed for kinetic studies 
conducted on lipid peroxidation are: 2,2’-azobis(2,4-dimethylvaleronitrile) 
(AMVN),  2,2’-azobis(2,4-dimethyl-4-methoxy-valeronitrile) (MeOAMVN), 2,2’-
azobis(2-amidinopropane) dihydrochloride (AAPH) and 2,2’-azobis(2-(2-
imidazolin-2-yl)propane) dihydrochloride  (AIPH).29 Structures of these 
compounds are given in Scheme 1.2. AMVN and MeOAMVN are soluble in lipid 
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layer and non-polar organic solvents whereas AAPH and AIPH are considered 
water soluble, and are used typically for oxidations in aqueous buffers.  
All azo-initiators undergo thermally induced breakage of C-N bonds 
yielding gaseous nitrogen and carbon centered radicals that react with oxygen, 
with a diffusion controlled rate, to form peroxyl radicals (Scheme 1.2). Thus 
formed initiator derived peroxyl radicals initiate lipid oxidation by hydrogen atom 
abstraction from the weakest C-H bonds of the lipid hydrocarbon chains (Eq. 1).30 
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N NR R R
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Scheme 1.2. Commonly used free radical azo-initiators. 
 
 The propagation element of the free radical process involves two steps. 
First is a radical coupling between lipid derived carbon centered radical and 
molecular oxygen, which has a partially free radical character, yielding lipid 
peroxyl radical (Eq. 2). This step typically occurs at the diffusion controlled rate of 
ca. 109 M-1s-1.31   A second propagation step, consisting of a hydrogen atom 
transfer from the lipid hydrocarbon skeleton to the peroxyl radical (Eq. 3), is 
much slower. Its rate depends predominantly on the strength of the bond being 
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broken, which itself is a function of the stability of the carbon centered radical 
formed in this process. Therefore, abstraction of a bisallylic hydrogen atom      
(ca. 60 M-1s-1) is much faster than abstraction of an allylic analogue (ca. 1 M-1s-1), 
which is itself much faster than formation of a localized carbon centered radical 
(ca. 10-3 M-1s-1).  As a result only compounds containing bisallylic hydrogens,   
e.g. linoleic and arachidonic acids, in contrast to more saturated lipids, are 
readily oxidizable at room temperature.30 
 Besides the two aforementioned radical chain propagation types, a radical 
coupling (Eq. 2) and an atom transfer (Eq. 3), other reactions, such as 
fragmentations, rearrangements and cyclizations have also been observed 
during oxidations of lipids (Scheme 1.3). Since the hydrogen atom transfer from 
lipid hydrocarbon chains to a lipid peroxyl radical is a relatively slow process,    
the later compound may decompose to reform carbon centered radical and O2      
(Eq. 5). This so called β-fragmentation occurs readily if the radical product is 
stabilized. The process has been studied extensively using methyl linoleate as     
a substrate for autoxidation, however rates of β-fragmentation of peroxyl radicals 
derived from other lipids are also available.7, 32, 33 Moreover, if β-fragmentation 
occurs, the solvent caged pair of oxygen and delocalized carbon centered radical 
may undergo a rearrangement to form a peroxyl radical that is different from     
the substrate (Eq. 6). Lastly, peroxyl radicals may undergo cyclization reactions 
forming 5- and 6-membered endoperoxide rings (Eq. 7).  The process involving 
arachidonic acid derived peroxyl radicals has been studied extensively, 
especially since the cyclic products obtained were found to have very high 
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biological activity.34-36 Peroxyl radicals produced from other PUFAs and the cyclic 
products derived from such species  are currently being investigated.37-39   
 
(5)
(6)
Fragmentation
Rearrangement
Cyclization
ROO R + O2
O O OO
O
O
OO OO
O
O
O2
(7)
 
 
Scheme 1.3. Additional propagation reaction types in autoxidation of lipids.  
 
 Termination of the radical chain occurs generally via coupling of two 
peroxyl radicals to form non-radical products (Eq. 4). Typically the two radicals 
combine to form a tetroxide intermediate, which further decomposes through      
a  6-membered ring transition state to give a molecule of oxygen, an alcohol and 
a ketone or aldehyde (Scheme 1.4).40 This reaction, called Russell termination, 
occurs readily unless the two interacting species are both tertiary peroxyl 
radicals. Alternatively, the radical chain process can be terminated in the reaction 
of the chain carrying radical with a scavenging antioxidant.  
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Scheme 1.4. Russel termination mechanism for chain carrying peroxyl radicals. 
 
Natural and Synthetic Antioxidants 
For aerobic organisms, molecular oxygen is a vital substance but also      
a lethal toxin. The main drawback of efficient aerobic catabolism is oxidative 
damage to important endogenous molecules, i.e. DNA, proteins, carbohydrates 
and lipids. Oxidative modification of these important molecules can lead to          
a series of mutations, cell damage or apoptosis. In order to minimize                
the damage, biological systems have developed antioxidant defense 
mechanisms which neutralize and/or prevent the formation of reactive oxygen 
species (ROS), produced from molecular oxygen.41 
 One electron reduction of molecular oxygen yields superoxide radical 
anion (O2•-), which can be further converted into uncharged hydrogen peroxide 
(HOOH). These two ROS together are able to form a potent reducing agent, 
hydroxyl radical (HO•). The reaction between them is very slow in an aqueous 
environment unless it is catalyzed by free transition metal ions. It has been 
commonly accepted that Cu+ or Fe2+ ions acts as catalysts in such 
transformation. Rapid formation of hydroxyl radical catalyzed by Fe2+ is 
historically known as a metal catalyzed Haber-Weiss reaction (Scheme 1.5), 
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whereas the second part of the process alone (Eq. 9) is ascribed to as Fenton 
chemistry.42, 43 More recent studies indicate that other species such as Ni2+, Co2+ 
and Cr5+ also possess the ability to catalyze hydroxyl radical formation.44, 45 
Another form of a reactive oxygen species is singlet oxygen, formed by energy 
transfer to ground state oxygen from photosensitizers, such as flavin-containing 
compounds. All of these ROS are potentially dangerous to cellular components, 
however special precautions apply to HO• since it has the highest reactivity of all 
reactive oxygen species. No specific antioxidant mechanism against hydroxyl 
radical is known, therefore prevention of the production of this ROS is favored.46 
 
Fe3+ + O2 Fe2+ + O2
Fe2+ + HOOH Fe3+ + HO + HO (9)
(8)
 
 
Scheme 1.5. Formation of hydroxyl radicals via the metal-mediated Haber-Weiss 
reaction.43 
  
 The specialized natural antioxidant mechanisms of action can be 
separated into four categories: prevention, diversion and neutralization, 
scavenging, and quenching (Table 1.1).46 Structures of selected naturally 
occurring non-enzymatic antioxidants are shown in Figure 1.6.  
Prevention can be attributed to proteins that are able to bind transition 
metal ions preventing Fenton chemistry. Transferrin and ferritin bind Fe2+ while 
Cu2+ is bound by caeruloplasmin. The dismutation process relies on enzymatic 
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conversion of superoxide radical anion into HOOH and molecular oxygen. This 
reaction is catalyzed by superoxide dismutase enzyme (Eq. 10). Diversion of 
HOOH into H2O in the presence of enzymes, catalase (Eq. 11) and glutathione 
peroxidase (Eq. 12), is another safe and efficient antioxidant mechanism.         
The oxidized form of glutathione (GSSG) is then recycled by another enzyme, 
glutathione reductase (Eq. 13). This efficient co-operative system effectively 
diverts the potentially harmful reactive oxygen species into water (Scheme 1.6).46 
 
Table 1.1. Types of naturally occurring antioxidants.46 
Type Action Example 
Prevention Protein binding/ 
inactivation of metal ions 
Transferrin, ferritin, 
caeruloplasmin, albumin
Enzymatic diversion/ 
neutralization 
Transformation of ROS 
into harmless products 
Superoxide dismutase, 
catalase, glutathione 
peroxidase 
Scavenging Sacrificial interaction with 
ROS by expendable 
substrates 
Ascorbic acid, uric acid, 
bilirubin, glutathione, α-
tocopherol, ubiquinol-10 
Quenching Absorption of electrons 
and/or energy 
α-Tocopherol, β-
carotene, lycopene 
 
Scavenging usually involves small molecules which react with primary 
ROS or secondary reactive molecules such as lipid peroxyl radicals. In humans, 
the most common endogeneous radical scavengers are water soluble uric acid, 
bilirubin, and glutathione as well as hydrophobic α-tocopherol (α-TOH) and 
ubiquinol-10 (CoQ10H2).  Some of these species can be recycled, whereas others 
have to be replaced de novo. Another important water soluble radical scavenger 
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is ascorbic acid (AscH). Together with uric acid, this dietary supplement is among 
the most highly abundant antioxidants in human plasma and tissues. 47, 48 
Quenching is an ability to prevent singlet oxygen formation by competitive 
energy adsorption from photosensitizers. Plant derived carotenoids, lipophilic 
compounds possessing a large number of conjugated double bonds in their 
structures, were found to be highly effective quenching antioxidants.46 
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Figure 1.6. Structures of selected naturally occurring antioxidants. 
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These diverse and coordinated antioxidant mechanisms are effective but 
not infallible. The radical theory of aging states that organisms age as a result of 
ROS induced damage to cellular components.49 In order to minimize                
the damage, nutritional supplementation of a diet with natural antioxidants has 
been suggested as a reasonable strategy.50-52 Additionally, extended research 
has been conducted to produce synthetic antioxidants able to reduce the rate of 
the oxidative damage even more profoundly.53-56 Such compounds could be 
especially useful for treatment of some serious medical conditions, with which 
development and/or progression of lipid peroxidation has been associated      
(vide supra).  
 
2 H2O2 2 H2O + O2
(10)2 O2 + 2H+ HOOH + O2
2 GSH + H2O2 GSSG + 2 H2O
GSSG 2 GSH
(11)
(12)
(13)
Superoxide dismutase:
Catalase:
Glutathione reductase:
Glutathione peroxidase:
 
 
Scheme 1.6. Enzymatic diversion of reactive oxygen species into water. 
 
Although there is some interest in mimicking ROS neutralizing and metal 
chelating properties of enzymes by small molecules, 57-59 synthetic compounds 
able to scavenge free radical chain oxidation reactions have attracted most of   
the attention in the scientific community. This has been partially due to the fact 
that some of the chain breaking antioxidants may serve as ROS neutralizing 
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agents, and sometimes also as metal ion chelators.60, 61  On the contrary, only     
a group of radical scavengers is able to terminate chain oxidation processes that 
have been already initiated.   
An introduction of a scavenging antioxidant into the environment of          
an ongoing lipid peroxidation effectively quenches the propagating step via 
hydrogen atom transfer from the antioxidant to a chain-carrying peroxyl radical 
(Eq. 14). Thus formed antioxidant derived phenoxyl radical usually reacts with     
a second lipid peroxyl radical to form non-radical products (Eq. 15). Rate 
constants of the chain propagation (Eq. 3) for polyunsaturated lipid substrates 
are rather slow (vide supra), while  the  chain  breaking  rate constant (kinh) for   
α-TOH,  the best  natural scavenging  antioxidant,  is undeniably greater         
(ca. 3.5 × 106  M-1s-1).32 Judging by the difference between rate constants of 
these two reactions, and the [LH]/[α-TOH] ratio in LDL of ca. 160 to 1, one could 
suspect that this micellar complex is greatly overprotected against peroxidation. 
This was however found not exactly  to be the case.62 
Experiments in which LDL particles, isolated from human blood plasma, 
were oxidatively modified (either by Cu2+ or a water soluble azo-initiator) showed 
that relatively little LOOH was formed until α-TOH had been consumed.63 On    
the other hand, very poor correlation between [α-TOH] in LDL and the duration of 
the induction period preceding lipid peroxidation was found.64 Furthermore, under 
mild radical flux conditions α-TOH depleted LDL was practically resistant to 
peroxidation comparing to native LDL particles.65 That observation led to the 
conclusion that α-TOH, which serves a crucial antioxidant function during severe 
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oxidative stress, is also capable of promoting oxidation under milder conditions. 
The pro-oxidant behavior of α-TOH, associated with its ability to catalyze phase 
as well as radical chain transfer processes, is referred to as tocopherol mediated 
peroxidation (TMP) since α-TOH derived phenoxyl radical (α-TO•) initiates radical 
chains by abstraction of a hydrogen atom from lipid residues.21 An analogous 
process, but generalized to all phenolic radical scavengers (Eq. 16) is commonly 
ascribed as an antioxidant mediated peroxidation (AMP). Although the rate of  
the TMP (kTMP) is not greater than 0.1 M-1s-1, the reaction can be efficient since      
the competitive chain termination reactions occur with extremely low frequency 
due to the restricted size of the LDL particle.62 
 
ArOH + LOO ArO + LOOH (14)
kinh
ArO + LOO non-radical products (15)
ArO + LH ArOH + L (16)
kAMP
ArOH + O2 ArOH + O2 (17)
ArOH + LOOH ArO + LOH + OH (18)  
 
Scheme 1.7. Ambivalent, pro- and antioxidant behavior of phenolic antioxidants. 
 
It has been proposed that phenolic compounds having lower O-H bond 
dissociation energies (O-H BDEs) than α-TOH should induce less AMP and react 
faster with lipid derived peroxyl radicals, and hence be better antioxidants than  
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α-TOH.23 Since the O-H BDE is a measure of stability of phenoxyl radicals 
formed upon hydrogen atom donation, compounds characterized by lower BDEs 
are desired because they give up hydrogen atoms quicker and produce more 
stable radicals that are less likely to react via AMP. Experimental data confirmed 
the prediction that an increase in the ring electron density caused by electron-
donating ortho- and para- substituents of phenols increased their O-H BDEs and 
enhanced antioxidant properties of these molecules.66, 67 Unfortunately, some of 
them were found to be very unstable upon exposure to the atmosphere.68, 69  Air-
stability of a phenolic antioxidant is related to its ionization potential (IP), defined 
as the ease in giving up a single electron to another molecule, oxygen in this 
case (Eq. 17). The lower the IP value, the easier an antioxidant becomes ionized, 
and hence the more likely it loses its valuable properties with a simultaneous 
production of reactive superoxide as a byproduct. Moreover, a low IP value for   
an antioxidant may result in its reactivity with LOOH via Fenton-like mechanism, 
leading to formation of extremely toxic hydroxyl radical (Eq. 18).  
Since O-H BDE depends mostly on resonance π-interactions with ortho- 
and para-substituents, while IP is a result of σ-induced ring electron density, it 
was proposed that incorporation of nitrogen atom into an aromatic ring of phenol 
should increase the IP value significantly and at the same time only slightly 
increase the O-H BDE of the pyridinol molecule. According to physico-chemical 
calculations, for any given electron donating group (ERG) substitution pattern,     
a pyridinol (PyrOH) possesses significantly higher IP and only slightly increased  
O-H BDE in comparison with an analogous phenol.70 For example,                
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2,4,6-trimethylphenol has an IP = 178.3 and BDE = 80.4, while 2,4,6-
trimethylpyridin-3-ol has IP = 186.3 and BDE = 81.1 kcal/mol. Indeed, it has been 
found that for a series of substituted 3-PyrOHs, the relevant properties measured 
empirically matched closely with the calculated predictions.71  
Analyzing the ERG substitution patterns for 3-PyrOHs, it was shown that 
2,4-dimethyl-4-dimethylamino substitution was the most efficient one (Table 
1.2).70 It should be emphasized that introduction of 4-amino substituent offers 
additional adventage. It enables control of lipophilicity for antioxidant molecules 
by adjusting the lengths of N-alkyl chain(s). Partition between aqueous and lipid 
layers is an important factor in designing biologically active molecules and it will 
be addressed later in the text.  It is also worth mentioning that a vacant 5-position 
of the aromatic ring raises a possibility of constructing a second ring adjacent to 
main aromatic ring. Given the opportunity, few potentially highly active bicyclic 
structures were synthesized and their properties have been measured.23  
 
Table 1.2. The computational BDE and IP values for selected pyridinols.70  
Generic Structure R1 R2 BDE IP 
H H 88.2 206.4 
H Me 85.4 196.6 
Me Me 81.1 186.3 
H OMe 82.0 186.1 
Me OMe 78.1 177.4 
H NMe2 77.0 164.6 
 
 
Me NMe2 73.5 157.7 
N
OH
R1R1
R2
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Based on the calculations and preliminary experimental results presented 
above, a number of water soluble (1-3) as well as lipophilic (4-7) compounds 
containing 2-amino-5-pyridinol moiety have been synthesized (Figure 1.7).  
 
 
 
Figure 1.7. Powerful pyridinolic chain breaking antioxidants. 
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The pyridinols have then been tested in non-polar homogeneous solutions 
(1-3) and in aqueous LDL suspensions (4-7) in order to measure their antioxidant 
behavior by several available techniques. The experimental results confirmed 
that these novel compounds were excellent hydrogen atom donors toward 
peroxyl radicals and thus very good oxidation inhibitors. The inhibition rate 
constants (kinhs) for PyrOHs 1, 2 and 3 were found to be 5, 28 and 88 times 
greater than the corresponding value ascribed to α−TOH.71 The studies also 
revealed that electron transfer from the PyrOHs to molecular oxygen (Eq. 17) 
occurs as electron density in the ring increased, but the rates for the process in 
an aprotic organic solvent were not as significant as corresponding rates for 
highly electron-rich phenolic compounds presented in the literature.23, 68, 69, 71   
The most unstable pyridinol 3 decayed for ca. 20% over a period of 3h in                   
t-butylbenzene at 37oC.23 
 Human LDL particles supplemented with lipophilic compounds 4-7 and 
subjected to water soluble radical initiator AIPH, have been efficiently protected 
against oxidative damage until vast majority of PyrOH molecules was consumed. 
Additionally, antioxidant consumption studies revealed that α-TOH, a native LDL 
component, was spared until PyrOH was severely depleted from                     
the lipoprotein.23, 72 These observations may indicate that indeed, PyrOHs 
scavenge peroxyl radicals much faster than α-TOH, and promote much less 
oxidation via AMP processes.  In these studies, the best antioxidant performance 
was ascribed to pyridinol 5, as it has protected LDL most efficiently. Compounds 
4 and 6 were also found to be relatively good radical scavengers, whereas     
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PyrOH 7 did not serve its designated function well, since it was readily depleted 
(ca. 3 times faster than compound 5).23 This happened most likely via electron 
transfer mechanisms (Eqs. 17 and 18), due to a relatively high IP value 
associated with antioxidant 7. Overall the novel pyridinols 1-6 were shown to 
possess high antioxidant potential against lipid peroxidation. 
 It should be also mentioned, that during the time the research presented in 
this thesis was conducted, some of the 2-amino-5-pyridinols presented herein 
were tested as potential inhibitors of prostaglandin H2 synthase enzymes.73 
Indeed, they were found to be reversible inhibitors of peroxidase sites of           
the enzymes, and therefore could be potentially used as anti-inflammatory 
agents. This, being in agreement with previous observations that 2-substituted 
methylamino-5-(hydroxy or alkoxy)pyridines inhibited leukotriene synthesis and 
therefore could be potentially utilized in treatment of pulmonary,                     
anti-inflammatory, dermatological, allergic and cardiovascular diseases.74 Aside 
from ability to inhibit lipid peroxidation, the above examples of biological activity 
of pyridinols prove that it is an interesting group of compounds which should be 
studied in more details. 
 Another important property of some formal hydrogen atom donors,          
i.e. ability to serve as co-antioxidants in the α-TOH containing systems, has been 
observed during the initial studies that lead to discovery of tocopherol-mediated 
peroxidation. It was found that during oxidative damage to an isolated LDL, 
induced by AAPH or AMVN, the minor lipoprotein associated antioxidant - 
ubiquinol-10 (CoQ10H2) was always consumed prior to α-TOH, and                    
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the disappearance of CoQ10H2 corresponded closely with the onset of rapid 
oxidation phase. Furthermore, in the presence of ascorbic acid (AscH),             
the CoQ10H2 was still consumed first but the oxidation was inhibited until AscH 
was also depleted.75, 76 Since CoQ10H2 is 10 times less reactive toward peroxyl 
radicals than α-TOH, it was expected that it had little or no effect on the lipid 
peroxidation rate.77 Also, water soluble AscH was expected to have little effect on 
the peroxidation rate in AMVN-initiated LDL due to its limited ability to cross 
phospholipid membranes.78 In order to rationalize these observations, three 
mechanisms of action were proposed: radical export, interparticle radical 
transport (Eq. 19) and radical import (Eq. 20).  All of these mechanisms retard 
TMP in LDL by transforming α-TO• back into α-TOH or into non-radical products. 
They can act independently and in co-operative mode, and they are referred to 
as anti-TMP mechanisms (Scheme 1.8).62 
 
α-TO
α-TO α-TOH α-TOH
NRP = non-radical products
or (XH)aq
(X )aq
(X )aq
+ XH + X
(19)
(20)
Radical Export / Transport
Radical Import
NRP
 
 
Scheme 1.8. Radical anti-TMP mechanisms.62 
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Radical export is defined as an irreversible transfer of a radical center 
from an LDL lipid to an aqueous phase. Rapid reduction of α-TO• to α-TOH on 
the surface of LDL by aqueous ascorbate (Asc-)aq could be an example of that 
mechanism (Eq. 21). Transformation of α-TO• into α-TOH in the presence of 
CoQ10H2 is also thought to proceed via this mechanism, the only difference is that 
the radical export occurs indirectly (Scheme 1.9). Since long alkyl chain (ca. 50 
carbon atoms) prevents ubisemiquinone radical (CoQ10H•) from diffusing out of 
the LDL into the aqueous environment, the radical export was proposed to be 
mediated by reduction of molecular oxygen (Eq. 22). Thus obtained superoxide 
radical (HOO•) is highly hydrophilic and therefore it is readily expelled out of the 
LDL particle (Eq. 23).62 
 
 
 
Scheme 1.9. Direct and indirect radical export mechanisms. 
 
The radical import mechanism enhances chain termination via formation 
of non-radical products from LDL-trapped tocopheroxyl radical (α-TO•)LDL.  This is 
achieved by an amphiphilic radical (X•)aq crossing from the aqueous environment 
into the LDL,  whereas interparticle radical transport inhibits TMP by combined 
radical export and radical import mechanisms. In order to effectively act via       
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the latter mechanism, an antioxidant (XH) needs to react readily with (α-TO•)LDL 
yielding antioxidant radical (X•) that diffuses rapidly to another particle and 
terminates rapidly with another (α-TO•)LDL forming non-radical products. The 
effectiveness of several potential natural and synthetic co-antioxidants during 
LDL oxidation, induced by azo-initiators, has been studied extensively.21, 62          
It was found that molecules containing a long alkyl chains in their structures act 
much worse via this mechanism, compared to their short alkyl chains analogues. 
This can be explained by the fact that long alkyl chain of XH retards diffusion of 
X• from the LDL to the aqueous environment disabling formation of non-radical 
products with a second (α-TO•)LDL. Another important observation that quinols, 
catechols and aminophenols used in these experiments were superior              
co-antioxidants with respect to the similar phenolic structures, was explained by 
the fact that, unlike phenoxyl, semiquinone radicals are strongly reducing agents 
that react very rapidly with α-TO•.62 
It can be expected that small, amphiphilic 2-amino-5-pyridinols will act well 
via these anti-TMP mechanisms, especially if the amino-substituent is 
monoalkylated. Of course, N-monoalkylated aminopyridinols are also thought to 
be an efficiently lipid peroxidation inhibitors in the absence of α-TOH, since they 
possess two hydrogen atoms that can be transferred to chain-carrying oxygen 
centered radicals. In fact, belonging to that category PyrOH 5 was found to 
protect LDL from an oxidative damage the most efficiently among the compounds 
tested (vide supra). Large scale syntheses of N-monoalkylated 2-aminopyridin-5-
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ols and evaluation of important properties of these compounds became therefore 
the major target of the project described in the next two chapters of these thesis. 
 
Research Aims 
The Aims of the research presented in Chapter II are: 
1. To establish a general low-cost synthetic method that enables the large 
scale, efficient preparation of N-monoalkylated 2-aminopyridin-5-ols. 
2. To establish a general low-cost synthetic method that enables the large 
scale, efficient preparation of N,N-dialkylated 2-aminopyridin-5-ols. 
 
The Aims of the research presented in Chapter III are: 
3. To evaluate important antioxidant parameters of the various pyridinol 
antioxidants in highly polar environments, such as aqueous buffers. 
4. An evaluation of important antioxidant parameters of the above 
compounds in non-polar environments, such as aprotic organic solvents. 
5. An evaluation of important antioxidant parameters of the above 
compounds in heterogeneous systems, such as liposomal suspensions in 
aqueous buffers. 
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CHAPTER II 
 
 
SYNTHESES OF NOVEL 2-AMINO-PYRIDIN-5-OL BASED ANTIOXIDANTS 
 
 
Introduction 
Even though theoretical calculations and primary experimental results 
confirmed that pyridinols presented in the previous chapter possessed excellent 
antioxidant properties, the studies performed on these compounds were rather 
limited. The number of experiments was constrained mostly due to the lack of    
an efficient method of preparation of these radical scavengers. The key 
hydroxylation step utilized typically proceeded in low yield and required a tricky 
chromatographic purification of the final product. A number of other hydroxylation 
protocols were investigated without success in syntheses of the desired 
compounds.1-5 The method found to be the most efficient relied on                     
the conversion of an aryl bromide into an aryl lithium followed by quenching with 
a nitroarene.6-8 Among the aryl lithium quenching reagents that have been 
utilized, 1,3-dimethyl-2-nitrobenzene gave the most reproducible results, 
therefore it was applied in the preparation of all the compounds presented in     
the previous chapter.1, 9  
The inspiration for an alternative method of preparation of the pyridinolic 
antioxidants came from an article describing the synthesis of a pyridoxamine 
derivative that contained the 2-amino-pyridin-5-ol moiety in its structure.10 
Undoubtedly, the existence of the hydroxyl moiety in the starting substrate is        
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a potentially great advantage of the proposed methodology. The wide availability 
and extremely low price of pyridoxyl hydrochloride (vitamin B6) made it 
additionally attractive as a starting material for organic preparations.11 It was 
therefore decided to establish a large scale procedure for syntheses of selected 
monocyclic (1, 2a-d and 3a-b) and bicyclic (8 and 9) PyrOHs utilizing vitamin B6 
as a starting material (Scheme 2.1). The methodology for syntheses of bicyclic 
antioxidants from vitamin B6 is, however, only briefly mentioned in this chapter 
since it was developed by another group member.12 
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Scheme 2.1. Retro-synthetic scheme for preparation of pyridinolic antioxidants. 
 
 It should be noted that the compounds presented above differ from         
the monocyclic pyridinols for which the antioxidant properties have been 
established (vide supra) by a presence of a methyl group in the 3-position of     
the aromatic ring. This substitution was predicted not to have a significant effect 
on the O-H BDEs of the PyrOHs, therefore not to alter the key properties of these 
radical scavengers. It is also of interest that the imino-pyridinone products of 
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oxidation from these compounds would have blocked or hindered Michael 
acceptor sites (Scheme 2.2).  
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Scheme 2.2. Potentially decreased toxicity of the vitamin B6 derivatives. 
 
In case of N,N-dialkylated pyridinols (3), additional mono-dealkylation by 
cytochrome P-450 or peroxidases is required whereas pyridinols 1 and 2 are 
expected to form imino-pyridinone products even in the absence of these 
enzymes.13, 14 Formation of the products that have inactivated Michael acceptor 
sites may be an important from the toxicological point of view. It is known        
that compounds such as catechols or aminophenols are good radical 
scavengers, 15, 16 but their utility in vivo is limited since they are converted into 
 
  39
toxic quinones or quinone-imines. They apparently react with a variety of protein 
or nucleic acid nucleophiles that results in cyto-toxicity.17-20 
 
Vitamin B6 Derived Precursor for Synthesis of Radical Scavengers 
The first step towards preparation of pyridinols 2 and 3 was                    
the development of the core compound 1, which could be easily converted into 
either N-mono or N,N-dialkylamino products, such as those shown in Scheme 
2.1. So far, compound 1 has been found to be very stable upon prolonged 
storage, therefore it proved to be a convenient key precursor for synthesis of 
theoretically more potent pyridinols 2 and 3.21  
Pyridoxyl hydrochloride was converted into compound 1 in a sequence of 
four basic transformations (Scheme 2.3). Benzylic hydroxyl groups were 
successfully reduced in two steps by conversion to the dichloride (99% yield) 
followed by reduction of the dichloride by zinc and acetic acid (90% yield).22, 23 
Several direct dehydroxylation pathways were also tested, but they did not lead 
to the desired product 5. Instead, high-temperature Wolf-Kishner reduction 
yielded 5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol in approximately 80% yield. 
The same product was quantitatively obtained via direct reaction of pyridoxyl  
hydrochloride with zinc in acetic acid. Although potentially useful in preparation of 
some bicyclic pyridinols or pyridinolic dimers, this partially reduced product did 
not present substantial value in preparation of the key precursor 1.24, 25 
Introduction of the amino group into the 6-position of the aromatic ring was also 
accomplished by a two-step strategy. An azo-coupling followed by 
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heterogeneous catalytic hydrogenation gave satisfactory results leading to 
formation of 6-amino-2,4,5-trimethylpyridin-3-ol hydrochloride (1) in ca. 70% yield 
over four steps from vitamin B6.10 Alternatively, if working with more than 40 
grams of the azo-intermediate, reduction by zinc in acetic acid was preferred as   
a final step yielding key compound 1 in up to 66% overall yield.26 It should be 
noted that large-scale preparation of the base compound 1 was achieved without 
necessity of chromatographic purification. Compounds 4, 5 as well as the product 
1 were all characterized as crystalline materials (especially as corresponding 
hydrochloric salts), therefore they could be easily purifiried via recrystalization    
or precipitation. This advantage has been possible most likely due to                  
an existence of hydroxyl moiety incorporated into aromatic cores of all of these 
compounds, since structurally similar 3-bromopyridines were characterized as 
oils.1,9 Therefore, the utilization of vitamin B6 as a starting material shows 
additional, advantages compared to the previously established routes. 
 
N
OH
HO
HO HCl N
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Cl
Cl HCl N
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HCl N
OH
NH2
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1
4 5
HCl
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Reagents and Conditions: (a) SOCl2, DMF (cat.), reflux, 30min, 99%; (b) 
Zn/AcOH, reflux, 2h, 90%;  (c) PhNH2, NaNO2, H2O, pH 8, 0°C, 1h, 87%; (d)  H2, 
Pd/C, MeOH, rt, 24-48h, 90%; (e) Zn/HCOOH, MeOH, reflux, 3h, 85%. 
 
Scheme 2.3. Preparation of the key compound 1. 
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Preparation of N-Alkylated 2-Amino-5-pyridinols 
 The general three-step strategy leading to preparation of N-monoalkylated 
pyridinols from the precursor 1 has been developed and successfully applied to 
produce compounds 2b-d (Scheme 2.4) in multi-gram scale. Application of N,O-
diacylation reaction followed by selective O-acyl hydrolysis yielded N-(5-hydroxy-
3,4,6-trimethylpyridin-2-yl) amides. These compounds were reduced by borane-
tetrahydrofuran complex (BH3•THF) to give the desired N-monoalkylated 
products.27, 28 An alternative pathway was considered and examined via                
a sample preparation of methylamino-pyridinol 2a. In the two-step strategy, 
preparation of 6-((1H-benzo[1,2,3]triazol-1-yl)methylamino)-2,4,5-trimethylpyridin 
-3-ol (from 1H-hydroxyalkylbenzotriazole and compound 1) was followed by 
reduction of this compound in the presence of sodium borohydride.1, 29, 30 Even 
though both of the reactions in the sequence were almost quantitative, the test 
trials revealed severe problems with separation of the product 2a from               
the reaction mixture. And since this problem could not be solved utilizing 
standard purification techniques, the pathway was abandoned.31 
 
N
OH
HN
2a
N
OH
HN N
N N
6-((1H-benzo[1,2,3]triazol-1-yl)methylamino)-
2,4,5-trimethylpyridin-3-ol  
 
Figure 2.1. A synthetic intermediate for preparation of compound 2a. 
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  Pyridinol 2a could be alternatively prepared based on the reaction 
sequence presented in Scheme 2.4, applying a mixed formic-acetic anhydride in 
the first step.27 This sequence was not pursued, however, due to the availability 
of 2a (ca. 0.5g formed by the alternative method) and the very close structural 
similarity of the compound to 2b.32 
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Reagents and Conditions: (a) RCOCl, 1,2-dichloroethane, reflux, 4h; (b) (AcO)2, 
THF, rt,12h; (c) NaOMe, MeOH, rt, 30-90min; (d) BH3•THF, THF, reflux, 2-3h, 
57-64% (for a-c-d)  or 74%  (for b-c-d).  
 
Scheme 2.4. Preparation of N-monoalkylated pyridinols 2b-d. 
 
The syntheses presented in Scheme 2.4 were repeated at least 3 times 
starting from different amounts of key compound 1 (1, 3 and 5g) in order to 
investigate reproducibility and test if scaling up has any effect on the overall yield 
of products 2b-d. It was found that total yields for compound 6b and 6c were 
consistent within trials (74±1% and 64±1% respectively) regardless of the scale 
of the reaction (within the range given). In case of compound 2b, purification was 
only performed after the last step, whereas during synthesis of pyridinol 2c, 
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purification procedures were applied before and after BH3•THF reduction. This 
strategy was found to give the best yield of PyrOH 2c. Production of compound 
2d was more difficult, and in order to obtain satisfactory purity, a silica gel 
adsorption–desorption technique was applied before and after the final step. In 
that case, the isolated product yield for the three-step process was found to be 
64, 62 and 57% for reactions starting from 1, 3 and 5g of precursor 1, 
respectively.  
It is worth mentioning that all synthetic pathways leading from vitamin B6 
to compounds 2b and 2c did not require use of any separation/purification 
technique other than filtration, extraction, precipitation or crystallization. Exclusive 
use of these simple techniques potentially enables the synthesis to be applied in 
large scale. Although the silica gel adsorption–desorption purification method 
could be potentially scaled up, limited oversized equipment availability prohibits 
increasing the scale of the reaction in a typical academic organic laboratory. 
Furthermore, the time required for purification using silica gel was not optimized 
according to the scale of the reaction. This might be a reason why relatively 
higher standard deviation for total yield of PyrOH 2d was obtained (61±4%). 
 
Preparation of N,N-Dialkylated 2-Amino-5-pyridinols 
 A one-pot reductive alkylation methodology was successfully applied to 
produce N,N-dialkylated derivatives of compound 1 in good yields (Scheme 2.5). 
The Eishweiler-Clark reaction was utilized to synthesize dimethylated pyridinol 3a 
(85% yield), while the N,N-dihexyl derivative 3b was obtained in the reaction of 
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precursor 1 and n-hexan-1-al in the presence of sodium triacetoxyborohydride 
(80% yield).33, 34  
 
N
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N
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NNH2 n-C6H13 n-C6H13
3b3a
1
a) b)
 
 
Reagents and Conditions: (a) HCOOH, HCHO, H2O, reflux, 42h, 85%;               
(b) hexanal, Na(AcO)3BH, AcOH, THF, rt, 6h, 80%. 
 
Scheme 2.5. Preparation of N,N-dialkylated 2-amino-5-pyridinols 3a and 3b. 
 
Antioxidant 3a was conveniently purified via recrystallization, whereas oily 
compound 3b failed to yield crystals (even as a hydrochloric salt) and had to be 
purified chromatographically. The silica gel adsorption–desorption technique, 
used to purify pyridinol 2d, could potentially be applied to efficiently prepare 
larger quantities of compound 3b. However, no such attempt has yet been 
pursued. 
 
Preparation of Naphthyridinolic Antioxidants 
 As already mentioned, bicyclic pyridinols can be prepared from pyridoxyl 
hydrochloride. The applied methodology for synthesis of 2,4-dimethyl-5,6,7,8-
tetrahydro-1,8-naphthyridin-3-ol (7) involved ten steps and gave over 60% overall 
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yield, Scheme 2.6.12 The N-methylated analogue of this antioxidant (8) was 
obtained utilizing a reductive alkylation procedure. The experimental details for 
these preparations will be presented elsewhere.35  
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Reagents and Conditions: (a) Zn, AcOH, reflux, 3 h; (b) 2M HCl in ether, MeOH, 
reflux, 1 h, 93% (for a-b); (c) Ac2O, NaHCO3, H2O, rt, 10 min; (d) NaOCl, 
TEMPO, NaHCO3, CH2Cl2, rt, 1 h, 93% (for c-d); (e) NaH, (EtO)2P(O)CH2CO2Et, 
CH2Cl2, rt, 1 h; (f) H2, 10% Pd/C, EtOH, rt, 3 h, 91% (for e-f); (g) K2CO3, EtOH, rt, 
2 h; (h) PhNH2, 6M-HCl, NaNO2, 2.5M-NaOH, H2O-THF, 0 °C to rt, 1 h, 93% (for 
g-h); (i) Zn, AcOH, reflux, 1 h, 92%; (j) BH3•THF, THF, reflux, 6 h, 93%; (k) 
HCHO, AcOH, NaCNBH3, MeOH, H2O, rt, 2h, 80%. 
 
Scheme 2.6. Synthesis of bicyclic pyridinols 7 and 8 from vitamin B6.12 
 
For the purpose of the investigation presented in the next chapter, 
however, compounds 7 and 8 were prepared from 2,4-dimethyl-1,8-naphthyridine 
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(9), Scheme 2.7. This was due to availability of multiple grams of this bicyclic 
precursor. The completed synthesis involved an improved method for 
hydroxylation of pyridines and naphthyridines utilizing copper-catalyzed coupling 
of iodo- pyridines/naphthyridines with benzylic alcohol as a key step.25, 36 Iodide 
10 was prepared from the substrate 9 in two steps, which involved selective 
reduction of non-alkylated aromatic ring and subsequent electrophilic substitution 
in the remaining aromatic ring. It was found that the key coupling step did not 
work unless the p-amino group was di-substituted. Therefore a protective group 
was typically put on the sp2 nitrogen atom.  
 
N N N N
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N N
BnO
Bn
N N
H
HO
N N
HO
a,b) c,d)
f)
e)
9 10 11
78  
 
Reagents and Conditions: (a) H2, Pd/C, MeOH, rt, 48h; (b) NIS, TFA, MeCN, rt, 
1h, 76% (for a-b); (c) NaH, DMF, rt, 30min; then PhCH2Br, NBu4I, DMF, rt, 12h; 
(d) PhCH2OH, CsCO3, CuI, 90°C, 48h, 35% (for c-d); (e) H2, Pd/C, MeOH, rt, 
48h, 96%; (f) HCHO, AcOH, NaCNBH3, MeOH, H2O, rt, 2h, 78%. 
 
Scheme 2.7. Preparation of naphthyridinols, an alternative route.  
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Introduction of benzyl protecting group was advantageous since it could be 
removed in the hydrogenation step following the copper-catalyzed coupling. 
Compound 7 was prepared from 9 with ca. 26% efficiency over five 
transformations, which is not comparable to the overall yield for the synthesis 
starting from vitamin B6. However, the route presented above was much quicker, 
and its efficiency would most likely be greater if optimization studies were 
conducted. It should be noted that bicyclic PyrOH 7 may be N-alkylated with 
hydrocarbon chains of different length to form compounds of varying lipophilicity. 
However, for the purpose of the investigation presented herein only methylated 
analogue was prepared, Scheme 2.7. 
 
Experimental Section 
General. Unless indicated otherwise, all reactions were carried out under 
an air atmosphere. Zinc dust applied in reduction reactions was activated prior to 
use according to the standard procedure.37 2,4-dimethyl-1,8-naphthyridine was 
prepared from 4,6-dimethylpyridin-2-amine via Skraup reaction.1, 25 Purifications 
by adsorption-desorption and column chromatography were carried out with silica 
gel 60 (230-400 mesh) from EMD Chemicals Inc. Progress of reactions was 
monitored using F254 silica coated TLC plates purchased from EMD Chemicals 
Inc.  Spots were visualized with UV, phosphomolybdic acid or potassium 
permanganate. Unless indicated otherwise, all chemicals were purchased either 
from Acros Organics or Sigma-Aldrich and used without further purification. NMR 
spectra were taken on 300 MHz Bruker instrument. Peaks were calibrated on 
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CDCl3 or DMSO-d6 and reported with respect to TMS. Melting points were taken 
on a Thomas Hoover melting point apparatus and were uncorrected. ESI-HRMS 
measurements (positive ion mode) were performed at Ohio State University or at 
Texas A&M University. Elemental analysis was conducted in Atlantic Microlab, 
Inc. (Norcross, Ga).  
 
4,5-Bis(chloromethyl)-2-methylpyridin-3-ol hydrochloride (4). This 
compound was prepared according to the literature with similar yield and purity.22 
The journal this synthesis has been published in is however rarely available, 
therefore the following detailed procedure was presented. Pyridoxyl 
hydrochloride (100g, 0.486mol) was refluxed in a mixture of DMF (3.7mL) and 
thionyl chloride (370mL, 4.86mol). After 30min the product precipitated out of the 
reaction mixture. Then, it was subsequently filtered and washed with ether 
(2×200mL). Drying under high vacuum yielded a white powder (117g, 99%). Mp 
203-204ºC; 1H NMR (300 MHz, DMSO-d6) δ 8.43 (s, 1H), 5.00 (s, 2H), 4.97 (s, 
2H), 2.65 (s, 3H); 13C NMR (75 MHz, DMSO-d6) δ 152.6, 144.7, 138.7, 133.8, 
132.8, 40.3, 35.3, 15.9; HRMS for C8H10NOCl2+ [M-Cl]+ 205.0056, found 
205.0039. 
 
2,4,5-Trimethylpyridin-3-ol hydrochloride (5). Compound 4 (117g, 
0.482mol) was dissolved in glacial acetic acid (420mL, 4.44mol) and zinc dust 
(98g, 1.5mol) was added in 3 portions. The resulting suspension was well stirred 
under reflux for 2h. The reaction mixture was cooled to the rt, unreacted zinc 
along with insoluble byproducts were filtered off and washed with acetic acid 
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(2×90mL). The filtrate was neutralized with 6M NaOH yielding an orange 
precipitate, which was filtered and washed with a small amount of brine (30mL). 
The orange precipitate was dissolved in 10M HCl solution and an obtained HCl 
adduct was salted out with solid NaCl. The crude product obtained after filtration 
was recrystallized from EtOH – ether system yielding white crystals (76g, 90%). 
Mp 217-218ºC (216ºC lit)38; 1H NMR (300 MHz, DMSO-d6) δ 10.5 (s, 1H), 8.10 (s, 
1H), 2.57 (s, 3H), 2.30 (s, 6H); 13C NMR (75 MHz, DMSO-d6) δ 151.4, 145.4, 
139.6, 136.0, 131.4, 16.4, 14.7, 13.1; HRMS for C8H11NO+ [M-Cl]+ 137.0835, 
found 137.0846. 
 
6-Amino-2,4,5-trimethylpyridin-3-ol (1). In a beaker equipped with a 
mechanical stirrer and pH electrode and immersed in an ice bath, substrate 5 
(76g, 0.44mol) was dissolved in water (850 mL) and the pH of the solution was 
adjusted to 8 with 2.5M NaOH. Diazonium salt, freshly prepared by slow mixing 
of aniline in 6M HCl (40mL, 0.44mol; 450mL) with aqueous NaNO2 (30g, 
0.44mol; 150mL) in ice bath, was added to the substrate solution portionwise 
along with 2.5M NaOH to maintain pH 8. After 1h, a red precipitate that formed in 
the reaction was filtered off and partially dissolved in chloroform. The organic 
solvent was dried over MgSO4, and condensed under vacuum forming dark red 
powder. The powder was partially dissolved in EtOH (400mL), insoluble material 
was removed by filtration and washed with the same solvent (2×75mL). 1M HCl 
solution in ether (500mL) was then added to the combined EtOH solutions in 
order to precipitate orange crystals, which were filtered off and washed with ether 
(2×75mL). Drying under high vacuum yielded a light orange product (104g, 87%). 
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 The orange product (40g, 0.14mol) was dissolved in MeOH (600mL) and 
palladium on carbon (10 wt. %, wet, Degussa type E101 NE/W) was added 
carefully to the solution. The resulting suspension was stirred under hydrogen 
atmosphere (hydrogenation balloon) at rt. After 48h catalyst was filtered off 
through celite and the filtercake was washed with MeOH (2×100mL). Filtrate was 
condensed, the residue was suspended in ether (600mL) and stirred for 1h at rt. 
The product was filtered off, washed with ether (2×50mL) and dried under high 
vacuum yielding 1 as  pale-pink powder (24g, 78% over 2 steps). Mp 242-243ºC 
dec; 1H NMR (300 MHz, DMSO-d6) δ 8.93 (s, 1H), 7.03 (s, 2H), 2.33 (s, 3H), 2.20 
(s, 3H), 2.04 (s, 3H); Anal. calcd. for C8H13ClN2O: C, 50.93; H, 6.95; Cl, 18.79, 
found: C, 50.81; H, 7.06; Cl, 18.84. 
 Alternatively, the light orange azo-compound (100g, 0.36mol) was 
dissolved in a mixture of MeOH (650mL) and formic acid (82mL, 2.2mol) and zinc 
dust (141g, 2.2mol) was added portionwise. After 2h of reflux, the reaction 
mixture changed color from red to dark green and the unreacted zinc along with 
insoluble byproducts were removed by hot filtration and washed with hot MeOH 
(2×125mL). The majority of MeOH was evaporated and the resulting white 
precipitate was filtered off, washed with ether, dried, dissolved in hot water and 
brought to pH 8 with 6M NaOH. Upon cooling the solution, a white precipitate 
formed. The precipitate was filtered off, dissolved in EtOH and filtered through 
silica pad. After solvent removal and drying under high vacuum a pale yellow 
powder (free base form of 1) was obtained (36.3g, 74% over 2 steps). Mp 170-
172ºC; 1H NMR (300 MHz, DMSO-d6) δ 7.41 (s, 1H), 4.84 (s, 2H), 2.15 (s, 3H), 
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2.03 (s, 3H), 1.90 (s, 3H); 13C NMR (75 MHz, DMSO-d6) δ 151.2, 141.2, 140.2, 
134.7, 112.5, 19.3, 13.3, 12.7; HRMS for C8H13N2O+ [M+H]+ 153.1022 found 
153.1024. 
 
6-(Dimethylamino)-2,4,5-trimethylpyridin-3-ol (3a). Free base form of 
pyridinol 1 (5.00g, 32.8mmol) was refluxed for 48 h in a mixture of formic acid 
(12mL) and 36% formalin (12.0mL, 318mmol). Due to the volatility of 
formaldehyde, additional formalin (12.0mL, 318mmol) was added each 12h. 
When all starting material was consumed, the reaction mixture was cooled to rt 
and neutralized with 2.5M NaOH (to pH 8).  The product was then extracted with 
EtOAc, organic extracts were combined, dried over MgSO4 and concentrated 
under vacuum. In order to obtain highly pure material, the crude product was 
recrystallized from benzene yielding white (85%, 5.03g). Mp 138-140ºC; 1H NMR 
(300 MHz, DMSO-d6) δ 8.00 (s, 1H), 2.55 (s, 6H), 2.25 (s, 3H), 2.09 (s, 3H), 2.06 
(s, 3H); 13C NMR (75 MHz, DMSO-d6) δ 154.4, 145.0, 139.6, 134.5, 121.4, 42.8, 
19.6, 14.2, 12.6; HRMS for C10H16N2ONa+ [M+Na]+ 203.1155 found 203.1147. 
 
6-(Dihexylamino)-2,4,5-trimethylpyridin-3-ol (3b). To a suspension of 
free base form of compound 1 (500mg, 3.28mmol) in THF (10mL) were added 
acetic acid (0.76mL, 13.1mmol) and n-hexan-1-al (0.89mL, 7.23mmol). Then 
sodium triacetoxyborohydride (2.09g, 9.85mmol) was added to the mixture in 
small portions. The resulting suspension was stirred for 6h at rt. After removal of 
THF by evaporation, the residue was diluted with water and then neutralized with 
sat. NaHCO3 solution. Extraction with EtOAc was performed and the combined 
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organic layers were washed with brine, dried over MgSO4 and concentrated. The 
residue was purified by flash silica gel chromatography (10:1 hexanes/EtOAc) to 
give 3b (842mg, 80%) as a light yellow oil. 1H-NMR (300 MHz, CDCl3) δ 4.52 (br 
s, 1H), 2.70 (t, 4H, J=7.2 Hz), 2.14 (s, 3H), 1.95 (s, 3H), 1.92 (s, 3H), 1.11-1.21 
(m, 4H), 0.95-1.10 (m, 12H), 0.63 (t, 6H, J=6.8 Hz); 13C-NMR (75 MHz, CDCl3) δ 
155.1, 145.2, 139.7, 134.0, 125.9, 53.4, 32.1, 28.3, 27.5, 23.0, 19.1, 14.7, 14.4, 
13.0; HRMS for C20H37N2O+ [M+H]+ 321.2906 found 321.2903. 
 
2,4,5-Trimethyl-6-(methylamino)pyridin-3-ol (2a). Free base form of 1 
(1.85g, 12.1mmol) and 1H-hydroxymethylbenzotriazole (1.81g, 12.1mmol) were 
independently dissolved in refluxing absolute EtOH (35mL, 25mL). The saturated 
solutions were mixed and refluxed for 30min. The mixture was then cooled slowly 
and stirred for 2h at rt. Reaction mixture was then cooled to -10ºC and stirred for 
15min. The solid product was filtered off and washed with cold EtOH (5ml) and 
ether (2×25mL). Solvent removal yielded a yellow powder (3.0g, 89%).  
The powder (3.0g, 11mmol) was dissolved in refluxing 1,4-dioxane 
(180mL) and powderized NaBH4 (1.4g, 33mmol) was added slowly to the 
refluxing solution, which was kept under a stream of argon. After 1h, reaction 
was quenched with water, solvents were evaporated, a small amount of water 
was added and the pH of the resulting solution was brought to 8.5. The product 
was then extracted with chloroform; extracts were combined, dried over MgSO4, 
and concentrated under vacuum. The crude material was purified multiple times 
by flash column chromatography (5-10% MeOH in CH2Cl2) which finally yielded 
pure pale-yellow product (0.50g, 31%). Mp 160-162 ºC; 1H NMR (300 MHz, 
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DMSO-d6) δ 7.39 (s, 1H), 5.21 (s, 1H), 2.73 (d, 3H, J=2.1Hz), 2.20 (s, 3H), 2.04 
(s, 3H), 1.90 (s, 3H); 13C NMR (75 MHz, DMSO-d6) δ 151.3, 140.5, 139.3, 134.6, 
113.1, 29.3, 19.8, 12.8; HRMS for C9H15N2O+ [M+H]+ 166.1101 found 166.1091. 
 
6-(ethylamino)-2,4,5-trimethylpyridin-3-ol hydrochloride (2b HCl). To 
a solution of 1 (5.00g, 26.5mmol) in warm MeOH (50mL) triethylamine (15mL, 
0.11mol) was added and the solution was stirred for 15min at 50ºC. Solvents 
were evaporated and residual mixture was suspended in THF (30mL), 
triethylamine (7.5mL, 53mmol) was added and acetic anhydride (20mL, 0.21mol) 
was dropped slowly at 0ºC. The mixture was brought to rt and stirred for 12h. 
Solvents were evaporated and extraction between chloroform and saturated 
aqueous NaHCO3 solution was performed. The organic layers were combined 
and dried over MgSO4. Evaporation of solvent followed by high vacuum drying 
yielded 6.66g of white powder (crude 6-acetamido-2,4,5-trimethylpyridin-3-yl 
acetate). 
 The crude product was dissolved in MeOH (90mL) and reacted with 30% 
sodium methoxide solution in MeOH (5.5mL, 29mmol) added dropwise at rt. The 
mixture was stirred for 30min, and then neutralized with 2M HCl in ether to pH 7-
8. Solvents were evaporated and the residue was dried under high vacuum 
yielding 6.94g of white powder (crude N-(5-hydroxy-3,4,6-trimethylpyridin-2-
yl)acetamide). 
 To the crude acetamide suspension in dry THF (140mL) under argon 
atmosphere, 1M borane-tetrahydrofuran complex in THF (90mL, 90mmol) was 
added dropwise at 0ºC. The mixture was brought to reflux temperature, stirred for 
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2h and cooled back down to 0ºC. MeOH (25mL) was added very slowly at 0ºC to 
quench excess of the reagent. The mixture was further refluxed for 1h and 
cooled to rt at which 2N HCl in ether (35mL) was added. Mixture was stirred for 
20min at that temperature and then condensed under reduced pressure. An 
extraction between chloroform and saturated aqueous NaHCO3 solution was 
performed, organic layers were combined and dried over MgSO4. Solvent was 
evaporated yielding crude 6-(ethylamino)-2,4,5-trimethylpyridin-3-ol, which was 
subsequently recrystallized from benzene. Thus obtained crystals were dissolved 
in MeOH (20mL) and acidified with 2M HCl in ether (30mL, 60mmol). Additional 
50mL of ether was added and the mixture was stirred for 15min, during which 
final product precipitated out. The white precipitate was filtered off, washed with 
0.2M HCl in ether and dried under high vacuum yielding 6-(ethylamino)-2,4,5-
trimethylpyridin-3-ol hydrochloride (4.31g, 75%). Mp 234-235ºC dec; 1H-NMR 
(300 MHz, DMSO-d6) δ 8.95 (s, 1H), 7.34 (s, 1H), 3.53-3.58 (m 2H), 2.49 (s, 3H), 
2.21 (s, 3H), 2.08 (s, 3H), 1.16 (t, 3H, J=7.0 Hz); 13C-NMR (75 MHz, DMSO-d6) δ 
147.1, 145.5, 140.5, 129.7, 117.7, 37.2, 14.2, 14.1, 14.0, 13.1; Anal. calcd. for 
C10H17ClN2O: C, 55.42; H, 7.91; Cl, 16.36, found: C, 55.17; H, 8.02; Cl, 16.61. 
 
N-(5-hydroxy-3,4,6-trimethylpyridin-2-yl)hexanamide (6c). To a 
solution of 1 (5.00g, 26.5mmol) in warm MeOH (50mL) triethylamine (15mL, 
0.11mol) was added and the solution was stirred for 15 minutes at 50ºC. 
Solvents were evaporated and residual mixture of neutralized compound 1 and 
triethylammonium chloride was further dried under high vacuum for 30min to 
ensure the complete removal of MeOH. To thus obtained dry solid mixture 
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suspended in 1,2-dichloroethane (200mL), triethylamine (15mL, 0.11mol) was 
added and hexanoyl chloride (15.5mL, 106mmol) was dropped slowly at 0ºC. 
The mixture was brought to rt and then refluxed for 4h. Solvents were evaporated 
and extraction between chloroform and saturated aqueous NaHCO3 solution was 
performed. The organic layers were combined and dried over MgSO4. 
Evaporation of solvent followed by high vacuum drying yielded 18g of sticky pale 
yellow solid (crude 6-hexanamido-2,4,5-trimethylpyridin-3-yl hexanoate).  
The crude product was dissolved in MeOH (120mL) and reacted with 30% 
sodium methoxide solution in MeOH (14mL, 75mmol) added dropwise at rt. The 
mixture was stirred for 90min, and then neutralized with 2M HCl in ether to        
pH 7-8. Solvents were evaporated to give a solid mixture from which organic 
compounds were extracted with chloroform. The solvent was condensed to about 
20% of the original volume and mixed with equal volume of toluene. The mixture 
was further condensed until the chloroform and half of the volume of toluene was 
evaporated. Thus obtained toluene solution was placed at -10ºC for 1h.              
A precipitate formed upon cooling was filtered off, washed with cold toluene then 
cold pentane and dried under high vacuum yielding white crystalline material 
(5.24g, 69%). Mp 187-188ºC; 1H-NMR (300 MHz, DMSO-d6) δ 9.58 (br s, 1H), 
8.46 (s, 1H), 2.27 (s, 2H), 2.22 (t, 2H, J= 7.5Hz), 2.10 (s, 3H), 1.93 (s, 3H), 1.55 
(m, 2H), 1.28 (m, 4H), 0.86 (t, 3H, J=6.9 Hz); 13C-NMR (75 MHz, CDCl3) δ 173.2, 
148.0, 142.1, 139.1, 134.6, 126.8, 36.4, 31.2, 25.1, 22.1, 18.4, 14.3, 13.7, 12.0; 
HRMS for C14H23N2O2+ [M-Cl]+ 251.1760 found 251.1755. 
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6-(hexylamino)-2,4,5-trimethylpyridin-3-ol hydrochloride (2c HCl). To 
the solution of 6c (5.24g, 18.3mmol) in dry THF (70mL) under argon atmosphere, 
1M borane-tetrahydrofuran complex in THF (75mL, 75mmol) was added 
dropwise at 0ºC. The mixture was brought to reflux temperature, stirred for 3h 
and cooled back down to 0ºC. MeOH (25mL) was added very slowly at 0ºC to 
quench excess of the reagent. The mixture was further refluxed for 1h and 
cooled to the rt at which 2M HCl in ether (35mL) was added. Mixture was stirred 
for additional 20min and then condensed under reduced pressure. An extraction 
between chloroform and saturated aqueous NaHCO3 solution was performed; 
organic layers were combined and dried over MgSO4. Solvent was evaporated 
yielding crude 6-(hexylamino)-2,4,5-trimethylpyridin-3-ol, which was 
subsequently recrystallized from heptane. Thus obtained white crystals were 
dissolved in MeOH (20mL) and acidified with 2M HCl in ether (40mL, 80mmol). 
The mixture was stirred for 20min; solvents were evaporated yielding thick oil 
which solidified under high vacuum. Thus obtained solid was washed with small 
amount of 0.2M HCl in ether (10mL) and dried again under high vacuum yielding 
6-(hexylamino)-2,4,5-trimethylpyridin-3-ol hydrochloride (4.77g, 95%). Mp 151-
152ºC; 1H-NMR (300 MHz, DMSO-d6) δ 9.00 (br s, 1H), 7.29 (s, 1H), 3.47-3.51 
(m, 2H), 2.47 (s, 3H), 2.22 (s, 3H), 2.00 (s, 3H), 1.52-1.61 (m, 2H), 1.20-1.39 (m, 
6H), 0.84-0.88 (m, 3H); 13C-NMR (75 MHz, DMSO-d6) δ 147.4, 145.7, 140.7, 
129.7, 118.8, 42.5, 31.3, 28.5, 26.2, 22.4, 14.3, 14.2, 14.1, 13.3; Anal. calcd. for 
C14H25ClN2O: C, 61.64; H, 9.24; Cl, 13.00, found: C, 61.11; H, 9.28; Cl, 12.83. 
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N-(5-hydroxy-3,4,6-trimethylpyridin-2-yl)palmitamide (6d). To a 
solution of 1 (5.00g, 26.5mmol) in warm MeOH (50mL) triethylamine (15mL, 
0.11mol) was added and the solution was stirred for 15 minutes at 50oC. 
Solvents were evaporated and residual mixture of neutralized compound 1 and 
triethylammonium chloride was further dried under high vacuum to ensure the 
complete removal of MeOH. To thus obtained dry solid mixture suspended in 1,2-
dichloroethane (200mL), triethylamine (15mL, 0.11mol) was added and palmitoyl 
chloride (33mL, 0.11mol) was dropped slowly at 0oC. The mixture was brought to 
rt and then refluxed for 4h. Solvents were evaporated and extraction between 
chloroform and saturated aqueous NaHCO3 solution was performed. The organic 
layers were combined and dried over MgSO4. Evaporation of solvent followed by 
high vacuum drying yielded 35g of sticky white solid (crude 2,4,5-trimethyl-6-
palmitamidopyridin-3-yl palmitate). 
 The crude product was dissolved in 1:10 MeOH in CH2Cl2 solution 
(250mL) and reacted with 30% sodium methoxide solution in MeOH (15mL, 
80mmol) added dropwise at rt. The mixture was stirred for 90 minutes, and then 
neutralized with 2M HCl in ether to pH 7-8. Solvents were evaporated to give a 
solid residue which was suspended in chloroform (1.5L). Silica gel (100g) was 
then added and the suspension was stirred at rt. After 1h solid particles were 
filtered off (filtrate was discarded), washed with chloroform (2×150mL) then re-
suspended in 1:3 MeOH in chloroform solution (1.5L) and stirred for 1h at rt. 
Adsorbent particles were filtered off again, washed with 1:3 MeOH in chloroform 
solution (2x150mL). Filtrates were combined and condensed under reduced 
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pressure yielding white solid (7.89g, 70%). Mp 136-137ºC; 1H-NMR (300 MHz, 
DMSO-d6) δ 9.56 (br s, 1H), 8.46 (s, 1H), 3.32 (s, 2H), 2.27 (s, 3H), 2.22 (t, 2H, 
J=7.3 Hz), 2.10 (s, 3H), 1.93 (s, 3H), 1.52 (m, 2H), 1.23 (m, 24H), 0.84 (t, 3H, 
J=6.6 Hz); 13C-NMR (75 MHz, DMSO-d6) δ 171.3, 147.5, 141.3, 140.8, 133.6, 
126.2, 35.2, 31.3, 29.0, 28.9, 28.8, 28.7, 25.2, 22.1, 19.2, 14.5, 14.0, 12.5; 
HRMS for C24H43N2O2+ [M-Cl]+ 391.3325 found 391.3319. 
 
6-(hexadecylamino)-2,4,5-trimethylpyridin-3-ol hydrochloride (2d 
HCl). To the solution of 6d (7.89g, 18.5mmol) in dry THF (120mL) under argon 
atmosphere, 1M borane-tetrahydrofuran complex in THF (70mL, 70mmol) was 
added dropwise at 0ºC. The mixture was brought to reflux temperature, stirred for 
3h and cooled back down to 0ºC. MeOH (25mL) was added very slowly at 0ºC to 
quench excess of the reagent. The mixture was further refluxed for 1h and 
cooled to rt at which 2M HCl in ether (35mL) was added. Mixture was stirred for 
20 minutes at that temperature and then condensed under reduced pressure. An 
extraction between chloroform and saturated aqueous NaHCO3 solution was 
performed; organic layers were combined and dried over MgSO4. The solution 
was acidified using 2M HCl in ether (30mL), solvents were evaporated to give a 
solid residue which was suspended in chloroform (600mL). Silica gel (80g) was 
then added and the suspension was stirred at rt. After 1h adsorbent particles 
were filtered off (filtrates were discarded), washed with chloroform (2×100mL) 
then re-suspended in 1:3 MeOH in chloroform solution (600L) and stirred for 1h 
at rt. Solids were filtered off again, washed with 1:3 MeOH in chloroform solution 
(2×100mL) and filtrate was condensed under reduced pressure. The residual 
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pale yellow oil was treated with 2N HCl in ether (10mL) to give pale-yellow solid 
which was then recrystallized from toluene to give bright white crystalline product 
(6.77g, 89%) upon drying. Mp 86-87ºC; 1H-NMR (300 MHz, DMSO-d6) δ 8.98 (s, 
1H), 7.29 (s, 1H), 3.36-3.45 (m 2H), 2.48 (s, 3H), 2.22 (s, 3H), 2.09 (s, 3H), 1.52-
1.65 (m, 2H), 1.15-1.37 (m, 26H), 0.79-0.86 (m, 3H); 13C-NMR (75 MHz, DMSO-
d6) δ 147.4, 145.6, 140.7, 129.7, 117.9, 42.5, 31.6, 29.4, 29.3, 29.1, 29.0, 28.5, 
26.5, 22.4, 14.2, 14.1, 13.3; Anal. calcd. for C24H45ClN2O: C, 69.78; H, 10.98; Cl, 
8.58, found: C, 68.96; H, 10.97; Cl, 8.16. 
 
2,4-dimethyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-ol hydrochloride (7 
HCl). This compound was prepared in five steps. The synthetic intermediates 
have been purified only briefly and have not been fully characterized. 
 First step, the transformation of naphthyridine 9 into 5,7-dimethyl-1,2,3,4-
tetrahydro-1,8-naphthyridine was performed according to the previously 
published procedure, with a comparable yield.1    
 To a solution of this partially hydrogenated compound 9 (3.3g, 21mmol) in 
MeCN (70mL) was added NIS (4.7g, 64.7mmol) and TFA (0.47g, 4.1mmol) at rt. 
After 1h of stirring, solvents were evaporated, and the residue was partitioned 
between sat. NaHCO3 solution and AcOEt. The combined organic layers were 
dried over MgSO4 and condensed to yield 5.8g of the solid product 10. 1H-NMR 
(300 MHz, CDCl3) δ 5.08 (s, 1H), 3.31 (m, 2H), 2.65 (t, 2H, 6.6Hz), 2.54 (s, 1H), 
2.28 (s, 1H), 1.89 (q, 2H, J = 5.7Hz). 
 To a solution of compound 10 (5.8g, 20mmol) and NaH (0.83g, 40mmol) 
in DMF (80mL) was added NBu4I (2.0g, 15mmol) and benzyl bromide (3.3mL, 
 
  60
67mmol). After the solution was stirred overnight at rt, sat. NH4Cl solution was 
added and the multiphase solution was stirred for 15min. Solid NaHCO3 was 
added till pH 7 and the product was extracted with DCM. The organic layers were 
combined, washed well with water, dried over MgSO4 and condensed. The 
residue was purified chromatographically (0-5% EtOAc/hexanes) to give 5.0g of 
1-benzyl-6-iodo-5,7-dimethyl-1,2,3,4-tetrahydro-1,8-naphthyridine as a pale violet 
solid. 1H-NMR (300 MHz, CDCl3) δ 7.25 (m, 5H), 4.87 (s, 2H), 3.22 (m 2H), 2.69 
(t, 2H, J = 5.7Hz), 2.57 (s, 3H), 2.30 (s, 3H), 1.52 (m, 2H). 
To a solution of this pale violet product (5.0g, 13mmol) in benzyl alcohol 
(200mL) were added portionwise (at 90ºC) Cs2CO3 (167g, 0.5mol) and CuI (1.4g, 
7mmol). After 48h of stirring at 90ºC, most of the solvent was distilled off.  The 
residue was partitioned between water and DCM. The organic layers were 
combined, washed with brine, dried over MgSO4 and condensed. The residue 
was purified chromatographically (0-5% EtOAc/hexanes) to give 2.4g of oily 
compound 11. 1H-NMR (300 MHz, DMSO-d6) δ 7.48-7.20 (m, 10H), 4.77 (s, 2H), 
4.66 (s, 2H), 3.19 (m 2H), 2.58 (t, 2H, J = 6.0Hz), 2.23 (s, 3H), 2.06 (s, 3H), 1.86 
(m, 2H); 13C-NMR (75 MHz, DMSO-d6) δ 151.1, 145.1, 143.1, 139.7, 138.2, 
137.7, 128.5, 128.4, 128.2, 128.1, 127.7, 126.7, 113.4, 74.6, 50.9, 46.6, 24.3, 
21.4, 19.4, 11.9. 
To a solution of compound 11 (2.4g, 6.7mmol) in EtOH (55mL) and THF 
(55mL) was added 10% Pd/C (0.55g).  After 48h of stirring under an atmosphere 
of hydrogen at rt, insoluble materials were filtered off and washed with EtOH. The 
filtrate was condensed to yield crude product, which was washed with 10:1 
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Et2O/EtOH mixture (2 x 10mL), and then with plain Et2O (3 x 15mL) to yield of 
pure compound 7 as a white solid (1.2g, 95%). To this solid dissolved in MeOH 
(3mL) was added 2M HCl/Et2O (5mL). After 15min of stirring, the mixture was 
condensed, and washed with Et2O to yield 7 HCl as a white powder. Mp        
219-220ºC dec; 1H-NMR (300 MHz, DMSO-d6) δ 8.87 (br s, 1H), 7.35 (s, 1H), 
3.30 (t, 2H, J=5.4 Hz), 2.63 (t, 2H, J=6.2 Hz), 2.31 (s, 3H), 2.15 (s, 3H), 1.80 (m, 
2H); 13C-NMR (75 MHz, DMSO-d6) δ 146.1, 145.2, 140.1, 129.8, 116.4, 22.6, 
19.6, 13.9, 12.9; HRMS for C10H15N2O+ [M-Cl] 179.1184 found 179.1186. 
 
2,4,8-trimethyl-5,6,7,8-tetrahydro[1,8]naphthyridin-3-ol hydrochloride 
(8 HCl). To a solution of compound 7 (400mg, 2.25mmol) in MeOH (20mL) were 
added acetic acid (6.75mL, 0.12mol), 36% formalin solution (8.0mL, 0.21mol) 
and NaCNBH3 (0.74mg, 12.4mmol). The resulting mixture was stirred for 2h at rt. 
After removal of MeOH by evaporation, the residue was diluted with water 
(25mL) and then neutralized with sat. NaHCO3 solution. Extraction with EtOAc 
was performed and the combined organic layers were washed with brine, dried 
over MgSO4 and concentrated. The residue was purified by silica gel flash 
chromatography (2:1 hexanes/EtOAc) to give a pale-yellow solid, which was 
subsequently dissolved in MeOH (0.6mL) and treated with 5mL of 1M HCl/Et2O. 
The mixture was stirred for 15min, condensed and washed with Et2O to yield 
pale-yellow solid (82mg, 80%). Mp 164-166ºC dec; 1H-NMR (300 MHz, DMSO-
d6) δ 8.94 (br s, 1H), 3.40 (t, 2H, J=5.7 Hz), 3.18 (s, 3H), 2.65 (t, 2H, J=6.3 Hz), 
2.43 (s, 3H), 2.17 (s, 3H), 1.87 (m, 2H) ; 13C-NMR (75 MHz, DMSO-d6) δ 146.1, 
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144.3, 140.2, 130.7, 118.2, 50.2, 39.1, 23.3, 19.9, 14.0, 13.3; HRMS for 
C11H17N2O+ [M-Cl] 193.1341 found 193.1334. 
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CHAPTER III 
 
 
ANTIOXIDANT PROPERTIES OF THE VITAMIN B6 DERIVED PYRIDINOLS 
 
 
Introduction 
 As described in Chapter I, a combination of different properties makes      
a molecule a good antioxidant. A key factor is an ability to donate hydrogen 
atom(s) to chain carrying peroxyl radicals in reasonably fast manner. 
Nevertheless, interactions of an antioxidant or the radical derived from it with 
oxygen (autoxidizability), natural antioxidants (co-antioxidant behavior) or other        
in vivo abundant molecules are also important. In order to establish which 
processes are likely to occur in lipid like surroundings, some experiments have 
been conducted in non-polar, aprotic solvent. On the other hand, to investigate 
the behavior of pyridinols in a polar environment, a series of experiments in an 
aqueous buffer of physiologically relevant pH have also been performed. Finally 
to better mimic behavior of PyrOH under conditions more likely to occur in vivo, 
the molecules have been investigated in heterogeneous systems. A model that 
has been commonly applied to mimic oxidation occurring in bio-membranes, a 
system consisting of oxidizable multi lamellar liposomes dispersed in an aqueous 
buffer, has been employed in these latter studies.1-6 All of the experiments were 
of a comparative nature. Two compounds structurally related to α-TOH, for which 
reasonably good antioxidant properties have been established, were chosen as 
reference compounds. 2, 2’, 5, 7, 8-Pentamethylchromanol (PMC) was utilized in 
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non-polar systems, whereas its water soluble analogue, 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid (Trolox) was chosen for studies in aqueous 
buffers.7-11 Additionally, α-TOH was used as a reference compound in liposomal 
suspensions. Structures of the PyrOHs that were investigated are presented 
together with the structures of the reference α-TOH analogues in Figure 3.1.  
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Figure 3.1. Pyridinols under investigation and relevant reference compounds. 
 
Although the pyridinols 1-10 have been stored as their hydrochloric salts, 
due to solubility issues for the experiments in organic solvents, they were 
converted into the free base forms before use. For all other experiments the salts 
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of compounds 1-10 were used.12 To avoid additional numbering, throughout this 
chapter, PyrOHs 1-10 will represent either the salts or their free bases. 
  
Properties in non-polar environment 
Air stability as well as tests of reactivity of selected pyridinols with peroxyl 
radicals were investigated. For air stability measurements, a representative 
group of pyridinols was incubated in benzene at 37°C in a closed vial that was 
opened from time to time to withdraw aliquots. After a quick sample preparation 
that included the addition of an internal standard (a molecule of similar electro 
activity and slightly different polarity), mixtures were analyzed by HPLC-ECD.13, 14 
From the results collected in Table 3.1, it can be seen that these compounds 
may be divided into two categories: stable for at least two days (all monocyclic 
antioxidants) and stable for a few hours (bicyclic pyridinols). The bicyclic 
compounds are considerably less stable due to the increased electron density of 
their aromatic rings compared to the monocyclic compounds. A fused ring on the 
pyridinol causes a decrease in dihedral angle between the exo-ring nitrogen’s     
p-type lone pair and the p-obrital of an adjacent aromatic carbon.15, 16 This 
increase in electron density makes IP values for compounds 8 and 9 smaller than 
the corresponding values for monocyclic pyridinols (1, 3, 6 and 10), thus 
increasing the reactivity of the former compounds with electron acceptors such 
as molecular oxygen (vide supra).  
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Table 3.1. Some properties of the representative PyrOHs measured in benzene. 
Compound Air stability [h]a nb λmax [nm] 
1 ≥ 48 2.1 307 
3 ≥ 48 2.0 314 
6 ≥ 48 1.9 298 
8 ≥ 3 1.9 325 
9 ≥ 2 1.7 326 
10 ≥ 48 2.0 321 
a Time period during which no consumption of the compound occurred, based 
on HPLC-ECD measurements. b Stoichiometric factors calculated with respect 
to PMC (n = 2.0), based on HPLC-ECD measurements. 
  
Due to structural similarity of compounds 2-5 as well as 6 and 7, only one 
member of each group was investigated. It is believed that no stereo-electronic 
differences exist within these groups of antioxidants therefore the measured 
properties can be associated with every group member. 
 To investigate the reactivity of pyridinols with peroxyl radicals, benzene 
solutions of these pyridinols were incubated with an excess of radical initiator, 
MeOAMVN.17 The radicals formed from the initiator were scavenged by              
an antioxidant resulting in its consumption. Rates of disappearance of 
antioxidants in the presence of MeOAMVN were compared with the rate of 
consumption of the reference compound, PMC, measured under identical 
conditions (Scheme 3.1).18, 19  
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Scheme 3.1. Scavenging of MeOAMVN derived radicals by antioxidants. 
 
The stoichiometric factor (n) is defined as a number of radicals that can be 
scavenged by one molecule of antioxidant, and it is an important property of 
radical scavengers. For PMC, it was found equal to two in several previous 
studies.7, 11 The n values associated with pyridinols were calculated according to 
the generalized Eq. 24, where tAOX is the time needed for complete consumption 
of the investigated antioxidant in the presence of radical initiator and tREF is        
the time required to deplete a reference antioxidant, PMC in this case.            
The stoichiometric factors measured for the representative pyridinols 1, 3, 6 and 
8-10 are included in Table 3.1. The applied initiator to antioxidants ratio of 20:1 
allows zero order kinetics over the course of the experiment. Regressions 
performed to obtain t values showed high linearity (R>0.99).20 A typical plot of 
relative disappearance of antioxidants during an initial period of incubation with 
MeOAMVN is presented in Figure 3.2.  
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Figure 3.2. The disappearance of 0.1mM PyrOH 3 (triangles) and 0.1mM PMC 
(circles) in the presence of 2.0mM MeOAMVN in benzene at 37ºC. Linear trend 
lines for depletation of PyrOH 3 (solid) and PMC (dashed) are also presented. 
 
As can be seen in Table 3.1, stoichiometric factors for all pyridinols tested 
are close to two and the conventional mechanism may be proposed to explain 
these results. When a pyridinol donates hydrogen atom to peroxyl radical it is 
converted to phenoxyl radical that could further react with another peroxyl radical 
by means of radical-radical coupling reaction to the ortho- or para- position of   
the aryloxyl radical.18 Alternatively, antioxidants that have the ability to donate 
two hydrogen atoms (1-5, 8) could scavenge two peroxyl radicals via two 
hydrogen atom transfers to yield imino-pyridinone products (Scheme 3.2).7, 21 
The fate of the pyridinols however, remains unknown at this time, since multiple 
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attempts performed to isolate or even characterize the products generated from 
these compounds in the mixture have failed.  
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Scheme 3.2. Proposed radical scavenging mechanisms for PyrOHs 3 and 6. 
 
Routine UV measurements performed on compounds under investigation 
revealed an interesting observation. Analysis of π-π* transition energies           
(via comparison of λmax values found for compounds presented in Table 3.1) 
indicates that the transition energy for N,N-dialkylated 2-aminopyridin-5-ol 6 is 
higher than the corresponding energy for 2-alkylaminopyridin-5-ol 3, and even 
higher than the energy for 2-aminopyridin-5-ol 1. This is unexpected since 
dialkylamino substitution gives better electron donation than the monoalkylamino 
or amino analogues. It is therefore proposed that steric interactions exist 
between the 3-methyl substituent and 2-dimethylamino group of 6, causing         
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a decrease in the dihedral angle between the 2-nitrogen’s p-type lone pair and 
the p-orbital of the adjacent aromatic carbon. This can be simply visualized as     
a twist of the nitrogen’s lone pair out of the plane of best interaction between     
p-orbitals (Figure 3.3).  
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Figure 3.3. An overlap of orbitals in compounds 3, 6 and 10. 
 
Such steric interactions do not exist in the case of compounds that have              
a hydrogen atom substituted in the 3-position of the aromatic ring (10) or have at 
least one hydrogen atom bonded to the nitrogen atom of the 2-amino substituent 
(1 and 3). This twisting of 6 is further supported by the fact that the ring nitrogens 
of 3, 1 or 10 are more basic than the corresponding nitrogen of 6 (vide infra).  
 Since the stronger the interactions between the 2-nitrogen’s lone pair and 
an aromatic ring, the lower the OH-BDE of an 2-amino-pyridin-5-ol (vide supra), it 
was predicted that compounds 3 and 10 should donate hydrogen atoms much 
more readily than PyrOH 6. Measurements recently carried out in our laboratory 
gave  kinh values for 3 (1.4±0.2 × 107 M-1s-1), 6 (1.6±0.3 × 106 M-1s-1) and 10 
(1.7±0.2 × 107 M-1s-1) that were consistent with that prediction.22 Overall,           
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the experiments described in this section suggest that N-monoalkylated 2-amino-
3,4,6-pyridin-5-ols are better hydrogen atom donors than their N,N-dialkylated 
analogues, hence they are better antioxidants (at least in a non-polar 
environment). 
 
Properties in aqueous media 
The stability of selected water soluble pyridinols in the presence and 
absence of a radical azo-initiator was investigated in phosphate buffered saline 
(PBS) at physiologically relevant pH = 7.4. Experiments were conducted using 
the same general protocol that was applied in non-polar solvent. The key 
changes include the usage of a different initiator, AIPH instead of MeOAMVN,23, 
24 and a different reference hydrogen atom donor Trolox in place of PMC. The 
results of air stability tests together with n values found for the representative 
pyridinols 1, 3, 6 and 8-10 are presented in Table 3.2. Again, compounds may be 
divided into two categories, stable for over 8h (all monocyclic antioxidants) and 
unstable (bicyclic pyridinols). The bicyclic compounds decayed linearly 
throughout the incubation and disappeared within a few hours, whereas 
monocyclic pyridinols retained their initial concentrations for at least 8h of 
incubation. Water, a solvent that is known to favor ionic reactions by stabilization 
of charged transition states is presumably an excellent medium for a rapid 
electron transfer (ET) from an antioxidant or phenoxyl radical to molecular 
oxygen, whereas aprotic benzene is not likely to facilitate such reactions. That is 
likely why compounds 8 and 9 are far less stable in aqueous media than in non-
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polar organic solvent.  Monocyclic pyridinols, on the other hand, are much less 
electron rich, compared to bicyclic compounds (vide supra) and therefore they do 
not readily undergo autoxidation even in an aerated aqueous environment. 
 
Table 3.2. Some properties of the representative pyridinols in aqueous media. 
Compound Air stability [h]a nb pKac Ep,ox [V]d
1 ≥ 8 1.4 6.9 0.16 (R)g
3 ≥ 8 0.92 7.3 0.12 (R)g
6 ≥ 8 1.4 6.2 0.18 
8 0 (4.0 x 10-9 M/s)e 0.48 (0.58)f 7.5 0.14 (R)g
9 0 (9.2 x 10-9 M/s)e 0.23 (0.28)f 7.5 0.11 
10 ≥ 8 0.90 7.2 0.16 
a Time period during which no consumption of the compound occurred in PBS 
pH 7.4 at 37ºC, based on HPLC-ECD measurements. b Stoichiometric factors in 
PBS pH 7.4 at 37ºC, calculated with respect to Trolox (n = 2.0), based on 
HPLC-ECD measurements. c The pKa value for the protonated form of the 
pyridinol measured in 25% aqueous solution of methanol at 25ºC. d The 2e 
oxidation peak’s maximum reported with respect to Ag/AgCl electrode, 
measured in degassed phosphate buffer at 25ºC. e The rate of autoxidation of 
the compound is presented in parenthesis. f Values in parentheses are 
corrected for autoxidation g The R indicates reversible process, two 1e 
reduction peaks were observed in each case (vide infra). 
 
Stoichiometric factors for pyridinols dissolved in aqueous buffers, 
calculated with respect to Trolox (n = 2.0), were smaller than expected.8 As can 
be seen in Table 3.2, all n values were less than 2 suggesting that initiator-
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derived peroxyl radicals were not the exclusive hydrogen atom acceptors in 
these systems. It was proposed previously that electron rich phenols undergo 
autoxidation in the presence of molecular oxygen dissolved in the reaction 
solvent (vide supra).  This may be the case for unstable compounds 8 and 9, but 
unlikely for much less electron-rich monocyclic antioxidants shown in Table 3.2. 
The proposed alternative mechanism for autoxidation of pyridinols in the 
presence of radical generator in aqueous media is illustrated in Scheme 3.3. 
In the presence of radical initiator peroxyl radicals are formed. These 
species are scavenged by a pyridinol to form hydroperoxide and phenoxyl 
radicals. It is proposed that the phenoxyl radical could either scavenge another 
peroxyl radical or transport an electron to molecular oxygen to form superoxide 
and thermodynamically stable pyridinoneiminium salt. The concentration of 
oxygen is relatively high in the system, whereas peroxyl radicals are generated 
rather slowly.23, 25 Therefore, the reduction of oxygen by pyridinol derived radical 
should be favored. Superoxide radical anion could then dismute (vide supra) or it 
could be reduced to hydroperoxide anion in reaction with the pyridinol. The 
concentration of superoxide in the system is much smaller than the concentration 
of the pyridinol. Therefore, it is more probable that the latter reaction occurs, 
especially since it was shown that the rate constants for both types of 
transformations are similar.26, 27 The stronger π-electron-donating interactions of 
p-amino group with the remaining molecular π-system, the better the charge 
stabilization in the pyridinoneiminium cation, hence the more likely it forms. 
Furthermore, the more electron rich the PyrOH, the easier the reaction with 
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superoxide should occur. That is the reason why the most active pyridinols are 
most readily consumed in aqueous media. Extremely electron rich compounds 8 
and 9 were depleted even in the absence of radical initiator (most likely via their 
reaction with O2).  However, in the presence of AIPH autoxidation of bicyclic 
pyridinols was about four times faster than their disappearance without added 
initiator, suggesting that AIPH induced autoxidation was a predominant process. 
The solvent effect on autoxidizability of active pyridinols must be emphasized, by 
comparing n values measured in benzene and PBS it is clear that a polar 
environment is necessary for the autoxidation to occur.  
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Scheme 3.3. The proposed mechanism for the disappearance of pyridinols in 
aqueous media. 
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It should be noted that the mechanism presented in Scheme 3.3 has not 
yet been directly validated. Attempts to detect superoxide or hydrogen peroxide 
in the reaction mixture failed due to poor specificity of analytical assays currently 
available. Cytochrome c assay, epinephrine assay, Cypridina luciferin analog 
chemiluminescence assay, and number of colorimetric assays for HOOH 
detection were found to be incompatible with a system containing so many 
different redox active species.28-33 In addition, products of oxidation of               
the investigated pyridinols in aqueous environment could not be identified. 
Currently, some toxicological experiments in cell cultures are being conducted on 
these and related molecules, presenting an opportunity to resolve this issue.  
 The autoxidation mechanism presented here is similar to one suggested 
for hydroquinols.26, 27, 34, 35 It was proposed that a p- or o-hydroxyphenoxyl 
radical, formed upon formal hydrogen atom transfer from a hydroquinol, reacts 
with oxygen to form a p- or o-quinone and superoxide. However, no direct 
evidence for the presence of superoxide in such system was presented. This lack 
of confirmatory experiments is most likely due to the already mentioned 
unavailability of a suitable analytical method. 
Another important factor in the determination of antioxidant properties for 
pyridinolic compounds is the basicity of their aromatic ring nitrogen atoms. It is 
crucial for pyridinols to have their ring nitrogen mostly deprotonated in              
the environment of action in order to act as powerful hydrogen atom donors.        
If pyridinols were to be used as antioxidants in vivo, pKa values for their ring 
nitrogens should not be greater than 7.4 allowing a majority of antioxidant 
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molecules to be active. The experiment revealed the pKa values for monocyclic 
pyridinols were smaller than 7.4, whereas bicyclic compounds gave                   
the dissociation constant above the physiological pH value (Table 3.2). 
Therefore, it can be concluded that monocyclic PyrOHs will be predominantly 
deprotonated, whereas bicyclic pyridinols will be predominantly protonated under 
the relevant conditions. One might consider increased protonation of PyrOHs 8 
and 9 at pH 7.4 as a mechanism for sparing these compounds from autoxidation. 
However, the observed fast disappearance of these pyridinols from aqueous 
media indicates that such sparing is rather ineffective. The phenolic pKa values 
could not be obtained from the titrations performed, possibly due to the rapid 
autoxidation of phenoxyl anions. The phenolic pKa reported for 3-pyridinol was 
equal to 8.7,36 and since the pyridinols under investigation are more electron rich 
than the latter compound, it is believed that at physiological pH their hydroxyl 
groups are predominantly protonated facilitating H-atom transfer from these 
antioxidants.36, 37 A sample titration curve is shown for compound 3 in Figure 3.4. 
It was previously suggested that pyridinols or their mono-radical forms are 
able to transfer electrons to molecular oxygen or superoxide (vide infra). It should 
also be mentioned that pyridinols are able to reduce metal ions at higher 
oxidation states. It was shown that compounds 1 and 3 (reductive properties of 
other pyridinols presented in this chapter have not been tested) effectively 
reduce ferryl myoglobin to its ferric form in a dose dependent manner. Because 
of their reducing properties, and also their ability to scavenge peroxyl radicals, 
pyridinols might be considered as important inhibitors of some serious 
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pathologies, such as myoglobinuric lipid peroxidation associated with 
rhabdomyolysis.38 It was also found that ferric cytochrome c is reduced to its 
ferrous form in the presence of PyrOHs 1 and 3 in a dose-dependent manner. It 
is however unclear at this point what in vivo relevant consequences that 
reduction of cytochrom c may yield. It was also suggested recently that 2-amino-
pyridin-5-ols interact with heme containing enzymes, such as cyclooxygenases 
(vide supra). 
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Figure 3.4. pH Titration curve (solid line) and its first derivative (dotted line) for 
0.5mmol of PyrOH 3 dissolved in 10mL of aq. HCl (0.1 mM) containing 25% 
MeOH and titrated with 25 μL portions of aq. NaOH (0.1 mM) containing 25% 
MeOH. pKa Value was found from the half distance between two maximums of 
the first derivative reflected on the pH axis via titration curves (dashed lines).  
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On the other hand, in the environments of increased levels of free 
transition metal ions, the excellent reducing properties of these compounds may 
promote formation of ROS, analogously to the process observed in the presence 
of Fe3+ and ascorbate.39 This issue is recommended for further exploration during 
the next phase of evaluation of the pyridinols. 
Redox properties of pyridinols are also of interest from the perspective of 
interactions between these compounds with other natural antioxidants. As it was 
already mentioned, aqueous Asc- as well as hydrophobic CoQ10H2 were found to 
be able to transform α-tocopheryl radical into α-TOH.40, 41 The oxidation potential 
measured for α-TOH (0.48V ref. Ag/AgCl) was much higher than corresponding 
values found for Asc- (0.28V) and CoQ10 (0.20V).42 It was that difference in        
the oxidation potential values that made regeneration of α-TOH 
thermodynamically possible. Oxidation potentials were therefore measured for 
pyridinols 1, 3, 6 and 8-10 (Table 3.2) to predict if any redox reaction with these 
natural antioxidants is suitable. Sample cyclic voltammetry curves obtained for 
PyrOH 1 and 10 are shown in Figure 3.5. Theoretically, a pyridoxyl radical could 
be reduced in the presence of Asc- or CoQ10, and/or parent pyridinol could serve 
to regenerate α-TOH from its radical. Judging by the oxidation potential values 
obtained, only the latter interaction would be thermodynamically possible for all of 
the pyridinols under investigation. 
Another interesting observation was that all of the compounds possessing 
at least one hydrogen on the 2-nitrogen atom (for example pyridinol 3) underwent 
semi-reversible electrochemical processes, whereas the N,N-dialkylamino 
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PyrOHs (for example compound 10) oxidized irreversibly. This result may be 
explained by formation of imino-pyridinones from the earlier group of compounds 
in two subsequent one electron processes with formation of semi-
iminopyridinones, easily oxidizable intermediates. In the past similar reversible 
electrochemical processes have been observed for quinols.43-45  
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Figure 3.5. Cyclic voltammetry curves for 1mM PyrOHs 3 (solid line) and 10 
(dotted line) dissolved in degassed 100mM phosphate buffer. Glassy carbon was 
used as a working, platinum as a counter, and Ag/AgCl as a reference electrode.  
 
Unfortunately, even though multi-milligram scale electrochemical oxidations of 
PyrOHs 1 and 3 appeared to be nearly completed (bulk electrolysis on glassy 
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carbon electrode, 12-24h, 1.2V, with stirring), spectroscopic analysis (1H NMR, 
ESI-MS) of the produced mixtures did not unambiguously support formation of 
the predicted products. 
 
Properties in heterogeneous systems 
Due to the fact that pyridinols behaved differently in a polar, aqueous 
environment than in non-polar, aprotic media, it was important to investigate their 
properties in a heterogeneous system. The heterogeneous system of choice 
consisted of 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphatidylcholine (PLPC) 
multi-lamellar liposomes (MLV) suspended in PBS (pH 7.4) at 37ºC.4, 8, 17 Water 
soluble AIPH acted as a radical initiator in the system, whereas antioxidants were 
applied to inhibit lipid peroxidation. For these experiments, both classes of 
pyridinols, highly water soluble (1, 3, 6, 10), as well as water insoluble (4, 5 and 
7) were used. Also reference compounds belonging to each of these categories 
were utilized: Trolox and uric acid, and PMC and α-TOH, specifically. Bicyclic 
PyrOHs 8 and 9 were not studied due to their high instability in aqueous media.  
Stoichiometric factors (n) and rates of oxidation during the inhibited phase 
(Rox, inh) were extracted from plots of [PLPC-OOH] versus time. An example of 
such a plot is shown in Figure 3.6. The formation of PLPC-OOHs was monitored 
via HPLC-UV analysis of methyl linoleate alcohols (MeLin-OHs) obtained upon 
reduction of PLPC-OOHs with PPh3 and trans-esterification with alkali methoxide 
in MeOH.46 Information about the quantity (n) and quality (Rox, inh) of the inhibition 
by pyridinols and reference antioxidants is collected in Table 3.3.   
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Figure 3.6. Formation of PLPC-OOH during oxidation of 26.6μmol of PLPC 
(MLV) suspended in PBS pH 7.4 (2mL) at 37°C initiated by 1.06μmol of AIPH: 
uninhibited reaction (circles), inhibited by 26.6nmol of PyrOH 1 (triangles) or      
α-TOH (squares). Dashed lines and solid arrows demonstrate how the relevant 
information can be extracted from the plots. 
 
Hydrogen atom donors in these systems were consumed in reactions with 
initiator derived and lipid chain-carrying peroxyl radicals, and potentially in 
autoxidation reactions. In an early stage of oxidation, when antioxidants were 
present in the system, relatively small rates of PLPC-OOHs formation were 
observed, followed by a rapid PLPC oxidation taking place after consumption of 
antioxidants. This phenomenon is illustrated in Figure 3.6, where oxidation 
profiles of systems containing α-TOH and PyrOH 1 are compared.   
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Table 3.3. Antioxidant properties of pyridinols in PLPC liposomes (MLV). 
Compound Rox, inh [nmol/min]a nb
1 1.9 1.3 
3 0.24 1.4 
4 0.10 2.2 
5 0.12 2.1 
6 0.23 1.6 
7 0.24 2.0 
10 0.18 1.4 
Uric acid 1.9 2.0 
Trolox 0.23 2.1 
PMC 0.22 2.0 
α-TOH 0.24 2.0 
n/a 17 n/a 
a The rate of oxidation during the inhibited phase based on the formation of 
PLPC-OOHs analyzed as MeLin-OHs by UV-HPLC. Composition of the mixture: 
PLPC (26.6μmol), AIPH (1.06μmol), antioxidant (26.6nmol), PBS pH 7.4 (2mL). 
b Stoichiometric factors in PLPC (MLV) / PBS pH 7.4 suspension at 37ºC 
calculated with respect to α-TOH (n = 2.0) based on the formation of PLPC-
OOHs analyzed as MeLin-OHs by UV-HPLC. 
 
Stoichiometric factors for antioxidants could be easily found from lengths of      
lag-period preceding the rapid phase of the peroxidation (Figure 3.6).  All of the n 
factors obtained for antioxidants in the heterogeneous systems were calculated 
according to Eq. 24, where tAOX was the lag-period found in the presence of 
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investigated antioxidant and  tREF was the lag-period found in the presence of     
α-TOH (n = 2.0).11, 21 
It is notable (Table 3.3) that, except for compound 1, peroxidation rates in 
the presence of pyridinols are similar or smaller than the corresponding rates 
obtained in the presence of reference phenolic antioxidants (Trolox, PMC,         
α-TOH). It is proposed that pyridinol 1 and urate have a limited access to     
chain-carrying lipid peroxyl radicals as well as to a part of initiator derived peroxyl 
radicals that diffused into lipid phase,13, 47 and as a result relatively higher 
peroxidation rates were observed in the presence of these compounds. It is 
believed that nearly all of the radical scavenging processes performed by these 
antioxidants took place in an aqueous environment. It was previously shown that 
urate is extremely hydrophilic and its presence had a rather small impact on 
processes localized in phospholipid bilayers.13, 47 On the contrary, more lipophilic 
phenols are able to penetrate the lipid more efficiently, therefore protecting 
oxidizable substrates better.8, 48 
A distribution of compound 1 between aqueous phase and the bilayer was 
studied and revealed that under experimental conditions over 92% of               
the antioxidant molecules were present in the aqueous phase, suggesting high 
hydrophilicity of this pyridinol. Distribution between the phases was also 
measured for Trolox and PyrOH 3, for which a relatively high solubility in 
aqueous media have been observed on various occasions.8, 49 It was found that 
25% of Trolox and 52% of compound 3 partitioned into the lipid phase. These 
measured partition properties indicate better accessibility of Trolox and     
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pyridinol 3 to radicals localized inside the bilayer and therefore better protection 
against oxidation for PLPC.  
 Stoichiometric factors found for pyridinols in the heterogeneous systems 
were generally greater than values measured in an aqueous buffer. A close look 
at these values revealed that the distribution of antioxidant between the two 
phases had an important effect on inhibition of lipid peroxidation not only in         
a qualitative but also a quantitative sense. Although the distribution among 
compounds having very short N-alkyl chains was investigated only for compound 
3, it is reasonable to predict that due to close proximity of the calculated LogP 
values (2.5-3.0),50 PyrOHs 10 and 6 will partition between liposomes and 
aqueous buffer similarly to compound 3. The increase in n factors observed in 
heterogeneous system, compared to the values measured in PBS, can be 
explained simply by the partition of antioxidant between layers. If pyridinols are 
partially present in lipid phase, their abilities to autoxidize decreases, therefore 
their stoichiometric factors increase. Among compounds that share stereo-
electronic properties (for instance 3-5 or 6 and 7) antioxidants that partitioned 
into the lipid phase significantly (4, 5 and 7) had greater n values than 
compounds that partitioned into both layers (3 and 6). Furthermore, pyridinol 1 in 
liposomal suspension gave an n factor close to the value measured in PBS, most 
likely because it partitioned almost exclusively into the aqueous phase. All of    
the observations described above show that partition between phases is one      
of the most important parameters to consider in investigating properties               
of pyridinols in heterogeneous systems. 
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Additional series of experiments were conducted in order to evaluate if 
pyridinols act as co-antioxidants and convert tocopheryl radical into its precursor.  
It can be seen in Table 3.3 that peroxidation of PLPC was slower in                  
the presence of α-TOH, than it was in the presence of pyridinol 1 or urate. This is 
most likely due to the relatively high lipophobicity of these compounds that 
decreases their accessibility to lipid peroxyl radicals (vide supra). An application 
of a lipid associated radical azo-initiator, instead of water soluble AIPH, should 
therefore additionally diminish antioxidant properties of these water soluble 
compounds compared to lipophilic α-TOH, hence their co-antioxidant properties 
will be easier to investigate. It can be predicted that when mixture of both types 
of antioxidants is introduced into PLPC (MLV) suspension containing such 
initiator, the lipophilic hydrogen atom donor (α-TOH) should be consumed first if 
an aqueous antioxidant does not react with tocopheryl radicals, or the water 
soluble scavenger should be consumed initially if it is able to act as                   
co-antioxidant. Additionally TMP should occur in the absence, but be diminished 
in the presence of a good co-antioxidant (Scheme 3.4). An asymmetric azo-
initiator, 2,2'-azo [2- (2-imidiazolin-2-yl) propane] {2- [2- (4-n-dodecyl) imidazolin-
2yl]propane} dihydrochloride (C-12), presented in scheme 3.4, was chosen for 
use in these experiments since it was shown to partition almost completely into 
the lipid phase and react with α-TOH, but poorly with aqueous urate in soy 
lecithin (MLV) suspension.47 The disappearance of equimolar mixtures of 
antioxidants from PLPC (MLV) suspended in PBS in the presence of C-12      
azo-initiator was monitored by HPLC-ECD, whereas formation of PLPC-OOH 
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was monitored via HPLC-UV analysis of MeLin-OHs (vide supra). The results are 
presented in Figures 3.7 and 3.8.  
It can be seen in Figure 3.7 that α-TOH is consumed first in the co-
oxidation with uric acid. Therefore it is concluded that this aqueous scavenger is 
not a good co-antioxidant. The observed small protective effect of urate on         
α-TOH was associated with its ability to scavenge a portion of the radicals 
generated by the unsymmetrical azo-initiator that diffused out of the lipid bilayer. 
The possibility of scavenging the radicals derived from that initiator by uric acid is 
not in agreement with a previous report,13 but it can be rationally explained. The 
C-12 initiator is asymmetric hence it generates both lipophilic and hydrophilic 
radicals. It is possible that a fraction of the hydrophilic species manage to escape 
into the aqueous phase where they may be scavenged by aqueous antioxidants. 
In the absence of a water soluble scavenger however, these aqueous radicals 
may diffuse back into the bilayer to initiate peroxidation or be scavenged by 
lipophilic antioxidant.  
 In the mixture containing pyridinol 1 and α-TOH the order of consumption 
of antioxidants was quite different (Figure 3.8). The pyridinol was consumed first 
and the initial concentration of α-TOH was preserved until scavenger 1 was 
depleted, suggesting strong co-antioxidant activity of the water soluble 
compound. In both antioxidant mixtures, the length of the lag-phase was closely 
correlated with the disappearance of α-TOH from the system. The rates of PLPC 
(MLV) peroxidation (Rox, inh) initiated by the C-12 azo-initiator in the presence of 
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radical scavengers and their mixtures are collected together with stoichiometric 
factors found for these antioxidants (Table 3.4). 
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Scheme 3.4. TMP vs. co-antioxidant properties of aqueous radical scavengers. 
 
The n value for α-TOH in the mixture with urate was found slightly higher 
than the corresponding value measured in the absence of the aqueous 
antioxidant. This phenomenon was explained by the ability of urate to scavenge 
radicals that diffused into the aqueous phase. Stoichiometric factors measured 
for aqueous antioxidants, 1 and uric acid were, interestingly, quite different from 
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one another. Due to a nearly exclusive (1) or complete (urate) partition of these 
antioxidants into aqueous phase, their scavenging interactions were very likely 
limited only to a fraction of radicals that diffused out of lipid bilayer.  
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Figure 3.7. The disappearance of the antioxidant mixture: 13.3nmol of α-TOH 
(open circles) and 13.3nmol of uric acid (closed circles), and formation of PLPC-
OOH (closed triangles) during peroxidation of 26.6μmol of PLPC (MLV) 
suspended in PBS pH 7.4 (2mL) at 37°C initiated by 2.12μmol of lipid associated 
C-12 azo-initiator. 
 
A relatively large n factor calculated for urate is in agreement with its limited 
scavenging ability in the system, whereas an unusually low n value found for 
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compound 1 was associated with increased autoxidazibility of the pyridinol under 
given conditions. In the heterogeneous systems, hydrophilic radicals generated 
from the C-12 initiator had to undergo an interface diffusion process to be found 
in an aqueous phase. 
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Figure 3.8. The disappearance of the antioxidant mixture: 13.3nmol of α-TOH 
(open circles) and 13.3nmol of compound 3 (closed circles), and formation of 
PLPC-OOH (closed triangles) during peroxidation of 26.6μmol of PLPC (MLV) 
suspended in PBS pH 7.4 (2mL) at 37°C initiated by 2.12μmol of lipid associated 
C-12 azo-initiator. 
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The effective concentration of radicals in the buffer was therefore relatively low. 
Hence, the reactivity of pyridoxyl radicals with initiator derived radicals was 
decreased and the competitive self-wasting reactivity of pyridoxyl radicals with 
oxygen was enhanced (Scheme 3.3).  
 
Table 3.4. PLPC (MLV) oxidizibility in the presence of antioxidant mixtures. 
Compound Rox, inh [nmol/min]a n (dLOOH/dt)b n (dAOX/dt)c
1 1.4 1.0 0.9 
UA 17 N/Dd 4.5 
α-TOH 0.28 2.0 2.0 
α-TOH + 1 0.17 3.3 3.3 
α-TOH + UA 0.27 2.6 2.5e
no antioxidant 22 N/A N/A 
a The oxidation rate during the inhibited phase, calculated based on initial time 
points (at least 4) obtained via measurements of formation of PLPC-OOHs (UV-
HPLC analysis of MeLin-OHs). Composition of the mixture: PLPC (26.6μmol), 
C12 azo-initiator (2.12μmol), H-atom donor (13.3nmol of single antioxidant or 
13.3nmol of each in the mixture of two), α-TOH (13.3nmol, if used), PBS (2mL). 
b Stoichiometric factors in PLPC (MLV) / PBS pH 7.4 at 37ºC, calculated with 
respect to α-TOH (n=2.0), based on the formation of PLPC-OOHs analyzed as 
MeLin-OHs by UV-HPLC. c Stoichiometric factors based on disappearance of 
antioxidants from the system, reported with respect to α-TOH (n=2.0), based on 
HPLC-ECD measurements. d No distinctive lag period was found, however, a 
small decrease in lipid peroxidation rate was observed. e The n value based on 
disappearance of α-TOH only (consumption of urate was not counted). 
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The cumulative n factor calculated for a mixture of α-TOH with compound 1 was 
found to be close to the sum of the corresponding values measured for individual 
antioxidants, which is in agreement with expectations. 
When radicals were generated inside the lipid bilayer, lipophilic 
scavengers had relatively easy access to a majority of these radicals, whereas 
water soluble antioxidants reacted mainly with radicals that escaped into the 
aqueous phase. This is the reason why α-TOH protected PLPC (MLV) against 
peroxidation much more efficiently than aqueous urate or compound 1. The 
difference between rates of the peroxidation in the presence of urate and 
pyridinol 1 could be also explained by a difference in distribution of these 
compounds between the phases of the heterogeneous system. More lipophilic 
scavenger 1 would have slightly better access to lipid chain-carrying peroxyl 
radicals than extremely hydrophilic urate. Therefore, it would better protect the 
lipid bilayer from peroxidation.  
It would be expected that two antioxidants introduced as a mixture into an 
oxidizable system undergoing peroxidation would compete for radicals to 
scavenge them. The rates of peroxidation in the presence of α-TOH alone and as 
a mixture with urate were similar, suggesting that location of α-TOH caused it to 
unconditionally win the competition with the aqueous scavenger. On the other 
hand, addition of pyridinol 1 to α-TOH significantly decreased the rate of the 
formation of PLPC-OOHs. It is proposed that due to its relatively poor ability to 
scavenge lipid peroxyl radicals (Table 3.3), compound 1 did not decrease the 
rate of peroxidation acting as antioxidant, but it rather inhibited tocopherol 
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mediated peroxidation by transferring a formal hydrogen atom to tocopheryl 
radical. The anti-TMP activity of pyridinol 3, observed as a result of good co-
antioxidant properties of this compound, could be potentially associated with all 
of the pyridinols presented in this manuscript. All of these compounds have 
oxidation potential lower than α-TOH, and all of the remaining pyridinols are 
more electron rich than compound 1 (maybe except for 6 and 7). Therefore, they 
should react with tocopheryl radical even more readily. It was, however, 
convenient to investigate highly hydrophilic compound 1, instead of other more 
lipophilic pyridinols . To distinguish if amphiphilic pyridinols acts via radical export 
mechanism alone or in combination with radical import, additional studies should 
be conducted. At the current level of our knowledge, it seems unlikely that highly 
oxidizable pyridoxyl radicals (vide supra) survive in aqueous media long enough 
to be diffused onto the surface of another lipid aggregate. 
 
Experimental 
General. Trolox, δ-TOH, α-TOH, PMC, uric acid, p-aminophenol,             
p-methoxyphenol and p-methylphenol, 2,6-di-t-butyl-4-methylphenol (BHT) were 
purchased from Sigma Aldrich and purified (except for uric acid) by flash column 
chromatography prior to use. Monocyclic pyridinol 10 was prepared as previously 
described,37 whereas bicyclic PyrOHs 8 and 9 were prepared utilizing 
methodology recently developed in our laboratory to obtain closely related 
PyrOHs.36 AIPH and MeOAMVN was purchased from Wako Chemicals and used 
without further purification. 2,2'-Azo[2-(2-imidiazolin-2-yl)propane]{2-[2-(4-
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ndodecyl imidazolin-2-yl]propane} dihydrochloride was synthesized by a former 
group member from AIPH according to previously published procedure.47, 51 All 
four isomers of conjugated MeLin-OHs were purchased from Cayman whereas 
all inorganic chemicals were purchased from Sigma Aldrich.  An ion pairing 
cocktail containing 0.5M solution of dodecyl triethylammonium phosphate was 
obtained from Regis Technologies, Inc. (Morton Grove, IL). Phosphate-buffered 
Saline (PBS, pH 7.4, 50 mM) was prepared from NaCl (8.00 g), Na2HPO4 (5.00 
g), NaH2PO4 (1.96 g) in deionized water (1.0 L) followed by adjustment of the pH 
to 7.4 with 10M aqueous NaOH. Phosphate buffer (pH 7.4, 100mM) was 
prepared from Na2HPO4 (10.00 g) and NaH2PO4 (3.92 g) in deionized water (1.0 
L) followed by adjustment of the pH to 7.4 with 10M aqueous NaOH. Both 
solutions were stored over Chelex 100 resin (ca. 3 g / L) for 24 h, then the resin 
was removed by filtration and the filtrate was stored at 5ºC. Benzene (HPLC 
grade) was passed through column of neutral alumina and stored over molecular 
sieves. PLPC was purchased as a solution in chloroform (25mg/mL) from Avanti 
Polar Lipids. After aliquots (20mg) were withdrawn from the solution, they were 
kept under argon at -40ºC until used in experiments (no later than 5 days after 
aliquoted). UV-spectra of antioxidants were recorded on Helwett Packard 
HP8453A spectrometer. HPLC analysis was performed with Waters 600 
Controller, 717 Autosampler, Waters 996 photodiode array detector and 
electrochemical detector (ECD; LC-4C, from BAS). All HPLC Analyses of 
phenols and pyridinols were carried out on a single Supelco 5 μm Discovery C-
18 column (4.6 mm x 25 cm) using reverse phase conditions  (mixture of MeOH 
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and water, both containing LiClO4 (1.06g/L) and pyridine (2mL/L)). A composition 
of solvents and speed of an isocratic elution depended on the antioxidant’s 
structure: 1mL/min, 30%MeOH/H2O (1); 1mL/min, 45%MeOH/H2O (3, 6, 8-10 
and Trolox); 1.25mL/min, 70%MeOH/H2O (4 and PMC); 1.5mL/min, 
100%MeOH/H2O (5 and α-TOH). HPLC analyses of uric acid were carried out on 
a single Supelco 5 μm Discovery C-18 column (4.6 mm x 25 cm) using reverse 
phase conditions (1mL/min, 0.54mM EDTA/5mM dodecyl triethylammonium 
phosphate/7.5% MeOH/40mM acetate buffer pH 4.75. p-Methoxyphenol (1), p-
methylphenol (3, 6, 8-10, Trolox and PMC), p-aminophenol (uric acid) and δ-TOH 
(α-TOH) were used as internal standards in HPLC-ECD analyses of antioxidants. 
The electrochemical detector was set for all analyses on 500mV (except for uric 
acid: 650mV). The working electrode was cleaned regularly with nonionic 
detergent, washed with water and dried under argon stream. All HPLC analyses 
of MeLin-OHs were carried out on single Beckman 5μm ultrasphere column 
(4.6mm x 25cm) using normal phase conditions (1.5mL/min, 0.5%IPA/Hex, 
30min). Cinnamyl alcohol was applied as an internal standard in these HPLC-UV 
analyses. pH Titration curves were obtained using Corning pH meter 340 
equipped with Beckman calomel  electrode.  
 
Stability of antioxidants in aerated benzene. Antioxidants (1.00 μmol) in 
10mL of benzene were placed in sand bath at 37oC. Aliquots (400 μL) were 
withdrawn every 20min for 3h (8 and 19) or every 8h for 48h (1, 3, 6 and 10) and 
added to an ice cold mixture of BHT and P(OMe)3 (2.0μmol each) in benzene 
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(100 μL). Internal standards were added in 80μL of benzene and the mixtures 
were vortexed for 30 seconds and solvent was blown off under a stream of 
argon. The residue was dissolved in 65% MeOH/H2O (150μL) and placed in the 
HPLC autosampler at 5oC prior to sample injection on HPLC. Information about 
stability was extracted from charts: [antioxidant] versus time. 
 
Stability of antioxidants in aerated PBS. Experiment were conducted as 
in benzene, except aliquots were withdrawn every 1h for 8h (1, 3, 6 and 10) or 
every 15min for 2h (8 and 9). Compounds were incubated in PBS pH 7.4 (50mM) 
and a mixture of BHT and P(OMe)3 (2.0μmol each) was added in MeOH (500μL).  
Internal standards were also added in MeOH and no solvent evaporation prior to 
analysis was required. 
 
Oxidation of antioxidants in benzene in the presence of MeOAMVN. 
Experiments were conducted similarly to stability measurements in benzene, 
except antioxidants were incubated in the presence of MeOAMVN (20μmol) and 
aliquots were withdrawn every 5min for 20min. The time periods needed to 
consume antioxidants were extracted from charts: [antioxidant] versus time. 
 
Oxidation of antioxidants in PBS in the presence of AIPH. 
Experiments were conducted similarly to stability measurements in PBS, except 
antioxidants were incubated in the presence of AIPH (20μmol) and aliquots were 
withdrawn every 15min for 90min (1, 3, 6 and 10) or every 5min for 25min (8 and 
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9). The time periods needed to consume antioxidants were extracted from charts: 
[antioxidant] versus time. 
 
Oxidation of PLPC (MLV) in PBS in the presence of AIPH. Antioxidants 
(26.6nmol) in methanol (100 μL) were added to PLPC (20mg) in chloroform 
(800μL). Solvents were blown off under a stream of argon to form thin films. PBS 
(1.90mL) was added to those films followed by an addition of AIPH (1.06 μmol) in 
PBS (100μL). Samples were vortexed for 2min and incubated at 37ºC for 4h. 
Every 30min, aliquots (200μL) were withdrawn, vortexed (20s) with an ice cold 
BHT/PPh3/MeOH (1.0mg/1.2mg/1mL), then vortexed (20s) with 1mL of 0.50M 
KOH/MeOH and left for 15min at rt. After that time, mixtures were vortexed (20s) 
with 1mL of aqueous NH4Cl (5%) and a hexanes extraction (2 × 1mL) was 
performed. Organic layers were combined and dried over Na2SO4, and then 
solvents were blown off under a stream of argon. The residual material was 
dissolved in 100μL of 12.5μM cinnamyl alcohol/hexanes and placed in the HPLC 
autosampler at 5oC prior to sample injection on HPLC. The lag-phase duration 
periods were extracted from charts: [PLPC-OOHs] versus time. 
 
Oxidation of PLPC (MLV) in PBS in the presence of 2,2'-azo[2-(2-
imidiazolin -2-yl) propane] {2- [2- (4-n- dodecyl) imidazolin-2-yl] propane} 
dihydrochloride (C-12). α-Tocopherol (13.3nmol) in methanol (100μL) was 
added (if applicable) to PLPC (20mg) in chloroform (800μL). Solvents were blown 
off under a stream of argon to form thin films. PBS (1.85mL) was added to those 
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films followed by an addition of an aqueous antioxidant (13.3nmol) in PBS 
(100μL), if applicable, or additional 100μL of PBS in case aqueous antioxidant 
was not used. Samples were vortexed for 2min, C-12 assymetrical initiator 
(2.12μmol) in MeOH (50μL) was added, and milky mixtures were vortexed for 
additional 20s and incubated at 37ºC for 120min (single antioxidant) or 210min 
(two antioxidants). To monitor disappearance of antioxidants, aliquots were 
withdrawn every 15min for at least 1h. In case of aqueous antioxidants, 100μL 
aliquots were vortexed (20s) with BHT/PPh3/MeOH (0.25mg/0.30mg/400μL) and 
50μL of an internal standard in MeOH. Samples were centrifuged (2min at 
10kRPM), 300μL of supernatants withdrawn, and solvents were blown off under 
a stream of argon. Residues were dissolved in 70μL of 70% aqueous MeOH (1) 
or 100μL of  50% aqueous MeOH (uric acid), and mixtures were placed in the 
HPLC autosampler at 5oC prior to sample injection on HPLC. For α-TOH 
analysis, 200μL aliquot was vortexed (20s) with BHT/PPh3/MeOH 
(0.50mg/0.60mg/700μL) and 100μL of internal standard in MeOH. Highly 
lipophilic components were extracted with hexanes (2 × 1mL), organic layers 
were combined and dried over Na2SO4. Solvents were blown off under a stream 
of argon, residues were dissolved in hexanes (60μL) and placed in the HPLC 
autosampler at 5oC prior to sample injection on HPLC. Analyses of MeLinOHs 
were performed as for oxidations initiated by AIPH. Antioxidant consumption 
profiles were shown on charts: [antioxidant] versus time; whereas the lag-phase 
duration periods were extracted from [PLPC-OOHs] versus time. 
 
 101
Partition of antioxidants between PLPC (MLV) and PBS. Antioxidants 
(52.2nmol) in methanol (100 μL) were added to PLPC (20mg) in chloroform 
(800μL). Solvents were blown off under a stream of argon to form thin films. 
Degassed PBS (2.00mL) was added to those films, mixtures were vortex (2min) 
and further degassed for 5min with bubbling argon. Vials containing milky 
suspensions were then carefully closed and incubated for 2h at 37ºC.  An 
aqueous phase was separated from the mixtures by ultrafiltration (3 × 5min at 
3500RPM with 10kD cut off).  Filtrates obtained after the initial 5min of 
centrifugation were discarded, 400μl of the remaining supernatants were 
vortexed with 400μl of an internal standard in MeOH and mixtures were placed in 
the HPLC autosampler at 5oC prior to sample injection on HPLC. The extent of 
partitioning of an antioxidant into liposomes was assign by comparison of 
[antioxidant]aq found in samples incubated with and without PLPC and otherwise 
identically following the above procedure.  
 
UV studies. Solutions of antioxidants (20μM) in benzene were transferred 
into quartz cuvettes and UV absorbance spectra were recorded. 
 
pH Titrations curves. Solutions of pyridinols (0.05 mmol) in 10 mL of 
aqueous HCl (0.1 mM) containing 25% MeOH were titrated with 25 μL portions of 
aqueous NaOH (0.1 mM) containing 25% MeOH. After addition of each portion of 
titrant, pH value was recorded (waiting for 5s for full mixing). The approximate 
first derivative was obtained by ploting the slope between the two direct 
neighbors for a certain data point. pKa Values were found from the half distances 
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between two maximums of the first derivative reflected on the pH axis via titration 
curves.  
 
Cyclic voltammetry. Solutions of antioxidants (1mM) were prepared in 
100mM phosphate buffer and degassed for at least 30min with bubbling nitrogen 
prior to measurements. Glassy carbon was used as a working electrode, 
platinum as a counter electrode, and Ag/AgCl as a reference electrode. The 
platinum electrode was flame burned whereas glassy carbon electrode was 
polished with diamond paste and sonicated in deionized water for 30s prior to 
each measurement. To ensure cleanness of electrodes blank measurement of 
degassed buffer was taken between measurements of solutions of antioxidants. 
 
Reproducibility of reported results. All experiments described herein 
were repeated at least three times and an average value (stoichiometric factor, 
rate of lipid peroxidation, rate of hydrogen atom donor autoxidation, UV 
absorption maximum, dissociation constant, percent distribution in aqueous and 
lipid phase) was reported for each measurement. In homogeneous systems, the 
repeated values were within 10% margin from the reported value. In 
heterogeneous systems, the highest standard deviation was close to 13%. 
Stability tests in aerated solvents were also repeated at least three times yielding 
consistent with each other results. 
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Research Summary (Part One) 
Free radical chain oxidation of lipids has been associated with a number 
of cardiovascular and neurodegenerative diseases. In vivo, α-tocopherol           
(α-TOH) is a major scavenger of lipid derived chain-carrying peroxyl radicals.       
It has been shown, however, that α-TOH-derived phenoxyl radicals under some 
conditions act as pro-oxidants, abstracting hydrogen atoms from lipids and 
initiating their peroxidation. Therefore, an interest exist in developing                 
an antioxidant that is a better hydrogen atom donor but also yields phenoxyl 
radicals that are more persistent than α-TOH derived species. It was previously 
demonstrated that some p-aminopyridinols possess such properties. However, 
limited quantities of these compounds could be prepared utilizing previously 
published synthetic methodology. Therefore, development of a new preparation 
route was essential to enable more extended studies on this class of compounds.   
An efficient multi-gram scale synthesis of 2-amino-5-pyridinols based on 
transformations of vitamin B6 was applied to address this issue (shown in            
a scheme below). An important advantage of this approach is the presence of      
a hydroxyl moiety in the desired position of the aromatic ring.  As a consequence, 
a low-yielding ring hydroxylation step may be avoided.  The new method also 
utilizes only simple reagents and purification methods, thus opening                 
the possibility for easy reaction scale-up. 
Antioxidant efficiency of a compound is a combination of several 
properties; its stability in the absence of radicals, its stoichiometric factor n 
(number of radicals that are quenched per antioxidant molecule), rate at which 
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the radicals are quenched by antioxidant, and persistency of the antioxidant-
derived radicals. The above properties of the newly synthesized compounds 
were studied in aprotic, aqueous as well as in heterogeneous environments. 
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Reagents and Conditions: (a) SOCl2, DMF (cat.), reflux, 30min, 99%; (b) 
Zn/AcOH, reflux, 2h, 90%;  (c) PhNH2, NaNO2, H2O, pH 8, 0°C, 1h, 87%; (d)  H2, 
Pd/C, MeOH, rt, 24-48h, 90%; (e) Zn/HCOOH, MeOH, reflux, 3h, 85%. (f) 
RCOCl, 1,2-dichloroethane, reflux, 4h; (g) (AcO)2, THF, rt, 12h; (h) NaOMe, 
MeOH, rt, 30-90min; (i) BH3•THF, THF, reflux, 2-3h, 57-64% (for f-h-i)  or 74%  
(for g-h-i). (j) HCOOH, HCHO, H2O, reflux, 42h, 85%; (k) hexanal, Na(AcO)3BH, 
AcOH, THF, rt, 6h, 80%. 
 
It was found that N-monoalkylated 2-amino-3,4,6-trimethyl-5-pyridinols (3-5) are 
superior to N,N-dialkylated analogues (6 and 7). This was due to steric 
interactions present in the latter molecules, which causes an increase in dihedral 
angle between 2-nitrogen’s p-type lone pair and the p-orbital of the adjacent 
aromatic carbon. In aerated aprotic systems, N-monoalkylated 2-amino-3,4,6-
trimethyl-5-pyridinols do not autoxidize and their stoichiometric factors are close 
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to two, which is consistent with known decomposition mechanism for vast 
majority of phenolic antioxidants.  In aerated aqueous solutions, all the tested      
2-amino-5-pyridinols are considered stable, but they autoxidize in the presence 
of a radical source (n= 0.9-1.45). A mechanism for the disappearance of these 
compounds in such systems was proposed (scheme immediately below). 
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In a heterogeneous environment consisting of oxidizable multi-lamellar 
vesicles suspended in aqueous buffer, n factors for pyridinols were generally 
greater than corresponding values measured in the buffer alone. It was found 
that distribution of pyridinolic antioxidants between phases of the heterogeneous 
system was crucial for their autoxidizability.  To the extent that a pyridinol 
partitioned into lipid bilayers, the better it was protected from self-consuming 
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reactions. It was also found in the heterogeneous systems that water soluble 
compound 1 acts as a co-antioxidant and regenerates α-TOH from                   
the corresponding phenoxyl radical, hence protecting lipids from oxidation by 
inhibiting tocopherol mediated peroxidation, TMP (scheme immediately below). 
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Such regeneration of α-TOH in heterogeneous systems is typical for water 
soluble quinols and ascorbic acid, but not for plasma abundant uric acid, which 
was used as a control aqueous radical scavenger. It is proposed that other 
structurally similar 2-amino-5-pyridinols possesses similar properties. 
Rates of hydrogen atom transfer from the pyridinols to oxidizable fatty 
esters were measured in our laboratory, where the bimolecular reaction under 
investigation competed with unimoleular transformations of fatty esters derived 
radicals. It was found that monoalkylated pyridinols (1.4 x 107 M-1s-1) gave up      
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a hydrogen atom much faster than α-TOH (3.5 x 106 M-1s-1). Some bicyclic 
pyridinols, e.g. compounds 8 and 9, have been shown to be the most reactive in 
these studies. However, they were also found to undergo very fast autoxidation 
in aqueous buffers in the presence of a radical source (n = 0.23-0.48). 
Additionally, they decomposed reasonably fast even in the absence of radical 
initiators (4.0-9.2 x 10-9 Ms-1). The instability of these compounds is expected to 
decrease their bio-utility compared to monocylic vitamin B6 analogues, which are 
proposed to be potent lipid peroxidation inhibitors in vivo (ongoing investigation).  
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Part Two 
 
 
 
 
ω-ALKYNYLATED FATTY ACIDS AS SUBSTRATES FOR 
PREPARATION OF MODIFIED PHOSPHOLIPIDS, NOVEL 
PROBES FOR EVALUATING LIPID-PROTEIN 
INTERACTIONS. 
 
 
 
 
 
 
 
 
CHAPTER IV 
 
 
INTRODUCTION 
 
 
Phospholipids as Components of Biological Membranes 
All living cells are surrounded by a membrane that separates their 
constituents from an external milieu. In other words: ”a membrane provides 
identity to a cell”.1 Sublime pathways of communication of a cell with the external 
environment are only possible because of the semi-permeability of                   
the membrane that surrounds the cell. This very property allows the membrane 
to participate in important cellular processes, such as transport, excitability, 
intercellular interaction, morphological differentiation, and fusion.1 
Biological membranes can be considered as two-dimensional matrixes 
consisting of the phospholipid bilayer that is interrupted by the presence of 
integral proteins (Figure 4.1).2 This so-called fluid mosaic model of membrane 
states that the hydrophobic interior of the membrane forms a fluidic matter.      
The components of the bilayer are held together as a consequence of             
non-covalent interactions. The lipid chains adhere to one another and to 
hydrophobic residues of the proteins due to van der Waals forces, whereas 
interactions between polar groups at the bilayer surface are mostly of coulombic 
and hydrogen-bonding types.1 
As a consequence of the nature of these interactions, both                     
the phospholipids and the integral proteins are able to move laterally in the plane 
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of the bilayer, but movement from either one face of the bilayer to another is 
restricted. Additionally, specific interactions between the components of               
a membrane produce their selective ordering and results in their segregation in 
the plane of the membrane, leading to a formation of a long-range order and     
co-operativity within the segregated domains.1 
 
 
 
Figure 4.1. The fluid mosaic model of a cell membrane.2  
 
Besides lipids (30-80%) and proteins (20-60%), biological membranes 
contain small amount of carbohydrates (up to 10%). The carbohydrates are 
exposed at the external surface of the cell and serve as recognition sites for 
signaling molecules, and other cells.  However, the amount of protein embedded 
in the bilayer is of special importance, since it is responsible for a number of 
metabolic functions of the membrane.1 
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The most abundant lipid membrane components, phospholipids consist of 
fatty acids esterified to a phosphate containing head group, derived from             
a glycerol molecule (Figure 4.2). Within this class of lipids, phosphatidylcholines 
(PCs) are major components of animal membranes. PCs typically contain both 
saturated (at sn-1 position) and unsaturated (at sn-2 position) fatty acid residues 
(Figure 5.2).1 In animals, the most abundant acyl chains are: saturated [palmitate 
(16:0) and stearate (18:0)] and polyunsaturated [linoleate (18:2) and 
arachidonate (20:4)].1
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Figure 4.2. Phospholipids classified with respect to their polar head groups.  
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Linoleic and Arachidonic Acid Derived Reactive Molecules 
Taking into account their relatively high abundance in biological 
membranes, it is not surprising that linoleic and arachidonic acid esters have 
been studied most intensively. It was found that in the presence of a free radical 
source, membrane constituents containing these acyl groups undergo chain 
oxidation processes that give rise to a rather complex mixture of products.3-7 
The pool of primary oxidation products obtained from a linoleic acid ester 
precursor is relatively small. During uninhibited lipid peroxidation,                     
the predominant products are two regioisomeric t,t-conjugated diene 
hydroperoxides (9- and 13-t,t-HPODE), and the minor products are two 
regioisomeric hydroperoxides containing two conjugated c,t-double bonds         
(9- and 13-c,t-HPODE) in their structures, Scheme 4.1.8-10 The enhanced 
formation of t,t-dienes is thermodynamically driven. Furthermore, each of the four 
HPODEs exists as mixture of two enantiomers.11  
All of these compounds may be further transformed via dehydrations 
and/or one electron reductions into a large number of secondary products, such 
as the electrophilic dienones and  α,β-unsaturated epoxides shown in Scheme 
4.2.5, 12, 13 In addition, all of the primary and secondary products with 
preserved α,β-unsaturated hydroperoxide moiety may undergo Lewis acid 
catalyzed fragmentation, referred to as Hock rearrangement, to form highly 
electrophilic  aldehydes (Scheme 4.3).14, 15 
The formation of reactive electrophiles is important for a number of patho-
physiologically relevant reasons (vide infra) and mechanisms have been written 
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for the formation of some of the compounds observed as peroxidation products. 
γ-Hydroxy-α,β-unsaturated aldehydes, such as 4-hydroxy-nonenal (HNE) are 
probably the most widely studied lipid derived electrophiles, since they have 
been found to be extremely cytotoxic.13, 15-18 One of the proposed pathways of 
the formation of HNE from 13-c,t-HPODE is presented in Scheme 4.3.15 
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Scheme 4.1. Formation of the primary linoleate oxidation products. 
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Scheme 4.2. Formation of selected electrophiles from 13-c,t-HODE. 
 
 Arachidonic acid, on the other hand, has six easily abstractable hydrogen 
atoms and its oxidation yields six regioisomeric c,t-conjugated diene 
hydroperoxides (5-, 8-, 9-, 11-, 12- and 15-HPETE) as primary products, each of 
which is a mixture of two enantiomers (Scheme 4.4).8, 19, 20 
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Scheme 4.3. A Mechanism for the Formation of HNE from 9-c,t-HPODE.15 
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As a result of intramolecular radical cyclization processes, a mixture of 
four regioisomeric bicyclic endoperoxides referred to as G2-isoprostanes           
(5-, 8-, 12- and 15-G2-IsoPs) is formed as additional primary oxidation products 
of arachidonate oxidation (Scheme 4.5). Each of the G2-IsoPs exits as a mixture 
of eight diastereoisomers.8 
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Scheme 4.4. Formation of acyclic hydroperoxides (HETEs) from arachidonate. 
 
 In addition to the aforementioned primary oxidation products, formation of 
monocyclic and serial cyclic peroxides has been observed during                     
the autoxidation of arachidonate. These compounds are believed to form as         
a result of a single or multiple 5-exo radical cyclization reactions.  
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Scheme 4.5. Formation of cyclic endoperoxides from arachidonate. 
 
All of these primary oxidation products can be further converted to α,β-
unsaturated ketones and epoxides in ways similar to those presented for 
linoleate derivatives. Additionally, Hock fragmentation of the arachidonate 
derived α,β-unsaturated hydroperoxides yields much more complex mixture of 
highly electrophilic aldehydes than the one obtained from linoleate substrate. 
A number of extremely reactive electrophiles, such as isoketals, 
malondialdehyde (MDA) and cyclopentadienone isoprostanes can be generated 
from bicyclic G2-IsoPs (Scheme 4.6).21-23 Isoprostanes H2 (H2-IsoPs) are formed 
upon one electron reduction of the hydroperoxide moiety of G2-IsoPs.24                    
As a result of a base catalyzed endoperoxide ring opening, H2-IsoPs can be 
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further converted into new classes of compounds, D2-IsoPs and E2-IsoPs, and 
corresponding isoketals (D2-IsoK and E2-IsoK) if retro aldol condensation occurs.   
A dehydration of D2 and E2 isoprostanes yields cyclopentadienone J2 and         
A2-IsoPs, respectively. On the other hand, a multistep degradation of bicyclic 
endoperoxide moiety leads to formation of MDA. 18, 21-23, 25-27 
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Scheme 4.6. Isoketals, pentadienone isoprostanes and MDA, the reactive 
electrophiles formed from bicyclic endoperoxides (shown for 15-series of IsoPs).  
 
 The PUFAs are also substrates for important enzymatic transformations.   
A family of oxygenase enzymes is mainly responsible for oxygen addition to fatty 
acids and their derivatives.  Lipoxygenases convert linoleate into HODEs and 
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arachidonate into HETEs, whereas cyclooxygenases facilitate transformation of 
arachidonate into bicyclic endoperoxides. Once formed these primary oxidation 
products may undergo further conversion into reactive electrophiles.28, 29  
Since the enzymatic catalysis is highly selective, a very stereo-specific set 
of products is formed. Therefore, the origin of the reactive electrophiles or their 
primary PUFA oxidation product precursors may be determined by evaluation of 
the enantiomeric and diastereomeric composition of the isolated products. In fact, 
an assay has been developed, which is used to evaluate the extent of free 
radical lipid oxidation in vivo that is based upon measurements of individual 
diastereoisomers of stable isoprostane products - 15-F2 series (15-F2-IsoPs), 
Figure 4.3.30 Since only PGF2α isomer is derived enzymatically, non-enzymatic 
peroxidation-derived products can be assigned by determination of the amount of 
PGF2α in the total of 15-F2-IsoP product mixture.30 It is of note that metabolism 
can complicate the analysis because stereo-isomeric species may be 
differentially metabolized. For comparison, most assays used in the past to 
quantitate oxidative damage to lipids did not distinguish between enzymatically 
formed compounds and non-enzymatic products. The most commonly used 
method of such, known as a TBAR assay was based on a measurement of a 
fluorescence response of the products obtained from a reaction between 
thiobarbituric acid and mixtures of low molecular weight products of lipid 
oxidation, mainly MDA.31 This relatively unspecific and misleading assay has 
been substituted by analysis of F2-IsoPs, which are generally referred to as gold 
standard biomarkers of oxidative stress in vivo.30, 32-34 Furthermore, the origin of 
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secondary oxidation products that retain chiral information can most likely be 
investigated on similar bases. 
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Figure 4.3. The diasereoisomers of the 15-F2-isoprostane subfamily. 
 
Assaying for isoprostanes requires utilization of either an enzyme-linked 
immunosorbent assay (ELISA) or mass spectrometry (MS).30, 32, 33, 35 For 
instance, PGF2 diastereoisomers can be separated utilizing high pressure liquid 
chromatography, followed by detection on MS upon electrospray (ESI) or 
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atmospheric pressure chemical ionization (APCI).30 The procedures based on 
LC-MS typically operate in selected reaction monitoring mode (SRM) that usually 
has excellent sensitivity, which is important while analyzing complex mixtures of 
products.8, 30 
The electrophilic oxidation products derived from linoleate and 
arachidonate form adducts with nucleophilic residues on nucleic acids, proteins 
and other biologically relevant molecules.36-41 The adduction of these 
electrophiles to nucleic acids, has to date been investigated the most extensively. 
However, the majority of the published research was focused on the reactivity of 
only a few lipid derived electrophiles. HNE, a compound that is highly abundant 
in biological membranes (up to 10μM),42 is the electrophile most widely 
investigated. It was shown that interactions of this  electrophile with DNA cause 
modulations in the expression of various genes, which may lead to serious 
disruption of important cellular functions. Furthermore, HNE affects the cellular 
redox balance (i.e. highly induces intracellular peroxide formation and                 
a stress-signaling pathway), and stimulates unfolded protein aggregation.43-45 
Covalent adduction of PUFA derived electrophiles to proteins has been 
studied less extensively. However, evidence accumulated so far suggested 
strong pathological implications of such processes. Significant amounts of 
covalently modified proteins have been found in cells of patients suffering from 
cardiovascular diseases, neurodegenerative disorders and malignancies.38, 46-48 
Again, HNE has been the most widely studied substrate for investigations 
regarding covalent modifications of proteins or peptides. For instance, it was 
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proposed that the adduction of HNE to Apo B-100 in LDL played an important 
role in the mechanism by which conversion of LDL into its atherogenic form 
occurred.46 Also, HNE may deplete cellular glutathione (GSH) by adduction, 
leading to apoptosis.49 
The protein and peptide sites which are reactive towards lipid-derived 
electrophiles are side chains of cysteine (Cys), lysine (Lys) and histidine (His).  
All of these nucleophiles may form Michael adducts with lipid peroxidation 
products that contain α,β-unsaturated carbonyl moieties in their structures. 
Additionally, ε-amino group of lysine residue may form Schiff base adducts with 
lipid-derived aldehydes. The possible adduction modes between nucleophilic 
amino acid residues and the model electrophile, HNE are presented in Scheme 
4.7.50 The hydroxyl moiety of γ-hydroxylated α,β-unsaturated aldehydes serves      
a dual function. It increases the electrophilic character of the β-carbon facilitating 
1,4-addition, and enables formation of a hemiacetal, thus  stabilizing the adduct. 
Additionally, it enables the conversion of a Schiff base to a thermodynamically 
stable pyrrole derivative, via an enamine intermediate (Scheme 4.7). The ability 
of a covalent adduct to be converted into a stable molecule may be essential for 
its stability, since the initial key steps, Michael addition and Schiff base formation 
are essentially reversible under numerous conditions.50, 51 
 Due to an existence of two electrophilic sites, α,β-unsaturated aldehydes 
via Michael addition and subsequent Schiff base formation can cause inter- and 
intramolecular protein crosslinking.  
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Scheme 4.7. Formation of covalent adducts between HNE and nucleophilic 
residues (Cys, Lys and His) of proteins or peptides.50 
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This phenomenon is illustrated in Scheme 4.8.52 Multiple sites of such 
crosslinking may lead to a cytotoxic protein aggregation.53, 54 
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Scheme 4.8. A possible mechanism of protein crosslinking by HNE.52 
 
A Novel Tool for Evaluating Phospholipid-Protein Interactions 
 Besides HNE, MDA and other low molecular weight aldehydes, one can 
imagine an enormous pool of electrophilic peroxidation products, generated in 
membranes, which are attached to a phospholipid head group. These products 
have been studied only briefly to date. However, there exists preliminary 
evidence suggesting that such compounds actively participate in atherogenesis. 
Products of this type, formed on the surface of LDL were shown to serve as 
potent ligands for scavenger receptor CD-36 presented on macrophages, leading 
to the LDL uptake and formation of foam cells.55 Furthermore, these electrophiles 
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may promote transport of monocytes, from which the macrophages are 
differentiated, into a vessel wall.56  
 Even though the chemical basis for adduct formation, i.e. Michael addition 
and Schiff base formation are unquestionable, mechanisms that governs site 
selectivity of the adductions remain unknown. Furthermore, an extremely limited 
number of studies have monitored adduction of more that one electrophile to      
a protein simultaneously. Therefore, structural features that control reactivity of 
mixtures of electrophiles in biologically relevant settings are yet to be 
established.  
 In a recently published report, a new tool for simultaneous evaluation of 
multiple adducts of phospholipid derived electrophiles to proteins was presented. 
The principles of this innovative methodology involved a synthetic preparation of 
a phospholipid molecule modified with a biotin unit, its insertion into biological 
membranes and upon adduction, isolation of the biotinylated adducts via avidin 
affinity chromatography followed by their proteomics MS analysis             
(Scheme 4.9).57 
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Scheme 4.9. A strategy proposed for simultaneous evaluation of mixtures of 
phospholipid derived electrophiles adducted to plasma proteins. 
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The structures of the synthetic phospholipid (PLPBSO) and its native analogue, 
1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphatidylcholine (PLPC) are shown in 
Figure 4.4. The modified phospholipid retains zwitterionic headgroup of the PCs 
and was concluded to have similar calorimetric and colloidal properties to those 
of PLPC.57 
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Figure 4.4. PLPBSO, a synthetic analogue of PLPC.  
 
In order to evaluate the analytical methodology, a series of oxidations in 
the presence and absence of nucleophiles have been performed in liposomal 
suspensions containing the modified phospholipid and non-oxidizable PCs.       
The biotinylated products were then isolated and analyzed.  It was found that 
during free radical initiated oxidations performed in liposomal emulsions,              
a number of PLPBSO oxidation products had formed. Overall the set of products 
obtained from the modified phospholipid was found to be similar to the one 
obtained upon oxidation of the natural analogue.57 
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It was further observed that during oxidations of PLPBSO initiated in       
the presence of a lysine containing model peptide, a number of peptide adducts 
formed. The compounds obtained have been successfully analyzed by tandem 
mass spectrometry. Following data collection, the proteomic software P-Mod has 
been used to screen for adducts.57  
 MALDI-MS analysis of the biotinylated compound mixture, obtained upon 
oxidation of a liposome emulsion in the presence of human serum albumin (HSA) 
followed by an avidin affinity separation, revealed a significant adduction of lipids 
to the protein. It was further demonstrated that HSA was a major substrate for 
modifications in human plasma, but other proteins were also found to be 
biotinylated.57  
Even though, the applied methodology yielded promising results for 
experiments conducted in vitro, one can argue that biotinylation of its polar head 
group may alter reactivity of the phospholipid in vivo. If the probe is to be used in 
complex biological settings, in cells or in living animals, it has been 
recommended that structural alterations to phospholipids should be minimized to 
ensure that modified compounds undergo the same metabolic pathway as their 
native analogues. Incorporation of alkyne unit at the ω-positions of fatty acyl 
chains only slightly alter their structures, and yet allow for their coupling to    
azido-reagents via triazole-forming click chemistry. Upon oxidation of bio-
membrane incorporated ω-alkynylated phospholipids, the phospholipid-protein 
adducts are to be coupled with azido-biotin, and they are to be purified via avidin 
affinity chromatography, prior to a tandem MS analysis (Scheme 4.10).  
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Scheme 4.10. A revised strategy proposed for simultaneous analyses of 
mixtures of phospholipid derived electrophiles adducted to protein targets. 
 
ω-Alkynylated fatty acids that have been chosen to be substrates for 
modified phospholipids [linoleic (aLA), arachidonic (aAA) and palmitic acids 
(aPA)] are presented in Figure 4.5. Additional advantage of possessing these 
free terminally modified fatty acids is a possibility of their bio-catalyzed 
incorporation into a variety of phospholipids produced by living systems.  
In the initial studies evaluating the new methodology two model 
phospholipids will be utilized: PLPC ω-alkynylated at sn-1 (aPLPC) or at both   
sn-1 and sn-2 positions (aPaLPC), Figure 4.5. Depending on the results obtained 
from those preliminary experiments, phospholipids containing alkynylated 
arachidonyl residues may also be prepared and applied in oxidation/adduction 
studies. Introduction of the alkyne group on the saturated lipid chain will allow for 
capturing of phospholipid bound adducts only, whereas ω-alkynylation of both 
acyl residues will increase the pool of the click-captured products by the adducts 
derived from small tail electrophiles. Depending on a particular problem to be 
solved, one of these classes of compounds will be utilized.  
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Figure 4.5. ω-Alkynylated fatty acids and sample phospholipids that can be 
prepared from them. 
 
Research Aims 
The aims of the research presented in Chapter V are: 
1. To establish a methodology for efficient multi-gram scale preparation of   
ω-alkynylated linoleic acid, which will be utilized in syntheses of modified 
phospholipids. 
2. To establish a methodology for efficient preparation of ω-alkynylated 
arachidonic acid, which will be utilized in synthesis of modified 
phospholipids. 
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The aims of the research presented in Chapter VI are: 
3. An evaluation of oxidizability of ω-alkynylated fatty acids; characterization 
of the primary oxidation products obtained during their chemical and 
enzymatic transformations. 
4. An evaluation of the formation of secondary electrophilic oxidation 
products from ω-alkynylated fatty acids. 
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CHAPTER V 
 
 
SYNTHESES OF TERMINALLY-MODIFIED FATTY ACIDS 
 
 
Introduction 
ω-Alkynylated fatty acids may prove to be useful for preparation of 
phospholipid-based probes that can be used to investigate lipid-protein 
interactions. The least complicated of this class of compounds to synthesize,      
ω-alkynylated palmitic acid has been made previously in two steps.1, 2 The key 
step involved an alkyne migration, commonly referred to as a zip reaction.1, 3, 4 
One can expect that preparations of ω-alkynylated polyunsaturated fatty acids 
will be more complicated. This is mainly because skipped polyenes are easily 
oxidizable (vide supra). Therefore, special care should be applied during 
chemical transformations as well as in purification procedures in order to 
minimize loses of these materials. Another synthetic challenge is a result of 
necessity of building up molecules that have multiple double bonds of specified 
(Z) geometry in their structures. Even though many C=C formation methods have 
been discovered to date, their stereo-selectivities are typically highly dependent 
on the applied substrates and reaction conditions.5 
 Since linoleic acid (LA) contains only two double bonds, synthesis of its  
ω-alkynylated analogue (aLA) was approached first. Two different approaches 
were employed. First one involved building the fatty acid from scratch (starting 
from the unsaturated chain and introducing two alkene units in separate steps). 
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Syntheses of terminally modified linoleic acids have been successfully applied 
using this approach in the past.6 Another strategy involved a cleavage of           
the 12,13-ene unit in the natural linoleic acid and reconstruction of that double 
bond with a simultaneous incorporation of a modification at the ω-position. 
Arachidonic acid (AA) is more unsaturated than linoleate, so the strategy 
based on constructing double bonds one after another would not be very 
efficient, if used. The methodology involving the 14-15-ene unit breakage 
followed by reconstruction of this bond with an introduction of a modification was 
therefore chosen to be applied in order to prepare ω-alkynylated arachidonic   
acid (aAA). 
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OHHO
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Scheme 5.1. Retro syntheses of ω-alkynylated PUFAs. 
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The methodology involving the 14-15-ene unit breakage followed by 
reconstruction of this bond with an introduction of a modification was therefore 
chosen to be applied in order to prepare ω-alkynylated arachidonic acid (aAA). 
This approach has also been used in the past to synthesize terminally modified 
arachidonic acid derivatives.7-11 The retro syntheses of ω-alkynylated 
polyunsaturated fatty acids (aPUFAs) are presented in Scheme 5.1. 
 
Synthesis of ω-Alkynylated Linoleic Acid from Scratch 
 The successful synthetic pathway consisted of eleven steps and was used 
to prepare multi-gram quantities of aLA, Scheme 5.2. 1,8-Octadiol was chosen 
as starting material, since it is inexpensive and easily obtainable. One of          
the hydroxyl groups of the substrate was protected throughout the synthesis and 
following deprotection was oxidized to the carboxylic acid moiety in the last step. 
The second hydroxyl moiety was used to build up the lipid chain of the aLA. 
Coupling of compound 4 and t-butyldimethylsilyl (TBDMS) protected 3-butynol in 
the presence of a strong base yielded internal alkyne, which upon terminal OH 
deprotection and controlled hydrogenation was converted to mono-ene 
compound 5. The hydroxyl group of 5 was then transformed into phosphonium 
iodide 6 via standard procedures.5 Compound 6 has already been reported in    
the literature and a small modification of the published procedure was applied in 
order to increase the overall efficiency of the synthesis.6  The coupling between 
compound 4 and 3-butynol was found low yielding. This was most likely due to 
interactions between the alkoxyl moiety of the alkyne and the electrophilic 
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iodinated carbon, since application of TBDMS protected 3-butynol, in place of  
the unprotected analogue, increased the yield of the coupling significantly.2  
 
HO
OH
I
OTHP
OTHPHO
OTHPPh3P
I
OH
OH
O
j,k)
a,b)
c-e)
h,i)
f,g)
3 4
5
6
7
1  
 
Reagents and Conditions: (a) 2,3-Dihydro-2H-pyran (DHP), tosic acid (TsOH), 
CH2Cl2 (DCM), rt, 1h; (b) I2, PPh3, Im, Et2O, MeCN,  0ºC -> rt, 90min, 50%        
(for a-b); (c) 3-butynyloxy-TBDMS, n-BuLi, THF, DMPU, 0ºC -> rt, overnight;     
(d) TBAF, THF, rt, 1h; (e) H2, Ni(OAc)4, NaBH4, Et(NH2)2, EtOH, rt, 3h, 52%      
(for c-e); (f) I2, PPh3, Im, Et2O, MeCN  0ºC -> rt, 90min; (g) PPh3, PhMe, MeCN, 
reflux, 72h, 94% (for f-g); (h) n-BuLi, 5-hexynal, THF, HMPA, 0ºC -> rt, 2h;         
(i) TsOH, MeOH, rt, 2h, 42% (for h-i); (j) DMP, DCM, 0ºC -> rt, 15min; (k) Jones 
oxidation, 0ºC, 15min, 80% (for j-k). 
 
Scheme 5.2. Synthesis of aLA from scratch. 
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 Wittig reaction between phosphonium iodide 6 and 5-hexynal yielded THP 
protected (9,12)-octadeca-9,12-dien-17-yn-1-ol in reasonable yield. The newly 
formed double bond was found to have the desired Z geometry in ca. 95%.12     
An alternative route leading to this compound would involve Wittig reaction 
between the carboxylic acid analogue of compound 6 and                     
5-hexynylphosphonium halide.13, 14 The strategy involving such transformation 
would be theoretically more efficient, since it would require fewer transformations 
of the longer chain substrate. This route has however not been tested, since     
the reaction involving carbonylated analogue of compound 6 with similar short 
chain phosphonium salt was reported to proceed with poor stereo-selectivity.6 
Upon deprotection of the terminal hydroxyl group, compound 7 was 
obtained, which was further oxidized in two steps to yield aLA. Direct Jones 
oxidation of alcohol 7 required a few hours to reach completion, and during that 
time some conjugated diene hydroperoxides formed. The hydroperoxides were 
further transformed into corresponding dienones, under these strong dehydrating 
conditions. Even though the amount of these byproducts did not exceed 10%, 
they were not readily separable from the desired product. Apparently, conversion 
of the alcohol into the corresponding aldehyde was problematic in the Jones 
reagent, since that aldehyde underwent oxidation to form the desired carboxylic 
acid in a matter of minutes, under the same reaction conditions. 
A conversion of the alcohol into the corresponding aldehyde was achieved 
in the presence of Dess-Martin periodinane. The reaction was very fast and 
almost quantitative and was followed by Jones oxidation to the target aLA.  
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Chromatographic purification of the final product yielded compound 1 in ca. 8% 
yield over eleven steps. The high purity of the product (≥96% Z,Z) was confirmed 
by NMR and HPLC-UV.   
 
Preparation of ω-Alkynylated Linoleic Acid from Methyl Linoleate 
 An alternative methodology has also been applied to prepare aLA 
(Scheme 5.3). This synthetic route starts from inexpensive methyl linoleate and 
involves fewer steps than the approach outlined above.15 On the other hand,     
the overall yield for this methodology was only ca. 4% (a half of efficiency of      
the “de novo” route), therefore relatively large amounts of the starting material 
had to be utilized in order to obtain multiple grams of the final product. This 
required the use of oversized laboratory equipment. A big chromatography 
column, which could separate dozens of grams of oily reaction mixtures at a time 
proved especially useful.  
 The first step, oxidation of the double bonds of methyl linoleate in           
the presence of m-CPBA, yielded a regioisomeric mixture of epoxides (9,10- and 
12,13-). This step was mainly responsible for decreasing the overall yield of      
the method. This essentially eqiumolar mixture was further hydrolyzed to yield     
a corresponding mixture of vicinal diols.16-18 Oxidative cleavage of the mixture by 
periodate led to the formation of 4 aldehydes which were subsequently reduced 
to the corresponding alcohols: hexanol, 3-nonen-1-ol, methyl                     
9-hydroxynonanoate and (Z)-methyl 12-hydroxydodec-9-enoate (10).               
The unsaturated fatty ester alcohol 10 was then converted into phosphonium 
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iodide 11 utilizing standard protocols. The Wittig reaction between compound 11 
and 5-hexynal led to the formation of the product 1, which was found to be highly 
pure (≥96% Z,Z) by NMR and HPLC-UV.  
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HO
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O
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O
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O
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OO
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OHO OH
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I
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+ 9,10-diol
c,d)
e-g)
h)
8
910
11
LA
aLA  
 
Reagents and Conditions: (a) m-CPBA, DCM,  5ºC, 5h; (b) HClO4, H2O, THF,  
5ºC, overnight; (c) NaIO4, H2O, THF,  0ºC, 60min; (d) NaBH4, MeOH, 0ºC, 45min, 
18% (for a-d); (e) I2, PPh3, Im, Et2O, MeCN  0ºC -> rt, 2h; (f) LiOH, H2O, THF, 
5ºC, overnight, 80% (for e-f); (g) PPh3, PhMe, MeCN, reflux, 48h, 77%;                    
(h) LiNH(TMS)2, 5-hexynal, THF, HMPA, -78ºC -> rt, 2.5h, 37%. 
 
Scheme 5.3. Synthesis of aLA from methyl lineleate. 
 
For syntheses of small amounts (<1g) of aLA, the method based on 
transformations of methyl linoleate is recommended. The same synthetic 
pathway may be applied during up-scaled preparations of the fatty acid, but only 
if bulky laboratory equipment is available. Otherwise, from scratch methodology 
is recommended to prepare multi-gram quantities of compound 1.  
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Preparation of ω-Alkynylated Arachidonic Acid from its natural analogue 
 As already mentioned, due to the presence of four unsaturated bonds,    
the synthesis of modified arachidonic acid from small-molecule precursors would 
be difficult. The alternative approach involves the use of arachidonic acid as     
the precursor.  A number of modifications to the ω-position of AA have been done 
by breaking the 14,15-double bond followed by its reconstruction by Wittig 
methodology.7-11  All of these protocols were based on the strategy developed for 
selective 14,15-ene cleavage by Corey that involves regiospecific intramolecular 
epoxidation of AA followed by hydrolysis and oxidative cleavage of the 14,15 
vicinal diol.19 We describe here the use of this methodology to the synthesis of  
ω-alkynylated AA.  
 The majority of the double bond reconstructive strategies toward AA 
reported involve the Wittig reaction between (5Z,8Z,11Z)-methyl                     
14-oxotetradeca-5,8,11-trienoate (an aldehyde analogue of compound 13, 
Scheme 5.4) with a short chain phosphonium salt. Although, this would provide   
a more direct route to aAA, it was observed that reaction between such              
an aldehyde and 5-hexynyltriphenyl-phosphonium salt led to formation of the AA 
isomer possessing a conjugated 11Z,13E-diene moiety in its structure.20          
The aldehyde was rarely isolated and characterized in the past due to its extreme 
instability. Since the bisallylic moiety formed in an alternative Wittig protocol   
(vide supra) was found stable, it is suggested that the formation of                     
the conjugated product has occurred due to the double bond migration from      
the 11,12- to the 12,13-position of the aldehyde prior to its reaction with the ylid.  
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Reagents and Conditions: (a) Im2CO, DCM, rt, 40min; then H2O2, LiIm (cat.), 
Et2O,  0ºC -> rt, 12h; (b) Im2CO, DCM, rt, 45min; then MeOH, rt, 2h, 55%          
(for a-b); (c) HClO4, H2O, THF,  5ºC, overnight; (d) NaIO4, H2O, THF,  0ºC, 1h;        
(e) NaBH4, MeOH, 0ºC, 40min, 55% (for c-e); (f) I2, PPh3, Im, Et2O, MeCN,      
0ºC -> rt, 2h; (g) LiOH, H2O, THF, 5ºC, overnight; h) PPh3, PhMe, MeCN, reflux, 
4d, 49% (for f-h); (i) LiNH(TMS)2, 5-hexynal, THF, HMPA, -78ºC -> rt, 2.5h, 54%. 
 
Scheme 5.4. Synthesis of aAA from its natural analogue. 
 
An alternative Wittig transformation, the reaction between compound 14 
and 5-hexynal was found to be relatively high yielding, Scheme 5.4.                
The phosphonium iodide was prepared in good yield by a standard protocol.7 
Utilizing the strategy outlined in the Scheme, aAA has been synthesized with    
ca. 8% overall yield over nine steps, and the high purity of the product          
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(≥96% Z,Z,Z,Z) has been confirmed by NMR and HPLC-UV. Due to relative cost 
of the starting material (AA) preparations of aAA have been conducted on            
a much smaller scale compared with syntheses of aLA.15 
  
Experimental Section 
General. All reagents and solvents were used as supplied commercially, 
except for HMPA, which was distilled from CaH2 and stored over molecular 
sieves. Fatty acids/esters were purchased from Nu-Check Prep Inc. (Elysian, 
MN), whereas ω-alkynylated aldehydes were obtained from TCI America. All 
other chemicals were purchased from Sigma-Aldrich Company. Ethereal 
hydrogen peroxide was obtained by extraction of 30% aqueous H2O2 with diethyl 
ether. The concentration of the reagent in the ethereal layer was found by 
iodometric titrations. Commercially unavailable 5-Hexyn-1-ol was obtained via 
PCC oxidation of the corresponding alcohol.21 TBDMS protected 3-butynol was 
synthesized in the reaction between the corresponding alcohol and TBDMS 
chloride.22  Lithium imidazole was prepared in reaction of imidazole with butyl 
lithium.23
 
All of the reactions described in this section, were performed under an 
atmosphere of argon. Purifications via flash column chromatography were carried 
out with silica gel 60 (230-400 mesh) from EMD Chemicals Inc. utilizing 
automated purification system from Biotage AB. Progress of reactions was 
monitored using F254 silica coated TLC plates purchased from EMD Chemicals 
Inc.  Spots were visualized with UV and phosphomolybdic acid. 1H and 13C NMR 
spectra were recorded on 300MHz spectrometer in CDCI3; individual peaks are 
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reported as (multiplicity, number of hydrogen atoms, coupling constants). HRMS 
analyses were performed in Laboratory for Biological Mass Spectrometry at 
Texas A&M University, College Station, TX.  
 
 2-(8-iodooctyloxy)tetrahydro-2H-pyran (4). This compound has been 
prepared from the diol 3 according to a previously published procedure, with a 
comparable yield.6 
 
(Z)-12-(tetrahydro-2H-pyran-2-yloxy)dodec-3-en-1-ol (5). This 
compound has been prepared form the iodide 4 via a modified literature 
procedure.6 To a solution of TBDMS protected 3-butynol (22.5g, 0.12mol) in THF 
(120mL) was added 2.5M n-BuLi in THF solution (55mL, 0.14mol) at 0ºC. After 
30min of stirring, the mixture was cooled down to -78ºC and a solution of 
compound 4 in a mixture of HMPA and THF (30.3g, 89mmol; 40mL; 120mL) was 
added dropwise. The mixture was stirred overnight (during that time it was 
gradually brought to rt), quenched with water and extracted with EtOAc. The 
combined organic extracts were washed with brine, dried over MgSO4 and 
condensed. The residue was chromatographed (1-10% EtOAc/Hexanes) to yield 
26g of a colorless oil.  
To this oily product (26g) dissolved in THF (270mL) was added 1M 
solution of TBAF in THF (120mL, 0.12mol). After 90min of stirring at rt, the 
mixture was poured onto brine and extracted with EtOAc. The combined organic 
layers were dried over MgSO4 and condensed. The residue was 
chromatographed (10-30% EtOAc/Hexanes) to yield 13.5g of a colorless oil.  
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To the mixture of Ni(OAc)2 x 4H2O (11.8g) and  NaBH4 (1.78g) in EtOH 
(550mL) under H2 atmosphere was added ethylenediamine (12mL) followed by a 
solution of oily alkyne product (13.5g) in EtOH (75mL). After 3h of stirring at rt, 
the mixture was filtered through celite, washed with EtOH, and the filtrate was 
condensed to leave ca. 80mL of the solution. Water was then added into it, and 
the product was extracted with hexanes. Organic layers were combined, dried 
over Na2SO4 and condensed. The residue was chromatographed (10-30% 
EtOAc/Hexanes) to yield a colorless oil (13.1g, 52% over 3 steps). NMR spectra 
of thus obtained compound 5 were identical with previously reported ones.6  
 
(Z)-triphenyl(12-(tetrahydro-2H-pyran-2-yloxy)dodec-3enyl)phospho- 
nium iodide (6). This compound has been prepared from the alcohol 5, 
essentially according to a previously published procedure, with a comparable 
yield.6 The only change that was made, involved modification of the conditions 
for the last reaction in the sequence (72h under reflux rather than 48h at 60ºC). 
 
(9Z,12Z)-octadeca-9,12-dien-17-yn-1-ol (7).  To a solution of compound 
6 (28.4g, 43mmol) in HMPA (26mL) and THF (380mL) was added 2.5M n-BuLi 
solution in THF (17.2mL, 43mmol) at 0ºC. After 40min of stirring, 5-hexynal (3.9g, 
41mmol) in THF (140mL) was added dropwise at 0ºC. The reaction mixture was 
stirred for additional 90min, and during that time it was gradually brought to rt. 
The reaction was quenched with water and the product was extracted with 
hexanes. Organic layers were combined, dried over MgSO4 and condensed. The 
residue was chromatographed (0-5% EtOAc/Hexanes) to yield 8g of a pale 
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yellow oil. 1H NMR (300MHz) δ 5.34 (m, 4H), 4.54 (m, 1H), 3.83 (m, 1H), 3.70 (m, 
1H), 3.47 (m, 1H), 3.34 (m, 1H), 2.77 (t, 2H, J = 6.0Hz), 2.16 (m, 4H), 2.02 (q, 
2H, J = 6.6Hz), 1.92 (t, 1H, J = 2.7Hz), 1.50-1.85 (m, 10H), 1.28 (m, 10H); 13C 
NMR (300MHz) δ 130.3, 129.2, 128.6, 98.8, 84.5, 68.3, 67.6, 62.3, 30.7, 29.7, 
29.6, 29.4, 29.2, 28.3, 27.2, 26.2, 26.1, 25.6, 25.4, 19.6, 17.8; HRMS Calcd for 
C23H38O2Li+ (M+Li)+  353.3032, found 353.3027. 
To a solution of this oily product (8g) in MeOH (250mL) was added     
TsOH x H2O (1.2g) at rt. After 2h of stirring, reaction was quenched with 5% 
Na2CO3 (30mL), the mixture was concentrated and partitioned between aqueous 
phase and hexanes. Organic layers were combined, dried over MgSO4 and 
condensed. The residue was chromatographed (5-20% EtOAc/Hexanes) to yield 
4.8g of a pale yellow oil. 1H NMR (300MHz) δ 5.36 (m, 4H), 3.64 (t, 2H, J = 
6.6Hz), 2.80 (t, 2H, J = 6.0Hz), 2.20 (m, 4H), 2.05 (m, 2H), 1.96 (t, 1H, J = 2.7), 
1.59 (m, 4H), 1.31 (m, 10H); 13C NMR (300MHz) δ 130.2, 129.2, 128.6, 127.7, 
84.3, 68.3, 63.0, 32.7, 29.6, 29.4, 29.3, 29.2, 28.3, 27.2, 26.1, 25.7, 25.6, 17.8;  
HRMS Calcd for C18H30OLi+ (M+Li)+  269.2457, found 269.2468. 
 
(9Z,12Z)-octadeca-9,12-dien-17-ynoic acid (1). To a solution of alcohol 
7 (4.8g, 18mmol) in DCM (100mL) was added Dess-Martin periodinone (8.2g, 
mmol) at 0ºC. The reaction mixture was stirred 10min at 0ºC and then for 5min at 
rt. A precipitate formed during the reaction was filtered off and washed with Et2O. 
The filtrate was condensed and chromatographed (0-10% EtOAc/Hexanes) to 
yield 4.4g of a pale yellow oil. 
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To a solution of this oily product (4.5g, 17mmol) in acetone (350mL) was 
added Jones reagent (5.1mL of the mixture prepared from 2g of CrO3, 2mL of 
fuming H2SO4 and 6mL of H2O) at 0ºC. After stirring for 15min, a precipitate 
formed during the reaction was filtered off, washed with acetone, and the filtrate 
was condensed. The residue was partitioned between an aqueous phase and 
EtOAc. Organic layers were combined, washed with brine, dried over MgSO4 and 
condensed. The residue was chromatographed (1-30% EtOAc/hexanes cont. 
0.1% AcOH) to yield the product as a pale yellow oil (4.0g, 80% over 2 steps).  
1H NMR δ 5.34 (m, 4H), 2.77 (t, 2H, J = 6.0Hz), 2.33 (t, 2H, J = 7.5Hz), 2.17 (m, 
4H), 2.01 (m,2H), 1.94 (s, 1H), 1.60 (m, 4H), 1.30 (m, 8H); 13C NMR (300MHz) δ 
179.5, 130.1, 129.1, 128.6, 127.8, 80.5, 68.3, 33.9, 29.5, 29.1, 29.0, 28.9, 28.3, 
27.1, 26.1, 25.6, 24.6, 17.8; HRMS Calcd for C18H2702- (M-H)- 275.2011, found 
275.2023.  
This compound was also prepared via an alternative route. To a solution 
of phosphonium iodide 11 (10.8g, 18.5mmol) in THF (225mL) and HMPA (55mL), 
was added over a 10min LiNH(TMS)2 solution (1M in THF, 38.6mL) at -78ºC. 
After addition of the base, the reaction mixture was stirred at -40ºC for 1h, and 
then it was brought back to -78ºC and 5-hexynal (1.74g, 18.1mmol) in THF 
(60mL) was added in few portions. The mixture was then allowed to gradually 
warm up to rt. over 1.5h. The reaction was quenched with water, and the pH of 
the mixture was brought to ca. 3 with 1M HCI. The mixture was partitioned 
between water (250mL) and EtOAc (4 x 200mL), and organic layers were 
combined and condensed. The residual liquid was dissolved in Et2O (150mL) 
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and it was washed with brine (5 x 150mL), the ethereal layer was then dried 
MgS04 and condensed. The residue was chromatographed (1-30% 
EtOAc/hexanes) to yield the product as a pale yellow oil (1.89g, 37%). Analytical 
data for thus obtained compound 1 matched well with the data collected for this 
products prepared from the alcohol 7 (vide supra).   
 
Methyl (Z)-12-hydroxydodec-9-enoate (10). To a solution of methyl 
linoleate (100g, 0.34mol) in DCM (2.6L), was added m-CPBA (75g, 0.43mol) at 
5ºC. After 5h, the reaction mixture was poured into sat. NaHCO3 solution (1L). 
Phases were separated, and the aqueous layer was extracted with EtOAc. The 
combined organic layers were dried with MgSO4, condensed, and the residue 
was chromatographed (1-6% EtOAc/hexanes) to yield 80g of a colorless oily 
mixture of epoxide 8 and its regioisomer.4  
To the mixture of epoxides (80g, 0.26mol) in THF (1.8L) at 5ºC was added 
dropwise a cold 5% HCIO4 solution (650mL). The mixture was stirred overnight at 
5ºC, and neutralized with 10% NaHCO3 solution. The majority of the organic 
solvent was evaporated, and the residual material was extracted with ethyl 
acetate. The combined organic layers were condensed to ca. 1L, washed with 
brine, and dried over MgSO4. Evaporation of solvents gave yellowish oil, which 
was chromatographed (5-30% EtOAc/hexanes) to yield 42g of the colorless oily 
mixture of diol 9 and its regioisomer. 
 To the mixture of diols (42g, 0.13mol) in THF (420mL) and water (160mL) 
at 0ºC, solid NaIO4 (42g, 0.20mmol) was added, and the resulting suspension 
was vigorously stirred for 1h. The mixture was then partitioned between water 
 158
and EtOAc. The combined organic layers were washed with brine, dried over 
Na2SO4 and condensed. The residual scented oil was dissolved in MeOH 
(400mL), and it was treated with solid NaBH4 (16g, 0.42mol) at rt. After 45min, 
water was added (800mL) and the mixture was stirred for additional 5min, 
followed by an extraction with EtOAc. The combined organic layers were washed 
with brine, dried over MgSO4 and condensed. The residue was chromatographed 
(10-22% EtOAc/hexanes) to yield compound 10 as a colorless oil (13.6g, 18% 
over 3 steps). 1H NMR (300MHz) δ 5.55 (m, 1H), 5.37 (m, 1H), 3.67 (s, 3H), 3.65 
(t, 2H, J = 6.6Hz), 2.32 (m, 4H), 2.06 (q, 2H, J = 6.6), 1.62 (m, 2H), 1.31 (m, 8H); 
13C NMR (300MHz) δ 174.4, 133.3, 125.0, 62.3, 51.4, 34.0, 30.8, 29.5, 29.0, 
28.9, 27.2, 24.9; HRMS Calcd for C13H24LiO3+ (M+Li)+235.1885, found 235.1890. 
 
(Z)-11-(carboxyundec-3-enyl)triphenylphosphonium iodide (11). 
To a solution of compound 10 (13.6g, 60mmol) in Et2O (220mL) and 
MeCN (80mL) were added imidazole (5.73, 85mmol), PPh3 (23.6g, 90mmol) and 
iodide (21.5g, 85mmol) at 0ºC. After 30min, mixture was brought to rt. and stirred 
for additional 1.5h. The resulting suspension was washed with 10% Na2SO3 
solution (350mL), organic layer was subsequently dried over MgSO4 and 
condensed. The residual material was chromatographed (1-5% EtOAc/hexanes) 
to yield 18g of a mixture of methyl (Z)-12-iodododec-9-enoate and PPh3 (ca. 20:1 
mol/mol). 
 The mixture was dissolved in THF (850mL) and water (160mL), and the 
solution was degassed by argon bubbling for 30min before and 30min after 
addition of 1M LiOH solution (120mL) at 5ºC. The Mixture was reacted overnight 
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at 5ºC, and the pH of the solution was brought to 3 with 1M HCl. THF was 
evaporated, and the residual material was extracted with EtOAc. The combined 
organic layers were washed with brine, dried over MgSO4 and condensed. The 
residue was chromatographed (6-40% EtOAc/hexanes) to yield 15.4g of (Z)-12-
iodododec-9-enoic acid as a colorless oil. 1H NMR (300MHz) δ 5.52 (m, 1H), 5.32 
(m, 1H), 3.14 (t, 2H, J = 7.2Hz), 2.63 (q, 2H, J = 7.2Hz), 2.35 (t, 2H, J = 7.5Hz), 
2.02 (m, 2H), 1.62 (m, 2H), 1.32 (m, 8H); 13C NMR (300MHz) δ 180.1, 132.5, 
127.8, 34.0, 31.4, 29.3, 29.1, 29.0, 28.9, 27.3, 24.6; HRMS Calcd for 
C12H21IClO2- (M+CI)- 359.0275, found 359.0282. 
To a solution of compound the above acid (15.4g, 48mmol) in toluene 
(105mL) was added PPh3 (18.1g, 69mmol) in MeCN (37mL). The mixture was 
refluxed for 96h, solvent was removed and the residual thick yellow oil was 
chromatographed (1-17% MeOH/AcOEt) yielding a mixture of compound 11 and 
silica gel, upon condensation. The mixture was partially dissolved in DCM, and 
the silica particles were filtered off. The filtrate was condensed to give the 
product as a yellow semi-solid (21.6g, 62% over 3 steps). 1H NMR (300MHz) δ 
7.77 (m, 15H), 5.53 (m, 1H), 5.49 (m, 1H), 3.73 (m, 2H), 2.44 (m, 2H), 2.33 (t, 
2H, J = 7.2Hz), 1.78 (m, 2H), 1.58 (m, 2H), 1.21 (m, 8H); 13C NMR (300MHz) 
δ 177.7, 135.2, 135.1, 133.8, 133.6, 132.7, 130.6, 130.5, 125.9, 125.7, 118.6, 
117.5, 33.9, 29.0, 28.8, 28.7, 27.1, 24.6, 23.7, 23.1, 20.6; HRMS Calcd for 
C30H36O2P+ (M-I)+ 459.2453 , found 459.2446. 
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Methyl (5Z,8Z,11Z)-14,15-epoxyeicosa-5,8,11-trienoate (12). This 
compound was prepared based on previously published procedures that 
somewhat differed in experimental detailes.7, 10, 19 The obtained yield was much 
lower then expected. Therefore, the detailed procedure that has been applied is 
reported. To a solution of arachidonic acid (5.0g, 16.4mmol) in DCM (50mL) was 
added 1,1'-carbonyldiimidazole (2.8g, 17.3mmol). After 40min of stirring, the 
resulting arachidonyl imidazolide solution was added over a 5min to a cold (ca. 
5ºC) 3.6M ethereal solution of hydrogen peroxide (120mL) containing lithium 
imidazole (25mg, 0.34mmol). Followed the addition, mixture was stirred for 5min, 
diluted with DCM (125mL) and treated with powdered anhydrous KHSO4 (35g). 
The mixture was stirred for another 5min, solids were then removed by filtration 
and the resulting filtrate was kept over anhydrous Na2SO4 (10g) overnight at rt., 
under an argon atmosphere. The drying agent was filtered off, and the filtrate 
was washed with brine (5 x 50mL). The organic layer was then dried over 
MgSO4, and solvents were removed yielding a colorless oil. The oil was 
dissolved in DCM (45mL) and it was treated with 1,1'-carbonyldiimidazole (4.2g, 
26mmol). After 45min, MeOH (8mL) was added and the mixture was stirred for 
additional 2h. Solvents were evaporated, and the residue was partitioned 
between water and ethyl acetate. The combined organic layers were washed 
with brine, dried over MgSO4 and condensed. The residue was chromatographed 
(1-7% EtOAc/hexanes) to yield compound 12 as a colorless oil (3.0g, 55%).        
Spectral characterization data set for thus obtained product was identical with 
already published data set.10 
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 Methyl (5Z,8Z,11Z)-14-hydroxytetradeca-5,8,11-trienoate (13). The 
hydrolysis part of the following protocol was written based a literature report,10 
whereas the conditions for other reactions have been optimized experimentally. 
To a solution of compound 12 (3.0g, 9.1mmol) in THF (80mL) at 5ºC was added 
dropwise a cold 10% HCIO4 solution (27mL). The mixture was stirred overnight at 
5ºC, and it was then neutralized with solid NaHCO3. The majority of the organic 
solvent was evaporated, and the residual material was extracted with EtOAc. The 
combined organic layers were washed with brine, dried over MgSO4 and 
condensed. The residue was chromatographed (10-30% EtOAc/hexanes) to yield 
2.4g of (5Z,8Z,11Z)-methyl 14,15-dihydroxyicosa-5,8,11-trienoate as a colorless 
oil.  
To a mixture of that diol (2.4g, 6.8mmol), THF (30mL) and water (12mL) at 
0ºC, solid NaIO4 (2.18g, 10.2mmol) was added, and the resulting suspension 
was vigorously stirred for 1h. Mixture was then partitioned between water (40mL) 
and EtOAc (4 x 20mL). The combined organic layers were washed with brine, 
dried over Na2SO4 and condensed. The residual scented oil was dissolved in 
MeOH (20mL), and it was treated with solid NaBH4 (0.86g, 22.7mmol) at 0ºC. 
After 35min, water was added (40mL) and the mixture was stirred for additional 
5min, followed by an extraction with Et2O. The combined organic layers were 
washed with brine, dried over MgSO4 and condensed. The residue was 
chromatographed (10-30% EtOAc/hexanes) to yield the product as a colorless oil 
(1.25g, 55% over 3 steps). Analytical data for thus obtained compound 13 
matched well with the data presented for this compound in the literature.7   
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(3Z,6Z,9Z)-13-carboxytrideca-3,6,9-trienyl)triphenylphosphonium 
iodide (14). To a solution of compound 13 (1.25g, 5.0mmol) in Et2O (18mL) and 
MeCN (6mL) was added imidazole (0.47g, 7.0mmol), PPh3 (1.97g, 7.5mmol) and 
iodide (1.78g, 7.0mmol) at 0ºC. After 30min, mixture was brought to rt. and 
stirred for additional 1.5h. The resulting suspension was washed with 10% 
Na2SO3 solution (25mL), organic layer was subsequently dried over MgSO4 and 
condensed. The residual material was chromatographed (1-5% EtOAc/hexanes) 
to yield 1.6g of a mixture of Methyl (5Z,8Z,11Z)-14-iodotetradeca-5,8,11-trienoate 
and PPh3 (ca. 20:1 mol/mol).  
The mixture was dissolved in THF (60mL) and water (12mL), and the 
solution was degassed by argon bubbling for 20min before and 20min after 
addition of a cold 1M LiOH solution (9mL) at 5ºC. Mixture was reacted overnight 
at 5ºC, and the pH of the solution was brought to 3 with 1M HCI. THF was 
evaporated, and the residual material was extracted with EtOAc. The combined 
organic layers were washed with brine, dried over MgSO4 and condensed. The 
residue was chromatographed (10-40% EtOAc/hexanes) to yield 1.4g of 
(5Z,8Z,11Z)-14-iodotetradeca-5,8,11-trienoic acid as a colorless oil. 1H NMR 
(300MHz) δ 5.52 (m, 1H), 5.37 (m, 5H), 3.15 (t, 2H, J = 7.2Hz), 2.81 (m, 4H), 
2.67 (q, 2H, J = 7.2Hz), 2.38 (t, 2H, J = 7.5Hz), 2.14 (m, 2H), 1.72 (m, 2H); 13C 
NMR (300MHz) δ 179.9, 130.3, 128.9, 128.8, 128.4, 128.3, 127.7, 33.4, 31.4, 
26.4, 25.8, 25.6, 24.4; HRMS Calcd for C14H21IO2CI- (M+CI)- 383.0275, found 
383.0270. 
To a solution of compound this oily compound (1.4g, 4.0mmol) in toluene 
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(9.6mL) was added PPh3 (1.57g, 6.0mmol) in MeCN (3.8mL). After the mixture 
was refluxed for 96h, solvent was removed and the residual thick yellow oil was 
chromatographed (1-23% MeOH/AcOEt) yielding upon condensation a mixture of 
product and silica gel. The mixture was partially dissolved in DCM, and the silica 
particles were filtered off. The filtrate was condensed to give salt 14 as a yellow 
semi-solid material (1.5g, 49%). 1H NMR (300MHz) δ 7.77 (m, 15H), 5.53 (m, 
1H), 5.30 (m, 5H), 3.75 (m, 2H), 2.63 (m, 4H), 2.49 (m, 2H), 2.34 (t, 2H, J = 
7.2Hz), 2.05 (m, 2H), 1.64 (m, 2H); 13C NMR (300MHz) δ 177.4, 135.2, 135.1, 
133.7, 133.6, 130.7, 130.6, 130.5, 129.0, 128.7, 128.5, 127.0, 126.3, 126.1, 
118.5, 117.4, 33.4, 26.4, 25.6, 24.4, 23.5, 22.9, 20.3; HRMS Calcd for 
C32H36O2P+ (M-I)+ 483.2453, found 483.2447. 
 
 (5Z,8Z,11Z,14Z)-eicosa-5,8,11,14-tetraen-19-ynoic acid (2). To a 
solution of phosphonium iodide 14 (1.5g, 2.4mmol) in THF (30mL) and HMPA 
(7mL) was added dropwise 1M solution of LiNH(TMS)2 in THF (4.8mL, 4.8mmol) 
at -78ºC. After addition of the base, the mixture was stirred at -40ºC for 40min, 
and then it was brought back to -78ºC and 5-hexynal (0.23g, 2.4mmol) in THF 
(9mL) was added dropwise. The mixture was then allowed to gradually warm up 
to rt. over a period of 100min. The reaction was quenched with water, and the pH 
of the mixture was brought to 3 with 1M HCl. The mixture was partitioned 
between water (50mL) and EtOAc (4 x 30mL), organic layers were combined and 
condensed. The residual liquid was dissolved in Et2O (30mL) and it was washed 
with brine (5 x 30mL), the ethereal layer was then dried over MgSO4 and 
condensed. The residue was chromatographed (1-28% EtOAc/hexanes) to yield 
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compound 2 as a pale yellow oil (0.39g, 54%). 1H NMR (300MHz) δ 5.35 (m, 8H), 
2.82 (m, 6H), 2.35 (t, 2H, J = 7.5Hz), 2.18 (m, 6H), 1.94 (s, 1H), 1.70 (m, 2H), 
1.60 (m, 2H); 
13
C NMR (300MHz) δ 179.5, 129.0, 128.9, 128.8, 128.7, 128.3, 
128.2, 128.1, 128.0, 127.9, 84.4, 68.4, 33.2, 28.2, 26.4, 26.1, 25.6, 25.5, 24.4, 
17.8; HRMS Calcd for C20H2702- (M-H)- 299.2011, found 299.2009. 
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CHAPTER VI 
 
 
PROPERTIES OF ω-MODIFIED FATTY ACIDS 
 
 
Introduction 
 The ultimate use of alkynylated phospholipids is the investigation of 
protein-lipid interactions in biological fluids, tissues and isolated cells (vide supra) 
that result from lipid peroxidation. We report in this chapter several studies that 
confirm the utility of the compounds.  We first investigated the radical oxidation of 
ω-alkynylated linoleate and arachidonate to determine if their radical oxidation 
chemistry was analogous to the authentic lipids. We chose to study the oxidation 
chemistry of alkynylated fatty acids instead of modified phospholipids. It was 
anticipated that free PUFAs would undergo essentially the same types of 
transformations as their esters and the analysis of aLA and aAA oxidation 
products was expected to be easier than analysis of products derived from 
oxidation of phospholipids.1 All of the studies presented in this chapter involved 
side by side oxidations of aPUFAs with their natural analogues and the products 
obtained from these transformations were directly compared.  The analyses were 
typically qualitative; however some quantitative data has also been collected. 
Major primary oxidation products of aLA and aAA have been well characterized, 
whereas identification of aPUFAs secondary oxidation products, due to their 
number, have only been investigated in preliminary studies.  ω-Alkynylated                
4-hydroxynonenal (aHNE) was an exception to this general approach, its 
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formation from aLA and aAA was confirmed in several studies.2, 3 This compound 
was also used as a model electrophile in adduction studies to lysine containing 
peptides. Formation of other highly reactive electrophiles, alkynylated isoketals 
and cyclopentenone isoprostanes, has been confirmed in peptide/protein 
adduction studies and enzymatic transformations of aLA and aAA have been 
investigated as well, Products of the lipids promoted by lipoxygenase and 
cyclooxygenase were characterized and relevant kinetic parameters have been 
measured. 
 
Formation of Primary Oxidation Products from Alkynylated Linoleic Acid 
 On peroxidation of linoleic acid four conjugated diene hydroperoxides 
(HPODEs) are produced as primary products.  Formation of analogous,              
ω-alkynylated compounds (aHPODEs) was therefore expected to result from 
oxidation of aLA. Both LA and aLA were therefore incubated in benzene, in       
the presence of radical initiator MeOAMVN. After the radical reaction was 
terminated by addition of an antioxidant, PPh3 was added to the reaction mixtures 
in order to reduce (a)HPODEs to the corresponding alcohols (a)HODEs, which 
are more stable and better suited for analysis. Sample chromatograms profiling 
conjugated dienols formed during these incubations are shown in Figure 6.1.  
Upon incubation of an equimolar mixture of both substrates, similar 
amounts of HODEs and aHODEs were obtained. The quantification statements 
presented above were based on the assumption that extinction coefficients 
(ε235nm) for HODEs and aHODEs were equal. 
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Figure 6.1. Elution profiles for conjugated dienol products obtained upon 
incubation of 4.5mg of LA (A) or aLA (B) with MeOAMVN (1.8mg) in benzene 
(200μL) for 45min at 37ºC, followed by reduction of the corresponding 
hydroperoxides with PPh3. Separation conditions are given in the experimental 
section. 
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This assumption was justified, since an isolated alkyne was found not to 
significantly absorb light at 235nm, and the strong chromophores - conjugated 
dienols, were identical in both classes of compounds. Additional support for 
equal oxidizability of modified and natural linoleic acid was obtained from to 
similarities of the observed ratios of c,t/t,t oxidation products.4 From these ratios 
of kinetic (c,t) to thermodynamic (t,t) products, it could be concluded that bisallylic 
hydrogen atoms abstractabilities in LA and aLA were approximately equal.5 
 To confirm that aHODEs were the products obtained from modified linoleic 
acid, the compounds were isolated by HPLC and analyzed by MS and NMR.  
The MS fragmentation profiles for HODEs have been previously reported.6  Upon 
cleavage of the weakest bonds of the deprotonated HODEs (bonds between 
hydroxylated carbon and the neighboring sp2 carbon atom), fragments of 171m/z 
(9-isomers) and 195m/z (13-series) have been observed. Since these fragments 
do not contain ω-carbons of the precursor in their structures, identical ions are 
expected to be observed during fragmentation of aLA, Scheme 6.1. MS analyses 
of the isolated aHODEs were performed via direct injections of solutions of 
HODEs into the ESI-MS source. Negatively charged parent ions at 291m/z were 
fragmented in the triple quadrupole setup, and locations of the hydroxyl moieties 
were deduced from the observed daughter ions (171 or 195m/z).  
Even though the above MS2 experiments suggested that the two initially 
eluted peaks in Figure 6.1B were 13-aHODEs, whereas the remaining two peaks 
were 9-aHODEs, the geometry of the double bonds was unknown. In order to 
solve this issue, NMR experiments were conducted.7 
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Scheme 6.1. Regiospecific fragmentation of (a)HODEs. 
 
Determination of coupling constants between vinyl protons permits the geometry 
of a carbon-carbon double bond to be deduced. Typically, if a coupling constant 
(J) is greater than 14Hz, the bond has trans geometry.7, 8 Spectra of the second 
and last eluting compounds in Figure 6.1B showed that all the vinyl protons 
coupled with 15±0.5Hz frequency, suggesting t,t geometry of these dienes.  
Spectra of the first and third eluting compounds showed only two vinyl protons 
coupled with J=15Hz, therefore the geometry of these dienes was assigned to be 
c,t. Furthermore, 2-D COSY NMR experiments confirmed that the compounds of 
interest were indeed conjugated dienols.9 Structural analysis analogous to        
the one presented above was performed in the past for linoleate-derived 
HODEs.7, 10 Based on the above results, it is concluded that the elution order of 
the isomeric ω-alkynylated HODEs is the same as the elution order observed for 
native linoleic acid oxidation products - HODEs, Figure 6.1.11 Sample proton 
spectra for 9-HODEs are shown in Figure 6.2. 
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Figure 6.2. Sample 1H NMR spectra of 9-t,t-aHODE (A) and 9-c,t-aHODE (B). 
 
Formation of Acyclic Primary Oxidation Products from                  
Alkynylated Arachidonic Acid 
 Peroxidation of arachidonic acid yields a mixture of acyclic (HPETEs) and 
cyclic hydroperoxides as primary products (vide supra). Due to formation of 
numerous products, the isolation of sufficient amounts of the acyclic compounds 
that were required for their full characterization was problematic under typical, 
MeOAMVN initiated, uninhibited oxidation condition. On the other hand, when    
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α-TOH was present during the oxidation as a hydrogen atom donor,                 
the formation of HPETEs (or their ω-alkynylated analogues, aHPETEs) was 
nearly exclusive, but the yields obtained from inhibited peroxidation was 
understandably poor. In order to produce quantities (ca. 100μg) of aHPETEs 
sufficient for analysis, oxidations were conducted in the presence of N-methyl 
benzohydroxamic acid (NMBHA), an efficient catalyst for radical based oxygen 
insertion reactions.12 Analysis was performed on (a)HETEs, formed by reduction 
of the corresponding hydroperoxides. Since six regioisomeric HETEs are formed 
during oxidation of AA, the same number of products is expected from oxidation 
of aAA.13 Sample chromatograms profiling conjugated dienols obtained from    
the oxidations in the presence of α-TOH are shown in Figure 6.3.  
As shown in the below chromatograms, the elution profile for aHETEs was 
similar to the profile obtained for their natural analogues. In both mixtures, ratios 
of the products were close to 1:1:1:1:1:1, which was expected from the inhibited 
peroxidation reaction.14 Furthermore, total amounts of acyclic hydroperoxides 
formed from AA and its alkynylated analogue were nearly identical.15 Additionally, 
oxidation of equimolar mixtures of AA and aAA yielded nearly equimolar mixtures 
of HETEs and aHETEs, suggesting similar oxidizabilities for both substrates 
(data not shown). 
To confirm the structures of peroxidation products obtained from modified 
arachidonic acid, compounds were isolated by HPLC and analyzed by MS and 
NMR. The MS analysis of aHETEs were similar to those observed for aHODEs.7 
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Figure 6.3. Elution profiles for conjugated dienol products obtained upon 
incubation of 2mg of AA (A) or aAA (B) with α-TOH (100μg) in thin film for 24h at 
37ºC, followed by reduction of the corresponding hydroperoxides with PPh3. 
Separation conditions are given in the experimental section. 
 
The fragmentation patterns for HETEs, however, gave typically more than 
one characteristic ion, and some of the spectra showed ω-terminal fragments of 
the precursor.16 Fragmentation of the deprotonated aAA yielded the expected 
daughter ions (Scheme 6.2) from which locations of the hydroxyl moieties were 
deduced. A sample tandem mass spectrum for 5-aHETE is presented in      
Figure 6.4. 
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Scheme 6.2. Regiospecific fragmentation of aHETEs. 
 
Since all of the conjugated dienes formed during inhibited peroxidation of 
AA were shown to have c,t-geometry,17 NMR structural analysis has been 
conducted on the isolated aHETEs to support the expected analogy in the double 
bond geometry. 1-D and 2-D NMR experiments were conducted in the way 
similar to the aHODEs. Careful analyses of the spectra (data not shown) 
supported the expected c,t-configuration of the conjugated dienes in aHETEs.   
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All the above experiments taken together confirmed that the elution order of      
the isomeric ω-alkynylated HETEs is the same as the elution order observed for 
native arachidonic acid oxidation products, HETEs (Figure 6.3).13 
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Figure 6.4. Sample ESI-MS2 spectrum obtained for isolated 5-aHETE. 
 
Formation of Some Cyclic Primary Oxidation Products from                  
Alkynylated Arachidonic Acid 
 Besides HETEs, a number of cyclic primary oxidation products are 
obtained from AA during free radical oxidation (vide supra). Bicyclic 
endoperoxides (G2-IsoPs) are of special interest, since they are known to be 
precursors for many biologically active compounds.18-21 In order to confirm       
the formation of ω-alkynylated analogues of bicyclic endoperoxides (aG2-IsoPs) 
from aAA, it was incubated in aprotic solvent in the presence of the free radical 
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initiator MeOAMVN.22 The aG2-IsoPs generated in this way were further 
converted into the alkynylated F2 isoprostanes (aF2-IsoPs) by P(OMe)3 in wet 
acetonitrile. Arachidonic acid was subjected to identical transformations in 
experiments carried out side by side with aAA. HPLC elution profiles for major 
(a)F2-IsoPs are shown in Figure 6.5.  
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Figure 6.5. Reverse-phase HPLC/MS chromatograms of aAA and AA oxidations 
detected by Selected Reaction Monitoring (SRM).  Isoprostanes [A (5-aIsoPF2), 
B (5-IsoPF2), C (15-aIsoPF2), D (15-IsoPF2)] formed upon oxidation of 2mg of AA 
(B and D) or aAA (A and C) in the presence of MeOAMVN (0.3mg) in benzene 
(60μL) for 24h at 37ºC, followed by reduction with P(OMe)3 in MeCN/H2O.  SRM 
was as follows: 5-aIsoPF2; 349m/z->115m/z, etc. Separation conditions are given 
in the experimental section. 
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Chromatograms of the 5- and 15-series (a)F2-IsoPs are shown in the Figure 
since these compounds are formed in a large access compared to the  8- and 
12-regioisomes.22 The preference for formation of the 5- and 15-regioisomers 
has been observed in the oxidation reactions of arachidonic acid and                   
a mechanism proposed to account for the observation.22, 23 Similar regio-
selectivity is observed for the transformations of aAA. 
In order to obtain the chromatograms presented in Figure 6.5, an ESI-MS 
triple quadrupole instrument was operated in selected reaction monitoring (SRM) 
mode. More precisely, transitions of negatively charges ions of 349m/z           
(aF2-IsoPs) or 353m/z (F2-IsoPs) into 115m/z (5-series) and 193m/z (15-isomers) 
have been monitored. During past studies, these fragmentations have been 
shown to be regio-specific and to occur very readily.22 Full MS2 spectra of 
individual species, represented by peaks at Figures 6.5A and 6.5C, did confirm 
that the product ions chosen for SRMs gave the strongest signals.  
The elution profiles observed for the 5- and 15-F2-IsoPs (Figure 6.5B and 
6.5D, respectively) were consistent with previous reports, and were similar to 
those obtained for the ω-alkynylated analogues (Figures 6.5A and 6.5C).22         
As can be seen in the chromatograms, not all of the aF2-IsoP diastereisomers 
can be separated under the reverse phase HPLC conditions applied. Attempts 
were made to improve the separation, but they were not successful. Separation 
of the diastereoisomeric aF2-IsoPs was observed to be somewhat worse 
compared to separation of the non-alkynylated compounds, Figure 6.5.  
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Terminal Alkyne Reactive Electrophiles Derived from aLA and aAA 
 Due to availability of the substrates as well as the expected relative 
simplicity of product mixtures (vide supra), reactive electrophiles formed during 
aLA oxidation were analyzed first. Initial studies were planned to provide 
evidence for the formation of as many electrophilic products as possible. 
Identification of compounds analogous to those proposed to form during           
the oxidation of LA is of special interest.2, 3, 24 Upon side by side incubation of 
aLA and LA in the presence of the free radical initiator MeOAMVN, mixtures were 
treated with BHT (to stop radical processes) and PPh3 (to reduce hydroperoxides 
into corresponding alcohols).  This reaction sequence was followed by analysis 
by RP-HPLC-UV or RP-HPLC-MS. 25 
A number of peaks were detected in UV chromatograms (data not shown), 
while monitoring wavelengths in the range of 220-280nm.3, 10, 26 Unfortunately, 
the identity of a majority of them could not be confirmed by MS studies. 
Compounds that were tentatively identified were 9,12-dioxododec-10-enoic acid 
(KODA) possibly formed upon Hock cleavage of 9-aHPODEs followed by 
dehydration of thus produced 9-hydroperoxy-12-oxo-10-dodecenoic acids,3      
and conjugated dienones resulted from dehydration of aHPODEs (Figure 6.6).10 
Their UV and MS characteristics (not shown) matched well or were analogous to 
the previously reported ones.3, 10 
Upon oxidation of aLA, the product mixtures were incubated in aqueous 
solutions of a lysine containing model peptide, TpepK (Ac-Ala-Val-Ala-Gly-Lys-
Ala-Gln-Ala-Arg). During these incubations, aLA derived electrophiles were 
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thought to be adducted to TpepK. Similar experiments have been conducted 
using native LA, side by side with its alkynylated analogue. Since the initial 
processes, Michael adduction and Schiff base formation are reversible           
(vide supra), adducts have been stabilized by reduction in the presence of 
NaCNBH3.27 The mixtures were separated by RP-HPLC and analyzed in an ion 
trap mass spectrometer.  
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Figure 6.6. Structures of the tentatively identified aLA secondary oxidation 
products. 
 
Formation of adducts of (a)LA derived electrophiles to TpepK were 
confirmed by the observed m/z signals in ESI-MS as well as by the fragmentation 
patterns observed in MS2. In peptides, amide bonds are the easiest bonds to be 
broken under typical MS conditions.28 Such fragmentations yield so-called              
b (N-terminal fragment) and y (C-terminal fragment) cations. Analysis of b and y 
ions has been used for a number of purposes, ranging from sequencing of the 
unknown peptides to localization of modifications to proteins or peptides.28 For 
the purpose of the investigation described here, analysis of these ions was 
performed to confirm that the relative increase of the peptide mass due to the 
adduction was localized at the lysyl residue of TpepK.27 
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Figure 6.7. Relative RP-HPLC/MS elution observed for the 1,4- (A) and 1,2- (B) 
adducts of aHNE (from aLA peroxidation) in the presence of TpepK (Ac-Ala-Val-
Ala-Gly-Lys-Ala-Gln-Ala-Arg). Detection was by HPLC/MS monitoring species at 
490.8±0.4m/z (A) and 481.8±0.4m/z (B) respectively. Fragmentation patterns     
(b and y ions) obtained upon breakage of the peptide bonds of the Michael (C) 
and Schiff base (D) parent ions are shown. Separation conditions are given in     
the experimental section. 
 
Analyses of the mixtures obtained upon incubation of oxidized aLA in     
the presence of the model peptide confirmed formation of Michael as well as 
Schiff base adducts of aHNE to TpepK, Figure 6.7. MS2 spectra of the ions 
corresponding to the doubly charges aHNE-TpepK adducts contained nearly all 
of the expected b and y ions. Furthermore, synthetic aHNE prepared in our 
laboratory,29 upon incubation with TpepK and analogous LC-MS analysis yielded 
peaks of identical retention times and fragmentation patterns. On the other hand, 
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HNE-TpepK adducts obtained by incubation of LA oxidation products with the 
model peptide, eluted as predicted a bit later then their alkynylated analogues.  
For both HNE and aHNE adducts, the Michael-type adduct was eluted 
earlier than the Schiff base.  It was also observed that the peak areas of both 
adducts of HNE were very close to the areas of aHNE adducts obtained side by 
side. This suggests that both compounds form and are adducted to TpepK with 
similar rates. However, in order to support this suggestion, detailed kinetic 
experiments would need to be performed.  
Since AA derived cyclopentenone isoprostanes and isoketals have been 
shown to possess biologically significant activity,17-20 it was decided to focus on 
detection of ω-alkynylated versions of these compounds produced from aAA.     
In order to confirm the formation of aA2/J2-IsoPs, aAA was subjected to a series 
of transformations. First, it was oxidized in aqueous solution of AIPH. Then      
the resulting mixture was treated with reducing agent, P(OMe)3, and  products of 
interest were dehydrated on prolonged incubation in the presence of HCl.        
The mixture was then incubated with glutathione (GSH) in the presence of 
glutathione transferase (GST) and the resulting GSH-aIsoP Michael adducts 
were analyzed by ESI-MS2, using a triple quadrupole instrument. Similar 
protocols have been applied to prove or quantitate formation of A/J-IsoPs,           
in the past.30-32 A schematic representation of the transformations applied to aAA 
is shown in Scheme 6.3.  
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Scheme 6.3. Schematic representation of the methodology (involving formation 
of GSH adducts) that was used to confirm formation of alkynylated 
cyclopentenone isoprostanes from aAA (shown for 15-aA2-IsoPs).  
 
The above scheme shows a typical fragmentation of the GSH-IsoP ions.31 The   
S-C bond formed in the Michael adduction fragments most readily in the MS.  
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Figure 6.8. RP-HPLC elution profiles observed for aA2/J2-IsoPs (A) and         
A2/J2-IsoPs (B) adducted to GSH, while monitoring conversions of the parent 
ions into protonated GSH and dehydrated (a)A2/J2-IsoPs. Separation conditions 
are given in the experimental section. 
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Cleavage of this bond yields GSH and A/J-IsoPs, which are subsequently 
dehydrated. Alternatively, side chain dehydration can occur prior to S-C bond 
cleavage. Elution profiles for A2/J2-IsoP-GSH adducts and their, side by side 
produced, aAA-derived analogues are shown in Figure 6.8. Full MS2 
characterization of the parent ions of interest is also presented (Figure 6.9). 
 
 
A 
 
 
 
 
 
 
 
 
 
B  
 
 
 
 
(A2/J2-IsoP-H2O+H)+ 
 
 
 
 
Figure 6.9. Full MS2 characterization of the parent ions of GSH adducts to    
A2/J2-IsoP (B) and their alkynylated analogues (A). 
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 Formation of ω-alkynylated IsoKs has been supported using a quite 
different method. The experiments were conducted by Dr. Sean Davies of 
Vanderbilt University Department of Clinical Pharmacology, an expert in the field 
of isoketals formation and reactivity.33 After incubation of ovalbumin in              
the presence of aAA and a radical initiator, t-butyl hydroperoxide (TBHP) to form 
lipid modified protein, the modified protein was proteolytically digested by 
pronase and aminopeptidase M to its amino acid constituents. This mixture of 
amino acids was subjected to MS analysis in order to investigate if any Lys-IsoK 
adducts were formed. Adduction of lysine to IsoKs initially leads to formation of 
hemiaminals that may be further converted to Schiff bases or pyrroles. The latter 
typically undergo facile oxidation to form more stable lactams and 
hydroxylactams, Scheme 6.4.18  
 
HO
O
NH
R1
R2
Lys
O
O
R1
R2
O
N
R1
R2
Lys
N
R2R1
OHHO
Lys
N
R2R1
Lys
N
R2R1
Lys
O
Lys
PyrrolePyrrolidine
ImineHemiaminal
Lactam
IsoK
- 2H2O O2
N
R2R1
Lys
O
Hydroxylactam
HO
 
 
Scheme 6.4. Mechanism for formation of lysine-isoketal adducts.18 
  
Routine analysis focuses on LC-MS2 (SRM mode) identification of          
the lactams, since they are usually the most abundant forms of adducts.19          
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The elution profile for Lys-aIsoK adducts compared to a Lys-IsoK standard 
mixture is shown in Figure 6.10. Retention times for alkynylated analytes were 
found to be a bit smaller than corresponding values for terminally unmodified 
adducts. Under RP-HPLC conditions, this was in agreement with our 
expectations based on the observed chromatography of other alkynyl adducts. 
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Figure 6.10. RP-HPLC-MS2 elution profiles for lysine adducts to aIsoKs (A),  475 
->84m/z,  and IsoKs (B), 487->90m/z . aIsoK-Lys adducts were obtained upon 
oxidation (10μmol TBHP) of aAA (25μg) in the presence of ovalbumin (10mg), 
followed by degradation of the protein to its constituent amino acids. Radio-
labeled IsoK-Lys adducts were formed in reaction of 13C615N2-Lys with a mixture 
o 15-IsoKs. Sample structures of adducts are shown for lactam adducts of lysine 
to 15-series (a)IsoKs.33 LC/MS conditions used as reported previously.18,19 
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  The preliminary data presented suggests that aPUFAs undergo similar 
transformations to ones reported for their natural analogues, yielding electrophilic 
products. Since oxidizabilities of PUFAs and aPUFAs have been found to be 
similar, proximal relevant properties of natural and alkynylated phospholipids are 
also expected.  
 
Transformations of ω-Alkynylated Polyunsaturated Fatty Acids                            
in the Presence of Oxygenase Enzymes 
 Behavior of the alkynylated compounds in the presence of two widely 
available classes of bio-catalysts, lipoxygenases (LOXs) and cyclooxygenases 
(COXs), is of special interest since products of reactions catalyzed by these 
enzymes may be further transformed into reactive electrophiles (vide supra).  
 In an initial set of experiments, aLA and aAA were incubated in              
the presence of highly oxygenated solutions of soybean lipoxygenase, and       
the products of enzymatic conversion were characterized.  The natural PUFAs 
were incubated under identical conditions, to insure that the enzymes and assays 
were working as expected. LA and AA were exclusively transformed into      
13(S)-c,t-HPODE and 15(S)-HPETE (data not shown)34 and similar 
transformations of aLA and aAA were observed. RP-HPLC elution profiles of 
product mixtures obtained during chemical and enzymatic aLA oxidation are 
shown in Figures 6.11A and 6.11C. 
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Figure 6.11. Elution profiles for aHODEs obtained from enzymatic (A) and 
chemical (C) oxidation. Chiral phase elution profiles for 13-c,t-HODEs methyl 
esters isolated from enzymatic (B) and chemical (D) oxidation mixtures. 
Separation conditions are given in the experimental section. 
 
As shown in the Figure, the retention time of the single product obtained 
from aLA in the presence of soybean lipoxygenase corresponded to                 
13-c,t-aHODE. It was also established that the amounts of the HODE or           
the HETE formed from LA or AA in the presence of soybean LOX were similar   
(<20% difference) to the corresponding amounts of the aHODE or the aHETE 
produced from aLA and  aAA, respectively. Furthermore, equimolar mixtures of 
aLA and LA as well as aAA and AA subjected to enzymatic transformations 
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yielded comparable amounts of alkynylated and non-alkynylated products on 
total consumption of starting materials. On the other hand, when a reaction was 
quenched before the substrates were completely consumed, it was found that 
natural substrates were oxidized somewhat faster than the modified fatty acids 
(data not shown).  
The optical purity of the LA lipoxygenase product was assigned based on 
HPLC chiral analysis. Chiralpak AD columns have been utilized in the past to 
separate mixtures of fatty ester based enantiomers,35 and in the present 
investigation they were found to be useful in separation of aHETE and aHODE 
methyl ester enantiomers. A sample separation of 13(R)- and 13(S)-c,t-HODE on 
one of these columns is presented in Figure 6.11D, whereas Figure 6.11B shows 
that only one enantiomer (S) has been obtained in the soybean LOX catalyzed 
oxidations of aLA.   
The absolute configuration of the product can be assigned based on      
the observation that R enantioners always elute first during separation of 
hydroxy-fatty esters on Chiralpak AD columns.35 In order to confirm this 
assignment, exciton-coupled circular dichroism (ECCD) spectra of naphthoyl 
derivatives of the two 13-c,t-HODE ester enantiomers were obtained,           
Figure 6.11.36 The preparation of the naphthoyl ester is illustrated in Scheme 6.5. 
It has been empirically established that scanning from longer wavelengths 
towards shorter ones, if a maximum is followed by a minimum in the CD 
spectrum curve, S configuration is to be assigned to the chiral carbon present in 
proximity of two interacting chromophores, Figure 6.12.  
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Scheme 6.5. Preparation of an S-naphthoyl ester enantiomer for ECCD studies. 
 
If the minimum is followed by maximum in such curves, the relevant carbon 
atoms will have R configuration.36 An analogous analysis was carried out for aAA 
oxidation mixtures to conclude that 15(S)-HETE was the only aAA product 
formed in the presence of soybean LOX. 
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Figure 6.12. Electron coupled circular dichroism spectra of naphthoylated    
13(S)-HODE (solid line) and 13(R)-HODE (dotted line) methyl esters, obtained 
from chemical oxidation followed by chiral separation of 13-HODE methyl esters 
and further derivatization.  
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Once it was established that ω-alkynylated substrates underwent 
oxidations in the presence of the model lipooxygenase, interactions with other 
oxygenases became of interest. This research was focused on aAA since, unlike 
aLA, it was thought to be potentially a good substrate for both LOX and COX 
enzymes. These experiments involved both enzymatic kinetics and product 
identification studies. 
  COX activities were quantified by following oxygen consumption using    
a polarographic electrode with an oxygen monitor, and maximal reaction velocity 
data were obtained from the linear portion of the oxygen uptake curves.             
On the other hand, LOX activities were quantified by spectrophotometric (UV) 
monitoring of the formation of conjugated diene products and maximal reaction 
velocity data was obtained from the linear portion of the absorbance curves.37 
These kinetics experiments were conducted by Melissa Turman in the Marnett 
laboratories at Vanderbilt. The important kinetic parameters measured during 
bio-transformations of aAA in the presence of available LOX and COX enzymes 
are presented in Table 6.1.38 
The observed small differences in kcat/KM values suggest that aAA is 
nearly as good a substrate for cyclooxygenases as its native analogue.           
The catalytic efficiency of human platelet-type 12-LOX in the presence of aAA 
was also found similar to the efficiency observed for AA as a substrate.            
On the other hand, porcine leukocyte-type 12-LOX and rabbit reticulocyte        
15-LOX-1 did not oxidize aAA nearly as efficiently as AA, as illustrated by 
relatively large differences in νmax/KM values. Noticeably lower catalytic 
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efficiencies for these enzymes in the presence of aAA are due mainly to much 
lower νmax values observed in the presence of the modified substrate. It could be 
speculated that the ω-alkyne unit of aAA was responsible for partial inhibition of 
the enzymes, but confirmation of this proposal would required additional studies. 
 
Table 6.1. Enzymatic kinetic parameters obtained for aAA vs. AA substrate.38 
Enzyme kcat (s-1) νmax (μMs-1) KM (μM) kcat/KM 
(μM-1s-1) 
νmax/KM  
(s-1) 
oCOX-1 
57±6 
(51±3)  
n/a 
6.2±0.8 
(3.4±0.6) 
9±6 
(15±3) 
n/a 
hCOX-2 
11±1 
(14.7±0.5)39
n/a 
4.5±0.7 
(6.1±0.6)39
2±1 
(2.4)39 
n/a 
plt12-LOX n/a 
4.53±0.08 
(13.3±0.3)37 
7.0±0.3 
(9.5±0.7)37
n/a 
0.6±0.3 
(1.4±0.7)37 
lk12-LOX n/a 
1.37±0.09 
(13.1±0.7)37 
4±1 
(7.8±1.3)37
n/a 
0.3±1 
(2±1)37  
r15-LOX-1 n/a 
0.61±0.05 
(8.6±0.4)37 
7±2 
(20±3)37 
n/a 
0.09±2 
(0.4±3)37  
Numbers given in brackets are the relevant values previously reported for AA. 
Abbreviations: oCOX-1, ovine COX-1; hCOX-2, human COX-2; plt12-LOX, 
human platelet-type 12-LOX; lk12-LOX, porcine leukocyte-type 12-LOX;  
r15-LOX-1, rabbit reticulocyte 15-LOX-1. Conditions used to obtain the reported 
kinetic parameters are outlined in Experimental Section. 
 
Mixtures of products obtained from the enzymatic conversions of aAA 
were analyzed by RP-HPLC-MS2 in order to investigate selectivity of the bio-
catalyses. Oxidation mixtures obtained in the presence of COXs were analyzed 
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for aPGD2, aPGE2 and aHETEs, whereas the analysis of the mixtures obtained in 
the presence of LOXs focused on identification of aHETEs only. The COX 
oxidations of aAA were accompanied by side by side transformations of           
the native substrate performed under identical conditions. As expected, (a)PGE2 
and (a)PGD2 were the major products obtained in the presence of both COX-1 
and COX-2, and only traces of (a)HETEs were observed.40 In the absence of 
enzyme insignificant amounts of the products were formed.38 As shown in Figure 
6.13, the total amount of the (a)PGD2/E2 products obtained in the presence of 
COX-1 was larger then the amount of the products produced in the presence of 
COX-2. This was in agreement with the kinetic data presented in Table 6.1.  
Analysis of mixtures obtained in the presence of lipoxygenases confirmed 
that, as expected, 12-aHETE was the major product of transformations catalyzed 
by investigated 12-LOXs, whereas 15-HETE was the major product obtained in 
the presence of the 15-LOX used.37 Besides the fact that the observed aHETE 
products yielded expected daughter ions in MS2, their identities have been 
additionally confirmed by spiking the mixtures with previously isolated aHETEs 
(data not shown). 
The presented data suggests that aPUFAs are substrates for                 
the important COX and LOX oxidizing enzymes and this fact should not be 
forgotten during in vivo studies on alkynylated PUFAs or phospholipids. First of 
all, the enzymatic conversions of alkynylated substrates into precursors for 
reactive electrophiles may account for hypothetical background formation of  
lipid-protein adducts, in the absence of radical initiator. Furthermore, chiral 
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analysis of adducts that retain stereochemical information may lead to biased 
conclusions if stereospecific enzymatic conversions are not taken into account. 
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A 
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Figure 6.13. RP-HPLC-MS2 (SRM) monitored formation of prostaglandins D2/E2 
(A-C), 351->271m/z, or their alkynylated analogues (D-F), 347->267m/z,            
in the presence of ovine COX-1 (A and D), human COX-2 (B and E) and            
in the absence of an enzyme (C and F). Conditions for enzymatic transformation 
and LC separations are given in the Experimental Section.   
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Experimental 
General. Unless stated otherwise, all the chemicals were purchased from 
Sigma Aldrich. NMBHA has been prepared as previously described.12 AIPH and 
MeOAMVN were purchased from Wako Chemicals and used without further 
purification. Benzene (HPLC grade) was passed through column of neutral 
alumina and stored over molecular sieves. Commercial α-TOH has been 
chromatographed before use. Diazomethane was prepared by portion wise 
addition of nitrosomethylurea (500mg) into heterogeneous mixture of 40% 
aqueous KOH (1.25mL) and Et2O (5mL) at 0ºC.41 The deep yellow organic layer 
was decanted and dried over NaOH. The dried ethereal MeN2 was used 
immediately.   Phosphate-buffered Saline (PBS, pH 7.4, 50 mM) was prepared 
from NaCl (8.00 g), Na2HPO4 (5.00 g), NaH2PO4 (1.96 g) in deionized water (1.0 
L) followed by adjustment of the pH to 7.4 with 10M aqueous NaOH. Buffer 
solutions were stored over Chelex 100 resin (ca. 3 g / L) for 24 h, then the resin 
was removed by filtration and the filtrate was stored at 5ºC ( for no longer than a 
month). Ammonium Bicarbonate Buffer (pH 7.4, 100mM) has been prepared by 
dissolution of NaHCO3 (791mg) in deionized water (100mL) followed by 
adjustment of the pH to 7.4 with 5M aqueous HCl. The buffer solution was stored 
at 5ºC (for no longer than 2 weeks). Borate Buffer (pH 9.5, 100mM) was 
prepared by dissolving boric acid (1.24 g) in deionized water (200 mL) followed 
by adjustment of the pH to 9.5 with 5M aqueous NaOH. This buffer was stored at 
5ºC (for no longer than a month). HPLC-UV analyses were performed with 
Waters 600 Controller, 717 Autosampler and Waters 996 photodiode array 
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detector. All HPLC Analyses of (a)HETEs and (a)HODEs, as well as separations 
of  naphthoyl derivatived of conjugated dienols, were carried out on a single 
Beckman 5μm ultrasphere column (4.6mm x 25cm) using isocratic normal phase 
conditions (1.2% IPA in hexanes contining 0.1% AcOH). Chiral HPLC analyses of 
HETE and HODE methyl esters were performed on a single Chiralpak AD 
column (4.6mm x 25cm) produced by Chiral Technologies Inc., Exton, PA. 
aHETE products have been eluted with 2% EtOH in hexanes, whereas aHODEs 
were eluted with 5% MeOH in hexanes. DLI-MS experiments were performed on 
ThermoFinnigan TSQ Quantum triple quadrupole mass spectrometer, whereas 
all HPLC-MS analyses, except for TpepK adducts studies, were conducted on 
the same instrument coupled with a Surveyor MS Pump and Surveyor 
Autosampler (for RP-HPLC) or with Waters Alliance 2690 Separation Module 
(NP-HPLC). Analyses of TpepK adducts were conducted on ThermoFinnigam 
LTQ (3-D ion-trap instrument) coupled with Waters Aquity UPLC system. All RP-
LC analyses of aPUFA oxidation products and their adducts were performed on 
single Phenomenex 5μm Luna column (4.6mm x 25cm), except for identification 
of PGE2/D2 products that was performed using a 3μm Luna column (2.0mm x 
5cm). Detailed information about solvent gradients and MS settings applied 
during these analyses is given in the appropriate protocols presented below. 
Unless stated otherwise, all the HPLC separations were conducted with rate of 
1mL/min. ECCD experiments were conducted on an Aviv 215 Circular Dichroism 
spectrophotometer equipped with temperature controller. NMR spectra were 
recorded on Bruker Biospin instruments (500MHz, 600MHz or 800MHz 
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depending of availability) equipped with CryoProbes. Oxygen uptake 
measurements have been performed using polarographic electrode with YS5300 
oxygen monitor (Yellow Springs Instrument Co. Inc., Yellow Springs, OH). UV 
assays (used for enzymatic kinetics studies) were monitored using a Hewlett 
Packard 8453 diode array spectrophotometer equipped with a thermostatted 
cuvette, with possibility of stirring of the reaction vessel.   
 
MeOAMVN initiated oxidation of aLA. To a solution of aLA (4.5mg) in 
benzene (180μL) was added 1.8mg of MeOAMVN in benzene (20 μL), and the 
mixture was incubated at 37ºC. After 45min, solution of BHT and PPh3 in 
benzene (3.26μmol/32.6μmol, 20μL) was added, and the mixture was vortexed 
for 1min. Benzene was evaporated under a stream of argon, and  the residual 
material was reconstituted in 1.0mL of 1.2% IPA in hexanes (+0.1% AcOH), from 
which 50μL was used for a single UV-HPLC analysis. Side by side oxidations of 
LA were performed using analogous procedure as well. For DLI-MS studies of 
aHODEs, eluted peaks from a single 50μL injection were collected, and solvents 
were evaporated under a stream of argon, then the residues were reconstituted 
in MeOH. For NMR studies, corresponding peaks collected from three 100μL 
injections were combined, solvents were evaporated and the residues were dried 
under highvac for 2h. These dried materials were reconstituted in 150μL of 
benzene-d6 and placed into 1.7mm OD sample tubes. Spectra were collected for 
samples were chilled to 5ºC.  
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Thin film oxidations of aAA. Solutions of aAA (2.0mg) in benzene 
(200μL) containing of α-TOH (100μg), have been evaporated while the reaction 
vials (20mL) were rotated, to for thin lipid films. After these films were incubated 
at 37ºC for 20h, PPh3 solution in benzene (10μmol, 200μL) were added, and the 
mixtures were vortexed for 2min. Benzene was removed under a stream of argon 
and the remaining material was reconstituted in 200μL of 1.2% IPA in hexanes 
(+0.1% AcOH), from which 60μL was used for a single UV-HPLC analysis. Side 
by side oxidations of AA were performed using analogous procedure. 
 
Oxidations of aAA in the presence of NMBHA. To a mixture of aAA 
(1mg) and NMBHA (1mg) in MeCN (120μL) was added MeOAMVN (100μg.) in 
MeCN (40μL). After 35h of incubation at 37ºC, BHT/PPh3 in MeCN 
(1μmol/10μmol, 40μL) was added, and the mixture was vortexed for 2min. 
Acetonitrile was removed under a stream of argon and the remaining material 
was reconstituted in 0.5mL of 1.2% IPA in hexanes (+0.1% AcOH). For DLI-MS 
studies of aHODEs, eluted peaks from a single 50μL injection were collected, 
and solvents were evaporated under a stream of argon, then the residues were 
reconstituted in MeOH. For NMR studies, corresponding peaks collected from 
three 100μL injections were combined, solvents were evaporated and the 
residues were dried under highvac for 2h. These dried materials were 
reconstituted in 150μL of benzene-d6 and placed into 1.7mm OD sample tubes. 
Spectra were collected for samples were chilled to 5ºC.  
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Oxidations of aAA in the aqueous AIPH solution. To a solution of aAA 
(2mg) in benzene (40μL) was added MeOAMVN in benzene (20μL) and the 
mixture was incubated at 37ºC for 24h. Afterwards, solvent was evaporated, the 
residue was treated with mixture of BHT and P(OMe)3 in MeCN/H2O (1mmol/ 
10mmol, 150μL/50μL),  and vortexed for 5min and kept at -40ºC prior to analysis. 
Injections of 10μL were performed, and the following solvent gradient has been 
applied: 10% MeCN (+5% MeOH) in 2mM aq. NH4OAc (0-10min); 10-25% MeCN 
(+5% MeOH) in 2mM aq. NH4OAc (10-55min). ESI- was used, and the important 
mass spectrometer parameters were optimized for commercially available 
PGF2α. The following MS fragmentations were monitored during the analyses: 
349->115m/z (5-aF2IsoPs); 349->127m/z (8-aF2IsoPs); 349->151m/z (12-
aF2IsoPs); 349->193m/z (15-aF2IsoPs). Side by side oxidations of AA were 
performed using analogous reaction conditions, however slightly different 
analytical conditions were applied to analyze the AA oxidation products [Solvent 
gradient applied: 20% MeCN (+5% MeOH) in 2mM aq. NH4OAc (0-10min);      
20-40% MeCN (+5% MeOH) in 2mM aq. NH4OAc (10-50min). MS 
fragmentations monitored: 53->115m/z (5-F2IsoPs); 353->127m/z (8-F2IsoPs); 
353->151m/z (12-F2IsoPs); 353->193m/z (15-F2IsoPs). 
 
Adduction of aPUFAderived electrophiles to TpepK. Solutions of aLA 
(200μg) or aAA (200μg) in benzene (200μL) were condensed in the vials (20mL), 
which were rotated, in order to form thin lipid films. After incubation for 16h at 
37ºC, to these films was added TpepK (130μg) in ammonium bicarbonate pH 7.4 
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buffer (100μL).  The mixtures were vortexed for 5min, and stirred well for 4h at 
37ºC. Then 1M aqueous NaCNBH3 (5μL) was added to the mixtures, followed by 
addition of 1M aqueous HCl (5μL).  Mixtures were then stirred at rt. for additional 
2h. Afterwards, they were diluted with 10% MeCN in H2O (400μl) and stored        
at -40ºC until analyzed. Injections of 20μL were performed, and the following 
solvent gradient has been applied: 0-50% MeCN in H2O (0-25min); 50-100% 
MeCN in H2O (25-35min); 100% MeCN in H2O (35-50min); both solvents 
contained 0.1% AcOH. ESI+ mode was used, and the important mass 
spectrometer parameters were optimized for TpepK. Data dependent MS2 as well 
as MS2 for number of selected ions, which were expected to be found in the 
mixtures, have been performed. The above protocol was also applied to LA and 
AA, side by side with their alkynylated analogues. 
 
Adduction of aAA derived cyclopentenone aIsoPs to GSH. To a 
solution of aAA (5mg) in EtOH (100μL) was added AIPH (3mg) in PBS pH 7.4 
(4.9mL), and the mixture was incubated at 37ºC. After 5h, a solution of P(OMe)3 
in water (30μmol, 100μL) was added, and the mixture was vortexed for 2min. 
The solution was acidified to ca. pH 3 with 0.1M aqueous HCl, and the 
compounds of interest were extracted with AcOEt (2 x 2mL).   Organic solvents 
were combined and evaporated under a stream of argon. The residual material 
was reconstituted in 0.1M aqueous HCl (5mL) and the mixture was stirred at 
37ºC. After 14h, 10x PBS pH 7.4 (2mL) was added to the mixture, and the pH 
was brought to 6.5 with 1M aqueous NaOH, followed by an addition of GSH 
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(4mg) and human placenta GST (250μg of 25-125U/mg) in water (300μL). The 
mixture was stirred for 2h at 37ºC, centrifuged at 3500rpm for 15min using 
Amicon Ultracell 10kD tube, and the filtrate was condensed to ca. 1mL. The 
condensed mixture was placed on a solid phase extraction cartridge (360mg 
Sep-Pak Plus C18), washed with 20mL of water (+1% AcOH), and eluted with 
6mL of MeCN (+1% AcOH). Acetonitrile was evaporated, and the residue was 
reconstituted in 100μL of 20% MeCN in water (+0.1% AcOH). Injections of 10μL 
were performed, and the following solvent gradient has been applied: 0-50% 
MeCN in H2O (0-15min); both solvent contained 0.1% AcOH. ESI+ mode was 
used, and the important mass spectrometer parameters were set as previously 
reported for analysis of analogous non-alkynylated adducts. Full MS2 (250-
700m/z) as well as SRM experiments (638->308m/z and  638->313m/z) were 
conducted. Side by side modifications to AA were performed using analogous 
conditions, however slightly different MS transitions were monitored to analyze 
the AA derived GSH adducts (642->308m/z and 642->317m/z).  
 
Adduction of aAA derived aIsoKs to ovalbumin. A detailed procedure 
by Dr S. Davies will be published elsewhere. 
 
Oxidation of aPUFAs in the presence of soybean LOX. To a solution 
aLA (1mg in 100μL EtOH) or AA (1mg in 100μL EtOH) in borate buffer pH 9.5 
(4mL) was added soybean LOX-1 (0.25mg, 20000U) in the buffer (1mL) and the 
mixture was vigorously stirred (while bubbling O2 into it) at ca. 0ºC. After 30min 
(or 5min, for uncompleted reaction), to the mixture were added 1M HCl (300μL) 
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and brine (1mL), and the products were extracted with DCM containing 10μmol 
PPh3 (2 x 2mL). Organic layers were combined, and solvent was evaporated 
under a stream of argon. The residue was reconstituted in 0.5mL of 1.2% IPA in 
hexanes (+0.1% AcOH). For Chiral analysis, peaks eluted from three 100μL 
injection were collected, solvent was evaporated and the residue was treated 
with an excess of freshly prepared CH2N2 in Et2O. Solvent was evaporated, and 
the residue was reconstituted in 120μL of 5% MeOH in hexanes (if started from 
aLA) or 2% EtOH in hexanes (if started from aAA), from which 15μL was injected 
for a single HPLC-UV analysis. For further transformations, peaks eluted from 
90μL injections were collected, and solvents were evaporated. The residue was 
reconstituted in dry MeCN (50μL) containing 2% DBU, and few crystals of 2-
naphthoyltriazole were added to that mixture followed by vortex mixing (2min). 
After 16h of incubation at rt, solvent was evaporated, the residue was 
reconstituted in 2mL of DCM, and the solution was washed with water (3 x 1mL). 
Organic layer was dried with Na2CO3, and condensed under a stream of argon.  
The residue was dissolved in 100μL of 0.2% IPA in hexanes (+0.1% AcOH). 
Peaks from 95μL injections were collected, solvents were evaporated and the 
residues were reconstituted in dry MeCN for ECCD analysis. Chiral analysis of 
products formed during chemical oxidations of aLA and aAA were performed on 
similar basis.  
 
Oxidation of aAA in the presence of animal LOX enzymes. The 
enzyme reactions included reaction buffer [50mM Tris-HCl (pH 7.4) with 0.03% 
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Tween-20] and substrate, and were initiated by the addition of enzyme 
(approximately 50U). Compounds were dissolved in acetonitrile (ACN) containing 
10 % acetic acid before addition to the reaction buffer; ACN was kept below 1% 
reaction volume (2ml). For kinetic experiments, substrate concentration was 
varied (1-50µM), and maximal reaction velocity data were obtained from the 
linear portion of the absorbance curves. Rates were converted from absorbance 
units/s to µM HETE/s using a absorption coefficients reported in the literature. 
Similar studies were conducted in order to obtain kinetic parameters in the 
presence of AA. For the product analyses, to the most concentrated samples 
was added Na2S2O3 and the products of interest were extracted with Et2O. 
Solvent was evaporated and the residue was reconstituted in 200μL of 1.2% IPA 
in hexanes containing 0.1% AcOH.38  
To characterize (a)HETEs formed in enzymatic reactions, injections of 
20μL of product mixtures were performed, and an isocratic elution with 1.2% IPA 
in hexanes (+0.1% AcOH) was applied. Analysis was conducted in APCI- mode, 
and the important mass spectrometer parameters were optimized for 
commercially available 12-HETE. Full MS2 (100-400m/z) as well as SRM 
experiments [315->115m/z (5-aHETE), 315->155m/z (8-aHETE), 315->139m/z 
(9-aHETE), 315->167m/z (11-aHETE), 315->179m/z (12-aHETE), 315->219m/z 
(15-aHETE)] were conducted.  
 
Oxidation of aAA in the presence of COX enzymes. Substrates were 
solubilized in dimethyl sulfoxide (DMSO). Activity assays were performed in 
100mM Tris-HCl buffer containing 500 µM phenol, with hematin-reconstituted 
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protein [oCOX-1 (50nM), hCOX-2 (100nM)]. For kinetic experiments, substrate 
concentration was varied (1-50µM), and maximal reaction velocity data were 
obtained from the linear portion of the oxygen uptake curves. For the product 
analyses, to the most concentrated samples was added Na2S2O3 and the 
products of interest were extracted with Et2O. Solvent was evaporated and the 
residue was reconstituted in 200μL of 20%MeCN in water containing 0.1% AcOH 
(for aPGD2/E2 analysis) or in 200μL of 1.2% IPA in hexanes containing 0.1% 
AcOH (for aHETEs analysis).38 
 For the analysis of prostaglandins, injections of 10μL were performed, 
and the following solvent gradient has been applied: 20% MeCN in water (0-
1min); 20->35% MeCN in water (1-6min); aqueous phase contained NH4OAc 
(5mmo/L), and MeCN contained 5% of the aqueous phase; HPLC column was 
heated to 40ºC during separation and low flow rate of 300μL/min was applied. 
Analysis was conducted in ESI- mode, and the important mass spectrometer 
parameters were optimized for commercially available PGF2α. Full MS2 (200-
800m/z) as well as SRM experiments (347->267m/z) were conducted. For 
analysis of products derived from AA, different HPLC solvent gradient was 
applied: 30% MeCN in water (0-1min); 30->45% MeCN in water (1-3.25min); 
aqueous phase contained NH4OAc (5mmol/L), and MeCN contained 5% of the 
aqueous phase; HPLC column was heated to 40ºC during separation and low 
flow rate of 300μL/min was applied. Also, different MS fragmentation was 
monitored, in case of AA derivatives: (351->271m/z). For the analysis of 
aHETEs, injections of 20μL were performed, and an isocratic elution with 1.2% 
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IPA in hexanes (+0.1% AcOH) was applied. Analysis was conducted in APCI- 
mode, and the important mass spectrometer parameters were optimized for 
commercially available 12-HETE. Full MS2 (100-400m/z) as well as SRM 
experiments [315->115m/z (5-aHETE), 315->155m/z (8-aHETE), 315->139m/z 
(9-aHETE), 315->167m/z (11-aHETE), 315->179m/z (12-aHETE), 315->219m/z 
(15-aHETE)] were conducted. For analysis of products derived from AA, different 
MS fragmentations were monitored [319->115m/z (5-aHETE), 319->155m/z (8-
aHETE), 319->139m/z (9-aHETE), 319->167m/z (11-aHETE), 319->179m/z (12-
aHETE), 319->219m/z (15-aHETE)]. 
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Research Summary (Part Two) 
Covalent modifications of proteins may severely alter their critical 
functions in vivo. A number of studies have suggested that formation of covalent 
adducts between reactive electrophiles formed in the course of free radical 
oxidation of phospholipids and the nucleophilic sites of peptides and proteins.      
A novel tool has been developed to provide information about the sites of 
electrophile adduction as well as the nature of the protein-lipid adducts.             
An important part of this strategy is the modification of the ω-position of fatty 
acids and phospholipids with an alkynyl moiety.  This structural modification is 
considered to be a minimal perturbation of the natural substrates but it will 
potentially allow for an easy separation of the alkynylated peptide adducts from 
complex protein mixtures.  
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The designed isolation method is based on a coupling of protein adducts derived 
from alkynylated phospholipids to an azido-biotin compound via triazole forming 
click chemistry, and subsequent purification of the adducts of interest by avidin 
affinity chromatography followed by their release. Such isolated species may be 
analyzed utilizing tandem MS techniques. The strategy is presented in the above 
scheme. 
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Chapters IV-VI of this thesis summarized the part of the project that 
focused on syntheses and properties of ω-modified polyunsaturated fatty acids 
(aPUFAs), precursors for modified phospholipids that have been designed to act 
as novel probes for investigation of interactions between membrane 
phospholipids and systemic proteins.   
    ω-Alkynylated linoleic (aLA) and arachidonic (aAA) acids have been 
prepared utilizing simple organic reactions as shown in the scheme below.       
The synthetic strategy applied is relatively general and could be utilized to 
prepare other ω-alkynylated PUFAs. Alternative strategies were also tested but 
were found to be less efficient.  
The terminally modified fatty acids (aLA and aAA) were oxidized in thin 
films and in solutions, in the presence of radical initiators. The analysis of acyclic 
hydroperoxides formed as primary oxidation products in these reactions, 
revealed that oxidations of the unnatural fatty acids parallel those of native 
linoleic (LA) and arachidonic (AA) acids. It is known that these hydroperoxides, 
HPETEs and HPODEs, formed from AA and LA, respectively, may be 
decomposed to yield reactive electrophiles, that react with proteins and peptides. 
We then inquired if the ω-alkynylated versions of these compounds (aHODEs 
and aHETEs) undergo similar decomposition processes. Some preliminary 
evidence was found that aHNE, an alkynylated analogue of highly cytotoxic       
9-hydroxynonenal (HNE), was produced upon prolonged oxidation of both aLA 
and aAA. Its formation was confirmed via tandem ESI-MS by the identification of 
an aHNE adduct to a lysine-containing model peptide (AcAVAGKAGAR).             
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It was found that aHNE adducted to the peptide in both a 1,2- (imine) as well as   
a 1,4-(Michael) fashion, and the amount of the adducts formed was comparable 
to the amount of adducts obtained in the presence of  HNE.   
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Reagents and Conditions: (a) Im2CO, CH2Cl2, rt., 40min,; (b) H2O2, Et2O, 0°C      
-> rt., 12h;  (c) Im2CO, CH2Cl2, 0°C, 3h; (d)  MeOH, rt, 1h, 53% (for a-b-c-d); (e) 
HClO4, THF, H2O, 5°C, 12h, 75%. (f) NaIO4, H2O, THF, 0°C, 1h; (g) NaBH4, 
MeOH, rt, 30min, 73% (for f-g); (h) I2, PPh3, Im, Et2O, MeCN,  0°C -> rt, 2h; (i) 
LiOH, H2O, THF, 5°C, 12h; (j) PPh3, MeCN, PhMe, reflux, 72h, 46% (for h-i-j); (k) 
i. LiNH(TMS)2, HMPA, THF, -78°C, 40min; ii. 5-hexynal, THF, -78 -> rt., 2h, 54%; 
(l) m-CPBA, CH2Cl2; 5°C, 6h. 
 
Additional types of reactive electrophiles are obtained via formation of 
cyclic PUFA-hydroperoxides and their subsequent decomposition. Upon 
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extended oxidation of aAA, production of cyclic peroxides was detected. 
Furthermore, the relative isomeric distribution as well as total amount of cyclic 
products was similar to the respective to the product set obtained upon oxidation 
of AA under the same conditions. Formation of cyclopentenone isoprostanes 
from aAA was confirmed in tandem ESI-MS studies by the identification of          
a Michael adduct of these compounds to a cysteine-containing peptide. It was 
reported previously that such electrophiles formed from AA reacted readily with 
glutathione (GSH) in the presence of glutathione transferase (GST) to form      
1,4-type adducts. Formation of alkynylated analogues of these adducts was 
observed upon extended oxidation of aAA followed by dehydration and 
incubation with GSH in the presence of GHT. Identical conditions were applied to 
AA to show that indeed, similar yields of the comparable adducts were obtained 
from the terminally modified and native fatty acids. Additionally, evidence for 
oxidative conversion of aAA into extremely reactive alkynylated isoketal species 
in vivo was obtained in collaborative studies with Sean Davies of Vanderbilt 
University. 
Since the general strategy for investigation of protein-lipid or peptide-lipid 
interactions is going to be eventually applied for cellular studies, transformations 
of aPUFAs by several oxygenase enzymes, for which native fatty acids are 
substrates, were also studied. Upon incubation of aLA and aAA with various 
dioxygenase enzymes, oxidative transformations have been explored.             
For instance, soybean lipoxygenase-1 transformed aLA into 13(S)-c,t-HPODE 
and aAA into 15(S)-HPETE, in agreement to regio- and stereoselectivity 
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observed during oxidations of native PUFAs. Additionally, a number of 
mammalian cyclooxygenases were shown to actively convert aAA to cyclic 
endoperoxide products analogous to those obtained from native AA. 
Furthermore, rates of the enzymatic transformations of aPUFA were found to be 
similar to the respective rates for transformation of unmodified fatty acids.        
The latter results were obtained in collaborative studies with Melissa Turman of 
Vanderbilt University. 
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